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Abstract 
 
This dissertation primarily describes studies of serotonin type 3 (5-HT3) receptors 
of the Cys-loop super-family of ligand gated ion channels. The first chapter provides a 
general introduction to these important proteins and the methods used to interrogate their 
structure and function. The second chapter details the delineation of a structural unit of 
the ligand binding site of homomeric 5-HT3A receptors on which the ligands serotonin 
(5-HT) and m-chlorophenyl biguanide (mCPBG) are reliant for effective receptor 
activation. Unnatural amino acid mutagenesis results show that the details of each 
ligand’s interaction with this organizing feature of the binding site differ, providing 
insights into general principles of receptor activation.  
The third chapter describes a study in which florescent protein fusions of the A 
and B subunits of the heteromeric 5-HT3AB receptor are employed to determine the 
subunit stoichiometry and order within functional receptors. Strong evidence is found for 
an A3B2 stoichiometry with A-A-B-A-B order. The fourth chapter investigates the 
potential for ligand binding across heteromeric binding sites in the 5-HT3AB receptor. 
Unlike serotonin, mCPBG is found to bind the receptor at heteromeric binding sites. 
Further mCPBG is capable of allosterically modulating the response of serotonin on the 
5-HT3AB receptor from these heteromeric sites.  
Finally, the fifth chapter describes progress towards the application of unnatural 
amino acid mutagenesis to an important new class of proteins, transcription factors. 
Experiments optimizing novel methods for the detection of function are described, using 
RARα of the nuclear receptor family of transcription factors.  
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Chapter 1 
 
Introduction 
 
1.1 Synaptic Transmission 
The brain is the most complex structure on earth (1). It is principally a highly 
inter-connected web of specialized cells called neurons. These cells feature extended 
processes that reach out to form connections with other neurons termed synapses. 
Sensation, consciousness, and all the other marvelous functions that brains perform arise 
from the patterns of activation that travel along this neural web. Within a neuron, 
activation is coded as an electrical current that travels the length of the cell. This current 
is propagated by voltage-gated ion channels. Upon sensing a sufficient change in 
membrane potential, these proteins change shape to allow ion passage across the plasma 
membrane. The ion flux depolarizes adjacent regions of the membrane, thereby activating 
further voltage-gated ion channels nearby and forming the leading edge of a wave of 
current called an action potential.   
This current is incapable of crossing the synapse and bridging cells. To solve this 
impasse, the activating electrical signal is converted to a chemical signal (Figure 1). 
When the action potential reaches the end of neural processes called axons, membrane 
vesicles are stimulated to fuse with the plasma membrane. Upon fusion, the vesicles 
dump their contents into the cleft between the two neurons of the synapse. The vesicle 
cargo is a class of small molecules called neurotransmitters. These neurotransmitters 
diffuse across the synaptic cleft and bind to protein receptors on the process of the 
2 
receiving neuron, referred to as a dendrite. This binding leads to ion flux that, depending 
on the identity and concentration of the neurotransmitters and receptors present, 
depolarizes the dendrite such that voltage-gated ion channels there are activated. This 
activation restarts the action potential in the receiving neuron where it rushes toward the 
cell body and its own axons, where the process will repeat.  
Figure 1.1 Synaptic transmission. (left) Two neurons forming a synapse. (right) 
Expansion of the synapse; axon at top and dendrite below; blue dots are 
neurotransmitters.  
 
1.2 Cys-loop Receptors 
There are two classes of protein receptors in the brain. The first class is G protein 
coupled receptors, or GPCRs. Neurotransmitter binding by these transmembrane proteins 
releases the G protein from the receptor, which then activates downstream intracellular 
3 
signaling cascades that indirectly modulate the membrane potential. The second class of 
protein receptors in the brain is ligand-gated ion channels. Ligand-gated ion channels 
may be classified by their oligomeric state: trimeric ATP-gated P2X receptors, tetrameric 
ionotropic glutamate receptors, and pentameric Cys-loop receptors. Like the voltage-
gated ion channels, these proteins open a pore in the membrane, allowing ion flux that 
directly alters the membrane potential.  
Cys-loop receptors are a broad family of ligand-gated ion channels that 
encompasses nicotinic acetylcholine, glycine, GABAA, and serotonin type 3 receptors. 
Cys-loop receptor function has been implicated in numerous essential cognitive processes 
and their disfuction has been found to underlie many neurological disorders (2-4). Given 
this, they are active pharmaceutical targets.  
 
Figure 1.2 Cys-loop receptor structure. (A) Schematic of cys-loop receptor domain 
architecture. (B) Top-down view of Cys-loop receptor showing M2 α-helix lining the 
central pore.  
 
!" #"
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Each of the five Cys-loop receptor subunits that form a functional receptor 
contains a large extracellular domain, four transmembrane helices, and an intracellular 
loop of variable length that bridges the third and fourth transmembrane helices 
(Figure 2A) (5). These subunits arrange semi-symmetrically around a central pore. Lining 
that pore is the second transmembrane helix (Figure 2B). The side chains of the residues 
on this helix occlude the channel pore in the resting state of the receptor.  
Ligand binding occurs at the interface of the extracellular domains of adjacent 
subunits. The binding site is composed of six loops, three on the principal subunit (A-C), 
and three on the complementary subunit (D-F) (Figure 3A). On these six loops, five 
highly conserved aromatic residues have been identified: a tyrosine on loop A (TyrA), a 
tryptophan on loop B (TrpB), two tyrosines on loop C (TyrC1 and TyrC2), and a 
tryptophan on loop D (TrpD); these are collectively referred to as the “aromatic box” 
(Figure 3B). The location of the binding site is nearly 60Å from the occlusion of the 
channel pore. Thus, a broad conformational change must occur to link neurotransmitter 
binding with channel opening.  
Each category of Cys-loop receptor listed above is itself a diverse family of 
receptors. In nicotinic acetylcholine receptors (nAChRs) for instance, there are 17 subunit 
types that are expressed in the brain (6). These different subunit types are able to co-
assemble, creating even more potential unique heteromeric receptors. As ligand binding 
spans adjacent subunits, this diversity of receptor subunit composition affords the 
potential for markedly different responses to the same neurotransmitter. In fact, subtle 
sequence differences between the muscle and neuronal nAChRs have been shown to 
explain why cigarette smoking does not result in body-wide muscle contraction (7).  
5 
 
Figure 1.3 The Cys-loop receptor ligand-binding site. (A) Conserved loops of the 
binding site. (B) Conserved aromatic residues of the binding site. Adapted from (12). 
 
In addition to the complexity generated by diversity in receptor composition, there 
is also the potential for variation in receptor subunit stoichiometry. Again, using nAChRs 
as our guide, the α4β2 subtype exists in both A(3)B(2) and A(2)B(3) stoichiometries. 
This subtle difference affords the receptors different sensitivities to neurotransmitter and 
different roles in the molecular pathology of addiction (8, 9).  
Knowledge of Cys-loop receptors has been greatly advanced by the efforts of 
structural biologists (10). The first relevant structural information came from x-ray 
crystal structures of acetylcholine binding proteins (AChBP) (Figure 4A). These soluble 
proteins found in snails share homology with the extracellular domains of Cys-loop 
receptors, and structures bound with numerous ligands have been crystallized (11). These 
!"
#"
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structures have provided much insight into possible ligand binding interactions, but 
subsequent functional data have, unsurprisingly given their evolutionary distance and 
functional divergence, shown them to be imperfect models of the full-length human 
membrane receptors (12).  
Figure 1.4 High resolution structures of relevance to Cys-loop receptors. (A) 
Acetylcholine binding protein crystal structure. PDB: IUW6. (B) Torpedo nAChR cryo-
EM structure. PDB: 2BG9. (C) GluCl receptor crystal structure. PDB: 3RHW.  
 
A cryo-electron microscopy structure of the nAChR from the Torpedo ray 
provided the first structural information on a full-length Cys-loop receptor (Figure 4B) 
(13). Unfortunately, the poor resolution of the structure limits its use to the demonstration 
of global receptor topology. More recently, the high resolution crystal structure of a full-
length Cys-loop receptor found in C. Elegans was solved (Figure 4C). Glu-Cl is a 
glutamate binding receptor with a chloride selective pore (14). It shows similar global 
topology to the cryo-EM nAChR structure and for the first time reveals ligand-binding 
interactions in a Cys-loop receptor. It is difficult however to extrapolate from this one 
out!
in! !"!#$%&"' in! !"!#$%&"'
out!
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snapshot to the many human Cys-loop receptors and the motions on which their functions 
depend.  
 
1.3 Methods for Perturbing Receptor Function 
1.3.1 Conventional Mutagenesis 
The time-honored method for gaining insight into the relation of a protein’s 
structure to that protein’s function is to analyze the many ways in which one can break 
that relation. This can involve something as simple as heating the sample until the protein 
falls apart or as complicated as screening hundreds of thousands of potentially interfering 
small molecules.  
A method that strikes a balance of technical ease and atomic level feedback is 
mutagenesis. Advances in the last twenty years have made it trivial to site-specifically 
change the coding sequence in the gene of a protein for in vitro or heterologous 
expression. By exchanging one codon for another, any amino acid can be swapped for 
one of its 19 conventional cousins. This has been extremely useful in determining sites 
crucial for protein function and for gaining some insight into what properties might be 
required at that site. The natural array of amino acids contains both hydrophobic and 
hydrophilic, bulky and diminutive, as well as positively, negatively, and non-charged side 
chains that allow for the importance of many features of a site of interest to be probed.  
1.3.2 Unnatural Amino Acid Mutagenesis 
Obviously, a repertoire of twenty amino acids cannot adequately cover chemical 
space, so many mutations actually change multiple features of the natural residue. This is 
highlighted by the case of the amino acid tryptophan. It has a large side chain capable of 
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forming extensive van der Waals contacts and filling a steric niche, an indole nitrogen 
capable of forming hydrogen bonds, and a conjugated aromatic system capable of 
forming interactions with other aromatic side chains or positive charges. The most subtle 
conventional alternative is to mutate to phenylalanine, which retains aromaticity, but this 
mutation both eliminates hydrogen bonding, changes steric bulk, and slightly weakens 
aromatic interactions. This ambiguity makes it difficult to confidently assign specific 
interactions of functional importance.  
Synthetic methods allow for the chemical preparation of a vastly larger array of 
amino acids than those provided by nature. Referring again to the case of tryptophan, one 
can imagine substituting naphthyl-alanine to eliminate hydrogen bonding while retaining 
strong aromaticity and steric bulk. Or one could substitute tryptophan analogues featuring 
sequential fluorination of the indole that additively deplete the aromatic system of π-
electron density, thereby selectively weakening aromatic interactions while leaving 
hydrogen bonding and steric contacts intact (15).  
 The challenge has long been not the synthesis of these molecules but their 
successful incorporation into proteins within a biological system. The critical 
consideration for a successful method is orthogonality (16). This is the concept that the 
unnatural amino acid incorporation should function alongside but completely 
independently of the existing machinery for conventional amino acids. In practice this 
requires that the unnatural amino acid should be charged only to a tRNA unique to it and 
that the unique tRNA should recognize an mRNA codon that is incompatible with all 
endogenous tRNAs. Additionally, the unnatural aminoacyl tRNA should then be an 
acceptable substrate for the ribosome.  
9 
 To accomplish this, tRNAs from various bacteria and archea have been identified 
and further engineered to be unrecognizable to eukaryotic amino acyl synthetases that 
append conventional amino acids to their tRNAs (17, 18). To charge the engineered 
tRNA several groups have evolved new aminoacyl synthetases that selectively recognize 
the unnatural amino acid (19). Unfortunately this tactic requires the creation of nearly as 
many synthetases as unnatural amino acids, and also requires that the unnatural amino 
acids be sufficiently different from any natural analogue in order to generate acceptable 
specificity. These requirements create an experimental bottleneck and preclude the use of 
many subtly different unnatural amino acids of potential utility.  
 An alternative pursued here is to chemically append the desired unnatural amino 
acid directly to its tRNA (20). This occurs in two key steps (Figure 5). The unnatural 
amino acid is reacted with a DNA-RNA hybrid dinucleotide, dCA, to ensure its 
installation at a translationally competent hydroxyl on the terminal nucleotide. The amino 
acyl dCA is then enzymatically ligated to a 74mer RNA that has been in vitro transcribed, 
generating the full-length tRNA. This approach results in the creation of a stoichiometric 
reagent however, as the tRNA cannot be recharged with the unnatural amino acid in the 
cell, unlike its endogenous counterparts. This results in significantly lower expression of 
the unnatural amino acid containing protein.  
10 
Figure 1.5 Direct chemical amino acylation of tRNA. (A) Reaction of protected amino 
acid with DNA/RNA hybrid dinucleotide dCA. (B) Enzymatic ligation of amino acyl 
dCA to in vitro transcribed 74mer to form full length amino acyl tRNA. 
  
The next challenge is to install the amino acid site selectively. To accomplish this, 
nonsense suppression methodology is utilized (Figure 6) (20). This involves the 
repurposing of one of the three stop or nonsense codons, typically TAG. Normally upon 
reaching a stop codon, the ribosome stalls until a release factor protein liberates the 
amino acyl chain from the tRNA on the penultimate codon. If the unnatural amino acid-
bearing, engineered tRNA is given an anticodon that pairs with the stop codon however, 
it will suppress the nonsense codon and the unnatural amino acid will be added to the 
growing amino acyl chain. This process will occur in competition with the endogenous 
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release factor though, further lowering expected yields of the unnatural amino acid 
containing protein.  
Figure 1.6 Nonsense suppression methodology.  
  
The final challenge is ensuring the amino acid itself is capable of successfully 
passing through the ribosome and being added to the growing amino acyl chain. 
Thankfully, the ribosome is relatively blind to the properties of the amino acid and places 
limits only on especially bulky side chains. Using this methodology, a vast collection of 
unnatural amino acids have been successfully incorporated (Figure 7).  
12 
Figure 1.7 Unnatural amino acids successfully incorporated into proteins by direct 
chemical acylation of tRNA via nonsense suppression metholodology in X. laevis 
oocytes. 
 
1.4 Methods for Detecting Functional Perturbations 
1.4.1 Electrophysiology 
 As unnatural amino acid mutagenesis is an inefficient process, highly sensitive 
assays for assessing function are necessary. Thankfully, ligand-gated ion channels, by 
nature of their ability to generate electrical current in their activated state, afford just such 
an assay. Electrophysiology is an extremely sensitive and well-developed method that 
detects changes in electrical current. The version of electrophysiology employed here is 
two-electrode, voltage-clamped, whole cell electrophysiology.   
13 
 In this method, reagents (mRNA only for conventional mutations, and both 
mRNA and aminoacyl tRNA for unnatural amino acid mutations) are micro-injected into 
Xenopus laevis oocytes (Figure 8A). Oocytes are a well precedented heterologous 
expression system for ion channels, in part because they are quite large (~1mm in 
diameter), allowing for easy delivery of reagents and easy access to the cytoplasm by 
penetrating electrodes (21).  
Figure 1.8 Heterologous expression in X. laevis oocytes for unnatural amino acid 
mutagenesis. (A) Microinjection of engineered amino acyl tRNA and stop codon 
containing mRNA into the oocyte. (B) Expression of protein containing mutation of 
interest and assaying of function by electrophysiology. 
  
After sufficient time for the oocyte to translate, process, and assemble the receptor 
on the plasma membrane (usually 24–72 hours), the oocytes are impaled with two 
electrodes (Figure 8B). These are used to hold or clamp the cell at a specific voltage 
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compared to an external reference electrode. When activating ligands, called agonists, are 
applied to the cell, ions flow through the open pores of the activated receptors and a 
change in current necessary to maintain constant voltage is detected.  
 As higher concentrations of agonist are applied, a greater percentage of the total 
receptors on the oocyte is activated (Figure 9A). This results in increasing amounts of 
current until the receptors reach a saturating concentration at which maximal channel 
opening is achieved. From these data, a dose-response relationship can be plotted 
(Figure 9B). By fitting this relationship to the Hill equation, several important properties 
of the receptor can be obtained.  
The EC50 is the concentration 
of agonist at which half maximal 
receptor activation occurs. Mutations 
that disrupt the ability of the receptor 
to activate result in a reduced 
sensitivity to the agonist. Thus, a loss 
of function mutation results in an 
increase in EC50 (Figure 9B). 
Conversely, mutations that improve 
channel function result in a decrease in 
EC50. The Hill equation also provides a 
Hill coefficient that is a measure of receptor cooperativity. This measure provides some 
insight into the number of ligand binding sites required for efficient receptor activation.  
!"
#"
Figure 1.9 Agonist dose-response curves. 
(A) Increasing current in response to 
increasing concentrations of agonist observed 
by electrophysiology. (B) Dose-response plot 
fit to the Hill equation showing the effect of 
gain and loss of function mutations.  
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 Cys-loop receptors are often capable of being activated by many ligands.  
However, not all of these ligands are equally capable of triggering the conformational 
change that links ligand binding with channel opening. Thus, two agonists, each at its 
saturating concentration or Imax, acting on the same number of receptors, may result in 
different absolute changes in current (Figure 10). 
This difference is reflected in the relative 
efficacy (Rmax or ε). This measure is a ratio of 
the maximal currents elicited by an agonist with 
respect to that of the endogenous agonist. 
Ligands that produce roughly the same current 
are called full agonists, those that produce less 
are partial agonists, and those that produce more 
are super agonists.  
 It is also possible to study ligands that deactivate ion channels, or antagonists. As 
electrophysiology is only sensitive to the open state, antagonist activity is measured in the 
presence of agonists. Increasing amounts of antagonist are added to a constant amount of 
agonist and current drops from the stable initial level observed in the absence of 
antagonist down to levels indistinguishable from baseline noise (Figure 11A). A dose-
response relationship from this experiment can also be plotted and fit to the Hill equation, 
yielding a measure called the IC50 (Figure 11B). This corresponds to the concentration of 
antagonist that produces half maximal receptor deactivation. As with the EC50, mutations 
that change the IC50 reflect changes in the sensitivity of the receptor to the ligand.   
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Figure 1.10 Electrophysiology 
traces showing maximal currents 
for the endogenous agonist 
serotonin and and the partial 
agonist mCPBG at the 5-HT3A 
receptor.  
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Figure 1.11 Antagonist dose-response curves. (A) Electrophysiology traces showing 
decreasing response to constant agonist as increasing antagonist is applied. (B) Dose-
response plot fit to the Hill equation.  
 
1.4.2 Fluorescence Microscopy 
 The discovery and optimization of genetically-encodable fluorescent proteins that 
are modular, cover a wide spectral range, and require no cofactor has transformed the 
study of molecular biology in the past twenty years. Fusions of fluorescent proteins and 
proteins of interest have allowed not only for the study of protein expression and sub-
cellular localization, but also of dynamic changes in protein conformation and oligomeric 
state.  
These latter findings are made possible by the study of Förster’s resonance energy 
transfer or FRET. FRET is the process by which a fluorophore, when excited, may 
undergo energy transfer to the excited state of another fluorophore from which it may 
fluoresce as it relaxes to the ground state. This process requires spectral overlap between 
!"
#"
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the emission profile of the donor fluorophore and the excitation profile of the acceptor 
fluorophore and is highly dependent on the distance between the two fluorophores, with a 
! 
1 r6  dependence. Thus FRET efficiency has been widely used as a molecular ruler.  
While there are several methods for determining FRET efficiency, the method 
used here is called donor recovery after acceptor photobleaching, or DRAP. This method 
relies on the ability of destroy a fluorophore by exposing it to high intensity light at its 
excitatory wavelengths, and on the insight that every photon that undergoes FRET and 
emits from the acceptor is a photon that does not emit from the donor. Thus, on the 
population level, one can compare the donor fluorescence emission levels before and 
after destroying all the acceptors, and donors that undergo FRET more efficiently will 
show a greater photobleaching dependent increase in donor fluorescent emission.  
This approach has many drawbacks. Fluorescent proteins are often quite large 
compared to the motions one wishes to observe, complicating or precluding their 
application to many interesting experimental questions (22). The DRAP method is also 
by its nature an ensemble methodology and incompatible with time-resolved systems. 
Thus the above methodology is best suited for studying relatively gross and static 
characteristics of proteins, such as stoichiometry.  
 
1.5 Summary of Dissertation Work 
 This dissertation describes studies on the structure of serotonin type 3 (5-HT3) 
receptors and how two agonists, serotonin (5-HT) and m-chlorophenyl biguanide 
(mCPBG), act on that structure. It also details efforts to expand the application of 
unnatural amino acid mutagenesis to a family of proteins called transcription factors.  
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 Chapter 2 describes a study seeking to identify differences in the sensitivity of 
5-HT and mCPBG to binding site organization. Through conventional and unnatural 
amino acid mutagenesis, we identify a structural element of the 5-HT3A binding site that 
orients critical side chains for binding interactions with serotonin. We find that mCPBG 
behaves differently than 5-HT and, unlike 5-HT, lacks a cation-π interaction at TrpB.  
 Chapter 3 describes a study that utilizes fluorescent protein fusions of the 5-HT3A 
and 5-HT3B subunits to determine the stoichiometry of the heteromeric 5-HT3AB 
receptor. Multiple FRET and other fluorescence experiments support an A3B2 
stoichiometry at the plasma membrane with a likely subunit order of A-A-B-A-B.  
 Chapter 4 examines the actions of 5-HT and mCPBG at the heteromeric 5-HT3AB 
receptor. Using conventional and unnatural amino acid mutagenesis, we find that while 
5-HT acts only at the A-A binding site, mCPBG binds and activates the receptor at all 
five binding sites. We also show that mCPBG is capable of modulating the response of 
5-HT from B subunit containing binding sites.  
 Chapter 5 describes efforts to expand the application of unnatural amino acid 
mutagenesis to a class of proteins called transcription factors. We have attempted to 
develop quantitative reverse-transcribed PCR experiments for the detection mRNA 
products of transcription factor activation in Xenopus laevis oocytes.  
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Chapter 2 
 
A Coupled Array of Noncovalent Interactions Impacts the Function 
of the 5-HT3A Receptor in an Agonist-Specific Way* 
 
2.1 ABSTRACT 
The serotonin type 3A (5-HT3A) receptor is a Cys-loop (pentameric) 
neurotransmitter-gated ion channel found in the central and peripheral nervous systems 
and implicated in numerous diseases. In previous studies with the endogenous agonist 
serotonin, we identified two interactions critical for receptor function: a cation-π 
interaction with W183 in loop B (TrpB) and a hydrogen bond to E129 in loop A. Here we 
employ mutant cycle analyses utilizing conventional and unnatural amino acid 
mutagenesis to demonstrate that a third residue, D124 of loop A, forms two functionally 
important hydrogen bonds to the backbone of loop B. We also show that these three 
interactions, the cation-π interaction, the backbone hydrogen bonds, and the E129 
hydrogen bond, are tightly coupled to each other, suggesting that they function as a single 
unit. We also identify key functional differences between serotonin and the competitive 
partial agonist m-chlorophenyl biguanide (mCPBG) at these residues. mCPBG displays 
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no cation-π at TrpB and extreme sensitivity to the positioning of E129, on which it is 
reliant for initiation of channel gating. 
 
2.2 INTRODUCTION 
The serotonin type 3 receptor (5-HT3) is a Cys-loop (pentameric) 
neurotransmitter-gated ion channel whose activation elicits fast excitatory responses. 
(1, 2) The 5-HT3 receptor is expressed in both the central and peripheral nervous systems 
and is known to be involved in multiple psychiatric and neurological disorders. (3) Five 
distinct subunits of the 5-HT3 receptor have been identified, (4) but only the A subunit 
forms functional homomeric receptors. These subunits, consisting of a large N-terminal 
extracellular domain, four transmembrane helices (M1–4), and a large intracellular loop 
(M3–M4), arrange into a symmetrical pentamer around a central pore. 
As with other pentameric receptors, the ligand binding domain is located at the 
interface between the extracellular domains of two adjacent subunits. More specifically, 
the binding site is composed of six loops from both the principle (A–C) and 
complementary (D–F) faces. Agonist binding leads to an opening of the channel gate at 
the M2 helix, over 60 Å distant. 
In previous studies of the 5-HT3A receptor, we identified critical roles for two 
residues. W183 on loop B (termed TrpB) makes a cation−π interaction to serotonin, (5) 
playing the same role as the aligning residue in most nicotinic acetylcholine receptors 
(nAChR). (6-8) E129 on loop A of the 5-HT3 receptor makes a hydrogen bond that is 
critical to receptor function. (9) We proposed that the hydrogen bond occurs with the OH 
of the agonist, serotonin. The aligning residue of nAChRs is Y93 (TyrA) (Figure 2.1). 
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Figure 2.1 Alignment of loops A and B from the mouse and human 5-HT3A subunits, the 
Torpedo nACh α1 subunit, the human nACh α7 subunit, and the Lymnaea AChBP.   
Residues contributing significant interactions through their side chains are shaded in 
gray. The numbering is that of the mouse 5-HT3A subunit. 
 
In the present work, we evaluate the role of a second residue on loop A that is 
very highly conserved across the entire Cys-loop family of neurotransmitter-gated ion 
channels, D124 of the 5-HT3A receptor. In the nAChR family, the aligning residue, D89, 
makes a number of hydrogen bonds to loop B, positioning the key TrpB residue (10-12). 
This role was suggested by crystal structures of acetylcholine binding proteins (AChBP) 
and confirmed by extensive mutagenesis studies. We also find interesting differences 
between the 5-HT3 receptor and the nAChR with respect to the role of D124. Mutant 
cycle analyses reveal a collection of interactions in which hydrogen bonds between D124 
and loop B serve to position W183, W183 makes the key cation−π interaction, and E129 
makes binding interactions with serotonin (Figure 2.2). Triple mutant cycle analysis 
shows that these three interactions are tightly coupled to each other, such that disrupting 
any one interaction destroys the coupling between the other two. In addition, we find that 
the natural agonist serotonin and the potent orthosteric agonist mCPBG are affected 
differently by mutations in this region of the receptor. 
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Figure 2.2 Schematic of the collection of interactions being probed here. Dashed red 
lines are hydrogen bonds. Purple dashed line is a cation-π interaction. 
 
2.3 RESULTS AND DISCUSSION 
2.3.1 Serotonin 
The 5-HT3A receptor differs from other members of the Cys-loop (pentameric) 
neurotransmitter-gated ion channel family in that one of the members of the canonical 
binding site aromatic box (TyrA) is missing (Figure 2.1). Alignment of loop A across the 
Cys-loop family is challenging, (9) but our previous functional studies suggested that the 
side chain of E129 points in toward the agonist binding site, making it the residue that 
corresponds to TyrA. In particular, we suggested that E129 forms a critical hydrogen 
bond with the 5-hydroxyl of serotonin. We have now further probed the role of E129 and 
established a collection of binding interactions that impact receptor function. 
Here we propose that another residue on loop A, D124, forms hydrogen bonds 
with both of the backbone nitrogens flanking the TrpB side chain (Figure 2.2). Based on 
the AChBP structures and mutagenesis studies of the nAChR, loop A of the 5-HT
3
A 
receptor in the vicinity of D124 lies “behind” loop B, such that the D124 side chain can 
hydrogen bond to the backbone of loop B in the vicinity of W183. The functional 
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significance of this conserved aspartate has long been appreciated, in that the D-to-N 
mutation very significantly impedes receptor function in Cys-loop receptors. (11) Not 
shown in Figure 2.2 is Ser182, the side chain of which could also contribute to this 
hydrogen bond network. However, as in studies of the nAChR, (12) we find that the 
S182A mutation has a negligible effect on receptor function (Table 2.1), and so we will 
not further consider hydrogen bonding interactions involving the side chain of S182. 
 
 
Table 2.1 Agonist dose-response data. All values are reported as mean ± SEM. Fold shift 
>1 indicates loss of function; fold shift < 1 indicates gain of function. b, Xah = α-hydroxy 
X. c, No response (Imax < 20 nA). d, Not determined. e, Small response (Imax < 100 nA). 
remaining three faces, all of which have one of the three
mutations present in all four corners, show ΔΔG values of ∼0.
Having any one of the three mutations completely decouples
the other two, suggesting a very tight interaction among the
three.
If the proposed model of E129 making a hydrogen bond to
the OH of serotonin is correct, we expect that mutations that
influence E129 would impact this interaction. We previously
showed that 5-FT (Figure 3) has a potency ∼10-fold lower
than 5-HT and acts as a partial agonist with a relative efficacy
(Rmax) of 0.64.
17 Assuming 5-FT binds in essentially the same
manner as serotonin, the F of 5-FT would be near the side
chain of E129 but cannot make a hydrogen bond. The high
relative efficacy of 5-FT compared with that of tryptamine
(serotonin without the OH; Rmax = 0.15) suggests that 5-FT
retains a steric or electrostatic interaction at the 5 position that
contributes to receptor function. Interestingly, when we
introduce the E129Q mutati n, 5-FT becomes an antagonist,
with an IC50 value comparable to its EC50 in the wild-type
receptor (Table 3). As expected, given their strong coupling to
E129, the W183Wah and L184Lah backbone mutations behave
similarly, strongly disrupting the ability of 5-FT to gate the
receptor. W183Wah converts 5-FT to a weak antagonist, while
the efficacy of 5-FT relative to serotonin decreases to three
percent in the background of L184Lah. This weak agonism
allows consideration of serotonin/5-FT as one component of a
double mutant cycle analysis. When the agonist pair is coupled
to the L184Lah backbone mutation, the ΔΔG value (0.73 kcal/
mol) is smaller than others we have seen but clearly
Table 1. Agonist Dose−Response Dataa
agonist mutationb EC50 (μM) fold shift Hill Rmax N
5-HT WT 1.9 ± 0.1 2.7 ± 0.3 7
W183Wah 27 ± 1 14 2.4 ± 0.3 6
L184Lah 13 ± 1 6 2.8 ± 0.2 23
E129Q 88 ± 7 46 1.5 ± 0.1 17
E129D 2.5 ± 0.3 1 1.6 ± 0.2 7
S182A 2.6 ± 0.1 1.4 2.3 ± 0.2 7
D124N 140 ± 10 70 2.6 ± 0.2 6
E129Q L184Lah 46 ± 10 24 1.5 ± 0.4 9
E129Q W183Wah 80 ± 10 41 1.8 ± 0.3 7
D124N L184Lah 61 ± 2 31 2.5 ± 0.1 6
D124N W183Wah 160 ± 10 85 4.1 ± 0.4 6
D124N E129Q 490 ± 60 255 3.2 ± 1.0 6
L184Lah E129Q D124N 230 ± 40 118 3.1 ± 1.3 8
T6′S 1.8 ± 0.2 0.9 2.3 ± 0.3 6
T6′S E129Q 6.0 ± 0.5 3 1.4 ± 0.1 6
5-FT WT 18 ± 1 2.2 ± 0.2 0.60 ± 0.03 6
W183Wah c 8
L184Lah 36 ± 4 2 3.2 ± 0.9 0.03 ± 0.01 10
E129Q c 8
mCPBG WT 0.61 ± 0.03 2.2 ± 0.2 0.73 ± 0.02 7
W183Wah c 8
L184Lah c 8
E129Q c 8
E129D 0.12 ± 0.01 0.2 1.1 ± 0.1 0.10 ± 0.01 11
S182A 0.15 ± 0.01 0.2 3.0 ± 0.4 0.74 ± 0.04 7
D124N 15 ± 1 24 3.4 ± 0.3 1.09 ± 0.07 6
D124N L184Lah 55 ± 2 90 3.5 ± 0.3 0.87 ± 0.04 6
D124N W183Wah c 8
W183−4-F-W 0.47 ± 0.03 0.8 1.5 ± 0.1 0.44 ± 0.03 6
W183−4,7-F2-W 0.34 ± 0.03 0.6 1.4 ± 0.1 d 19
W183−5−F-W 5.8 ± 0.1 10 2.1 ± 0.1 0.11 ± 0.01 8
W183−5,7-F2−W 2.8 ± 0.1 5 1.9 ± 0.1 0.38 ± 0.03 8
W183−5,6,7-F3-W 9.7 ± 0.3 16 2.4 ± 0.1 0.57 ± 0.03 11
W183−4,5,6,7-F4−W 7.3 ± 0.3 12 2.1 ± 0.2 0.59 ± 0.01 8
W183−5-Br-W 20 ± 2 33 2.5 ± 0.4 0.06 ± 0.01 8
mCPG WT 0.61 ± 0.03 2.2 ± 0.2 0.73 ± 0.02 7
E129Q c 8
E129D c 8
W183−4-F-W 2.7 ± 0.4 0.8 2.4 ± 0.8 0.23 ± 0.03 7
W183−4,7-F2-W e 8
W183−5-F-W 13 ± 2 4 2.2 ± 0.4 0.09 ± 0.01 7
W183−5-Br-W 42 ± 3.4 12 1.9 ± 0.3 0.02 ± 0.01 8
aAll values are reported as mean ± SEM. Fold shift >1 indicates loss of function; fold shift < 1 indicates gain of function. bXah = α-hydroxy X. cNo
response (Imax < 20 nA).
dNot determined. eSmall response (Imax < 100 nA).
ACS Chemical Neuroscience Research Article
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The key potential hydrogen bonding interactions involving D124 are to a pair of 
backbone NHs on loop B, contributed by W183 and L184. Using nonsense suppression 
methodology, (13, 14) we can perturb the loop B backbone by replacing W183 and L184 
with their corresponding α-hydroxy acids (Wah and Lah; ah standing for α-hydroxy) 
(Figure 2.3). This subtle mutation deletes the hydrogen bond donor but leaves nearly all 
other aspects of the receptor intact. The functional effects of these mutations are 
determined by constructing dose-response curves of the agonist-induced currents 
(Figure 2.4). 
Figure 2.3 (A) Structures of unnatural 
amino acids considered here. Unless 
specified, a, b, c, and d are H. (B) The α-
hydroxy acid strategy for probing 
backbone hydrogen bonding interactions. 
(C) Structures of agonists considered here.  
 
 
 
 
Figure 2.4 Examples of responses for 5-
HT on receptors in which a nonsense 
mutation (TAG) at L184 is suppressed by 
THG73 tRNA bearing either leucine 
(wild-type recovery) or α-hydroxy leucine 
expressed in Xenopus oocytes and their 
corresponding concentration–response 
curves. Circles correspond to L184TAG + 
THG73-Leu; squares correspond to 
L184TAG + THG73-Lah. Each data point 
represents the mean ± SEM (n = 7–23). 
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As shown in Figure 2.5 and Table 2.1, both backbone mutations in loop B cause 
partial loss of function (rise in EC50) with serotonin as agonist. The magnitudes of the 
perturbations are similar for the two backbone mutations, but they are markedly less than 
what is seen for the D124N mutation. It is interesting that although these hydrogen 
bonding interactions were first highlighted in structures of the acetylcholine binding 
protein (AChBP), comparable backbone mutations of the nAChR did not have strong 
effects on receptor function. (12) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 Results of select mutagenesis studies. 
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To establish that the backbone mutations are indeed influencing a hydrogen bond 
to D124, we performed double mutant cycle analyses (15, 16) with the D124N mutation. 
We consider a ΔΔG° > 0.65 kcal/mol (i.e., a 3-fold deviation from additivity) to represent 
a meaningful interaction energy. For both the W183Wah and the L184Lah mutations, a 
significant interaction energy is seen when paired with the D124N mutation (Table 2.2). 
The magnitude of the interaction is consistent with a hydrogen bond. 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2 Serotonin mutant cycle analyses. a, Xah = α-hydroxy X. b, Coupling 
coefficient. 
 
Because of the key role of TrpB (W183) in making a cation-π interaction to 
agonists, it seems reasonable to think of the loop A aspartate as positioning loop B 
through the hydrogen bonds just probed. However, given our earlier findings (9) of a key 
role for a second loop A residue (E129), we considered the reverse scenario: that loop B 
positions two key residues on loop A (Figure 2.2). If this were so, one expects that 
disruption of the hydrogen bonding interactions between D124 and W183/L184 would 
impact E129. We find that this is indeed the case. Both the W183Wah and the L184Lah 
E129 and the 5-hydroxyl of serotonin contributes to the
initiation of channel gating.
mCPBG. In addition to the endogenous ligand serotonin,
the 5-HT3A receptor is capable of being gated by many
structurally diverse molecules, including the pot nt orthosteric
agonist mCPBG. The biguanide mCPBG (Figure 3)22 is an
agonist at 5-HT3 receptors with a potency comparable to that
of serotonin and a relative efficacy of 0.74. The structures of 5-
HT3 and mCPBG are different enough that is seemed possible
that the two might interact differently with the receptor. Along
with a clearly different shape and size (Figure 7), mCPBG
displays a weak and diffuse positive electrostatic potential across
its biguanide moiety compared with the primary amine of
serotonin. The chlorine atom of mCPBG may provide some
steric and electronegative interactions of the sort shown to be
important for 5-FT gating but without the hydrogen bonding
ability of the serotonin OH. We have probed all the mutations
discussed above using mCPBG as the agonist, with intriguing
results. As with serotonin, the D124N mutation produces
marked loss of function.
A surprising result is seen with both of the backbone
mutations: when either W183Wah or L184Lah is introduced,
mCPBG becomes an antagonist, with a comparable IC50 for
both mutants (Table 3). Remarkably, restoring the hydrogen
bond between L184 and D124 by pairing a D124N mutation
with a backbone ester at L184 rescues the ability of mCPBG to
gate the receptor, with significant loss-of-function but a relative
efficacy of 0.87 (Figure 5). The W183Lah/D124N receptor still
shows mCPBG as an antagonist, with a further elevated IC50,
suggesting that the two backbone mutants may assume different
geometries. We cannot do mutant cycle analyses on these
systems, because one cannot meaningfully mix EC50 and IC50
values. The functional necessity of the hydrogen bonds linking
loops A and B suggests that proper positioning of E129 is
critical for mCPBG channel gating.
There are two other important ways in which mCPBG
responds to mutations in a qualitatively distinct way from
serotonin. First, the single mutation E129Q also converts
mCPBG into an antagonist. Second, activation or block by
mCPBG is not affected by fluorination of the W183 side chain,
although serotonin and many agonists at other Cys-loop
receptors are affected by such fluorination.5 Substituting W183
with 5-F-Trp does produce a 10-fold increase in EC50, but
further fluorination does not produce the progressive increases
in EC50 that are indicative of a cation−pi interaction. This
suggested that the 5-F-Trp effect could reflect a steric
interaction, so we incorporated 4-F-Trp (Figure 3). This
should produce an equivalent response if we are probing a
cation−pi interaction but a different response if steric
interactions are important. The EC50 value for 4-F-Trp was
close to wild-type. Increased fluorination, avoiding the 5
position, also resulted in near wild-type behavior. Greatly
increasing the steric bulk at the 5 position via 5-Br-Trp led to a
larger increase in EC50, further supporting the idea of a steric
interaction. This lack of fluorination effect could be due to a
slight positioning difference, or it could be that the positive
charge of mCPBG is so diffuse that it cannot pick up an
energetically significant electrostatic interaction with the side
chain of W183.
mCPG. The guanide analogue of mCPBG, termed mCPG
(Figure 3, 7), is also an agonist at 5-HT3 receptors with an
efficacy relative to serotonin of 0.31. Compared with mCPBG,
the smaller mCPG contains a less delocalized positive
electrostatic potential that would seemingly be more capable
of forming a cation−pi interaction. As with the biguanide
however, mCPG shows wild-type behavior with the 4-F-Trp
mutant at W183 and increasing losses of function as increasing
steric bulk is introduced at the 5 position.
As with the biguanide, mCPG also forms a crucial interaction
at E129. Mutation to glutamine results in the conversion of
mCPG to an antagonist with an IC50 comparable to that of
mCPBG. mCPG behaves uniquely in one regard however
(Table 3). E129D, which is only mildly disruptive for both
serotonin and mCPBG, converts mCPG to an antagonist with
an IC50 in the low nanomolar range, or ∼100-fold stronger
inhibition than that observed for any other converted agonist.
■ CONCLUSIONS
Together these results suggest an interesting cycle of
interactions that mutually reinforce each other. The essential
Figure 5. Results of select mutagenesis studies.
Table 2. Serotonin Mutant Cycle Analyses
mutant paira background Ωb ΔΔG° (kcal/mol)
W183Wah, D124N 0.080 1.5
W183Wah, E129Q 0.064 1.6
L184Lah, D124N 0.064 1.6
L184Lah, D124N E129Q 0.90 0.062
L184Lah, E129Q 0.076 1.5
L184Lah, E129Q D124N 0.93 0.043
E129Q, D124N 0.076 1.5
E129Q, D124N L184Lah 0.94 0.037
L184Lah, 5-HT/5-FT 0.29 0.73
E129Q, T6′S 0.072 1.6
aXah = α-hydroxy X. bCoupling coefficient.
ACS Chemical Neuroscience Research Article
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mutations are coupled via mutant cycle analysis to the E129Q mutation (Table 2.2), and 
the magnitude of the coupling is comparable to that measured for couplings to D124N. 
These results implied a collection of interactions: the loop B backbone NHs 
interact with loop A via D124; this in turn positions E129 on loop A properly for 
interaction with the agonist OH, and the agonist protonated amine makes a cation-π 
interaction to W183 back on loop B (Figure 2.2). This suggested experiments that 
constitute a triple mutant cycle analysis, combining D124N, E129Q, and L184Lah 
(protein expression for W183Wah mutants was too low to consider triple mutant studies). 
Such an analysis is best described by a cube, as in Figure 2.6. The wild type is in the front 
lower left corner, and the triple mutant is in the back upper right corner. Each face of the 
cube is a double mutant cycle analysis. Both the front and back faces, for example, depict 
the D124N/L184Lah double mutant cycle, but in the background of the wild type or the 
E129Q mutant, respectively (i.e., all four corners of the back face contain the E129Q 
mutation). As noted above, ΔΔG for the front face is 1.6 kcal/mol. However, ΔΔG for the 
back face is 0.06 kcal/mol. That is, the coupling between D124N and L184Lah is 
completely absent if we include the E129Q mutation. The coupling between D124 and 
L184 (backbone) depends on the presence of the E129 side chain. The difference between 
the ΔΔG values for the front and back faces produces a ΔΔΔG, the extent to which the 
three mutations all influence each other. In the present system, ΔΔΔG is 1.5 kcal/mol. 
The value for ΔΔΔG can also be obtained by subtracting ΔΔG values for the left and right 
faces or the top and bottom faces; the same ΔΔΔG value is always obtained. 
Interestingly, any double mutant cycle analysis that includes the wild-type receptor, the 
front, left, and bottom faces, shows a significant ΔΔG of 1.5 kcal/mol. However, the 
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remaining three faces, all of which have one of the three mutations present in all four 
corners, show ΔΔG values of 0. Having any one of the three mutations completely 
decouples the other two, suggesting a very tight interaction among the three. 
 
 
Figure 2.6 Triple mutant cycle analysis. ΔΔG values (kcal/mol) are given on each face of 
the cube. ΔΔΔG for the diagonal from lower left front to upper right back is 1.5 kcal/mol. 
The structural image is a simple docking of 5-HT into a previously described (9) 
homology model of the receptor and is for illustrative purposes only. See text for a full 
description and analysis. 
 
If the proposed model of E129 making a hydrogen bond to the OH of serotonin is 
correct, we expect that mutations that influence E129 would impact this interaction. We 
previously showed that 5-FT (Figure 2.3) has a potency 10-fold lower than 5-HT and acts 
as a partial agonist with a relative efficacy (Rmax) of 0.64. (17) Assuming 5-FT binds in 
essentially the same manner as serotonin, the F of 5-FT would be near the side chain of 
E129 but cannot make a hydrogen bond. The high relative efficacy of 5-FT compared 
with that of tryptamine (serotonin without the OH; Rmax = 0.15) suggests that 5-FT retains 
a steric or electrostatic interaction at the 5 position that contributes to receptor function. 
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Interestingly, when we introduce the E129Q mutation, 5-FT becomes an antagonist, with 
an IC50 value comparable to its EC50 in the wild-type receptor (Table 2.3). As expected, 
given their strong coupling to E129, the W183Wah and L184Lah backbone mutations 
behave similarly, strongly disrupting the ability of 5-FT to gate the receptor. W183Wah 
converts 5-FT to a weak antagonist, while the efficacy of 5-FT relative to serotonin 
decreases to three percent in the background of L184Lah. This weak agonism allows 
consideration of serotonin/5-FT as one component of a double mutant cycle analysis. 
When the agonist pair is coupled to the L184Lah backbone mutation, the ΔΔG value 
(0.73 kcal/mol) is smaller than others we have seen but clearly meaningful, bolstering the 
interpretation that the backbone NHs and E129 are linked. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.3 Dose-response data for mutations in which the ligand is converted to an 
antagonist. All values are reported as mean and SEM. b, Xah = α-hydroxy X. 
 
In the model that we are proposing (Figure 2.2), two of the interactions 
considered, the cation-π interaction to TrpB and the hydrogen bond between E129 and 
the OH of serotonin, involve direct binding between the receptor and the drug. Two 
others, the hydrogen bonds to the backbone of loop B, occur within the receptor itself. It 
role of TrpB for the natural agonist serotonin is clear, making a
cation−pi interaction to the positive charge of the neuro-
transmitter. Loop A residue D124 makes two hydrogen bonds
to loop B that no doubt serve to position TrpB, an effect that
has been seen in the nAChR. Also on loop A, E129 interacts
strongly with serotonin, and we propose that this interaction is
a hydrogen bond to the OH of the agonist. The
interconnectedness of these i teractions suggested in Figure 2
is supported by mutant cycle analyses. Several pairwise
interactions are significant, and the triple mutant cycle analysis
of Figure 6 is especially compelling. In particular, we find that
mutating any one of the trio of residues D124, E129, or L184
(backbone) decouples the other two from each other. This
suggests that this cyclic array acts as a single unit, with an
important functional role in the 5-HT3 receptor.
We have also found that the structurally distinct agonist
mCPBG displays some differences from serotonin. In
particular, the cation−pi interaction to TrpB that is seen for
serotonin and many other agonists at Cys-loop receptors is not
present for mCPBG activating the 5-HT3A receptor.
■ METHODS
Mutagenesis and Preparation of cRNA and Oocytes. Mutant
5-HT3A receptor subunits, within the complete coding sequence for
the mouse 5-HT3A receptor subunit (accession number Q6J1J7), were
cloned into pcDNA3.1 (Invitrogen, Abingdon, U.K.). Mutagenesis
reactions were performed using the QuikChange mutagenesis kit
(Stratagene) and confirmed by DNA sequencing. For unnatural
mutagenesis, a stop codon, TAG, was made at the site of interest.
Harvested stage V−VI Xenopus oocytes were washed in four changes
of Ca-free OR2 buffer (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5
mM HEPES, pH 7.5), defolliculated in 1 mg/mL collagenase for
approximately 1 h, washed again in four changes of Ca-free OR2 and
transferred to ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2, 5 mM HEPES, pH 7.5) supplemented with 0.28 mg/mL
pyruvate, 0.05 mg/mL Gentamicin, and 0.12 mg/mL theophylline.
Oocytes were injected with 5−25 ng of mRNA produced by in vitro
transcription using the mMESSAGE mMACHINE kit (Ambion,
Austin, Texas, USA) from cDNA subcloned into pGEMHE as
Figure 6. Triple mutant cycle analysis. ΔΔG values (kcal/mol) are given on each face of the cube. ΔΔΔG for the diagonal from lower left front to
upper right back is 1.5 kcal/mol. The structural image is a simple docking of 5-HT into a previously described9 homology model of the receptor and
is for illu trativ purposes only. See text for a full description and analysis.
Table 3. Dose−Response Data for Mutations in Which the
Ligand Is Converted to an Antagonista
mutationb antagonist IC50 (μM) Hill N
L184Lah mCPBG 21 ± 1 −2.1 ± 0.2 12
W183Wah mCPBG 20 ± 1 −1.8 ± 0.1 7
5-FT 140 ± 20 −1.6 ± 0.3 11
W183Wah D124N mCPBG 160 ± 10 −2.6 ± 0.3 7
E129Q mCPBG 0.28 ± 0.03 −1.6 ± 0.1 6
mCPG 0.32 ± 0.08 −1.2 ± 0.3 7
5-FT 8.6 ± 2.7 −0.8 ± 0.2 7
E129D mCPG 0.0094 ± 0.0024 −0.9 ± 0.1 11
aAll values are reported as mean and SEM. bXah = α-hydroxy X.
Figure 7. Structures and electrostatic potential surfaces for agonists considered here. Structures and surfaces were generated at the HF 3-21G* level.
Electrostatic potentials are plotted with blue most positive and red least positive over a range from 0 to +750 kJ/mol. For the individual molecules,
the electrostatic potentials span the following ranges: 5-HT, 13−733; 5-FT, 47−745; mCPBG, 116−636; mCPG, 152−698.
ACS Chemical Neuroscience Research Article
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may be that these various interactions impact different aspects of the receptor activation 
process. 
The metric we use to evaluate receptor function is EC50, the effective 
concentration of agonist needed to induce half-maximal response. This is a functional 
measure of agonist potency. The actual process of activating the 5-HT3A receptor and 
related molecules is complex, involving multiple equilibria reflecting drug binding to and 
coming off the receptor, conformational changes of the protein, and “gating” equilibria 
between the open and closed states of the channel. It is important to acknowledge the 
ambiguity that a change in EC50 could reflect a change in “binding” or a change in 
“gating”. Certainly there is value in knowing which step(s) in the gating process is 
impacted by a particular mutation, but this requires much more detailed studies, typically 
at the single channel level; such studies are further complicated in the present case by the 
low single-channel conductance of the 5-HT3A receptor. An alternative strategy would be 
to determine Ki values for various ligands at mutant receptors. The standard strategy for 
5-HT3 receptors is displacement of tritiated granisetron. However, it has been reported 
that various mutants at E129, including E129Q, show no binding of granisetron. (18) A 
further complication with the determination of binding constants is the large amount of 
receptor required, quantities greater than what can typically be produced with unnatural 
amino acid mutagenesis. In light of these limitations, we do not believe binding studies 
would be feasible on the most interesting of the mutants studied here. 
An alternative way to evaluate the role a particular residue plays is through 
employing a different type of mutant cycle analysis. In previous studies of the nAChR, 
we have often introduced a mutation in the transmembrane domain, quite far from the 
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agonist binding site, that facilitates gating and thereby lowers EC50 in a general way (19, 
20). Typically, such transmembrane mutations show simple additivity when paired with a 
second mutation in the agonist binding site (ΔΔG = 0). However, meaningful coupling 
between the two sites can be observed when the agonist binding site mutation 
significantly impacts gating. We considered a similar strategy here, using a mutation in 
M2 termed T6′S (21), where 6′ denotes the sixth amino acid from the cytoplasmic end of 
the transmembrane helix. As noted earlier, the E129Q mutation is strongly perturbing, 
producing a high EC50 of 88 µM (46-fold shift from wild type) for serotonin (Table 2.1). 
With the addition of the T6′S mutation, EC
50
 drops 15-fold to 6.0 µM, following a pattern 
we have seen with other mutations of this sort. However, the same effect is not seen in 
the otherwise wild-type receptor; the T6′S single mutant shows an EC50 of 1.8 µM, 
indistinguishable from wild-type. Of course, this means that the T6′S and E129Q 
mutations are coupled, and a mutant cycle analysis gives a large ΔΔG of 1.6 kcal/mol 
(Table 2.2). Since the T6′S mutation presumably affects channel gating, the coupling 
seen here suggests that the proposed hydrogen bond between E129 and the 5-hydroxyl of 
serotonin contributes to the initiation of channel gating. 
The observed lack of effect on EC50 upon introduction of the T6’S mutation to the 
wild type receptor strays from our original model for employing a long-range reporter of 
gating (Figure 2.7, A) (20). This simplified kinetic model for activation leads to an 
expression for EC50, where A is the agonist; RC and RO denote the closed and open states 
of the receptor; k1 and k-1 are forward and reverse rate constants for agonist binding; KD 
is the dissociation constant for the agonist; and Θ is the gating equilibrium constant, 
given by the ratio of the channel opening rate, β, to the channel closing rate, α. At 
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regions of low Θ, the KD is invariant to small changes in Θ. At higher (and more 
physiologically relevant) values of Θ, there is a linear relationship between KD and Θ 
with negative slope. Thus, a reporter mutation that affects the gating equilibrium should 
display a marked gain of function by EC50.  
Figure 2.7 Models of receptor activation. (A) A simple receptor activation model and 
resultant relationship between EC50 and Θ. (B) A receptor activation model that includes 
agonist disassociation from open receptors and its resultant relationship between EC50 
and Θ. In both panels the lines show the relationship between EC50 and Θ, with the red 
line corresponding to a larger KD than the black line. For both plots, in the negative slope 
region changes in Θ produce significant changes in EC50, as shown when the reporter 
effect is added to the wild-type receptor. However, when beginning with Θ in either 
plateau region, a much smaller shift in EC50 occurs for equivalent shifts in Θ. Figure 
adapted from Gleitsman, K.R. et al. (2009) Biophys. J. (20) 
 
The EC50 of mutations that purely affect gating will slide along this function 
(black curve). Mutations that affect ligand binding directly however will result in a 
vertical shifting of the entire function (red curve). As the receptor would reside in the 
same horizontal region of the function in a purely binding mutation, the effect of the 
reporter will be purely additive. In contrast, a purely gating mutation may push the 
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receptor into the horizontal region where EC50 is invariant with respect to Θ, thereby 
leading to non-additivity and functional coupling. This model captures all necessary 
phenomena for application in numerous nicotinic receptors, however, it clearly fails to 
explain the current mutation in the 5-HT3A receptor.  
A slightly more complex (and naturalistic) model may be constructed, however, 
that accounts for the response of the T6’S mutant (Figure 2.7, B). When rates are 
included for the dissociation of ligand from open receptors without channel closure, a 
third region in the relationship between KD and Θ emerges. At Θ of 103-104 the function 
again plateaus. The dynamic between binding and gating mutations and their 
(non-)additivity from the prior model, however, remain intact for other regions. Thus, if 
the serotonin receptor were to have a markedly higher Θ than typical for nicotinic 
receptors, a reporter mutation might access this region. While the low single channel 
conductance of the wild type 5-HT3A receptor precludes direct determination of Θ, 
recent studies using a high conductance variant have suggested that the 5-HT3A Θ does 
indeed lie within the predicted region of the high Θ plateau (22). 
2.3.2 mCPBG 
In addition to the endogenous ligand serotonin, the 5-HT3A receptor is capable of 
being gated by many structurally diverse molecules, including the potent orthosteric 
agonist mCPBG. The biguanide mCPBG (Figure 2.3) (23) is an agonist at 5-HT3 
receptors with a potency comparable to that of serotonin and a relative efficacy of 0.74. 
The structures of 5-HT3 and mCPBG are different enough that it seemed possible that the 
two might interact differently with the receptor. Along with a clearly different shape and 
size (Figure 2.8), mCPBG displays a weak and diffuse positive electrostatic potential 
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across its biguanide moiety compared with the primary amine of serotonin. The chlorine 
atom of mCPBG may provide some steric and electronegative interactions of the sort 
shown to be important for 5-FT gating but without the hydrogen bonding ability of the 
serotonin OH. We have probed all the mutations discussed above using mCPBG as the 
agonist, with intriguing results. As with serotonin, the D124N mutation produces marked 
loss of function. 
 
Figure 2.8 Structures and electrostatic potential surfaces for agonists considered here. 
Structures and surfaces were generated at the HF 3-21G* level. Electrostatic potentials 
are plotted with blue most positive and red least positive over a range from 0 to +750 
kJ/mol. For the individual molecules, the electrostatic potentials span the following 
ranges: 5-HT, 13–733; 5-FT, 47–745; mCPBG, 116–636; mCPG, 152–698. 
 
A surprising result is seen with both of the backbone mutations: when either 
W183Wah or L184Lah is introduced, mCPBG becomes an antagonist, with a comparable 
IC50 for both mutants (Table 2.3). Remarkably, restoring the hydrogen bond between 
L184 and D124 by pairing a D124N mutation with a backbone ester at L184 rescues the 
ability of mCPBG to gate the receptor, with significant loss-of-function but a relative 
efficacy of 0.87 (Figure 2.5). The W183Lah/D124N receptor still shows mCPBG as an 
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antagonist, with a further elevated IC50, suggesting that the two backbone mutants may 
assume different geometries. We cannot do mutant cycle analyses on these systems, 
because one cannot meaningfully mix EC50 and IC50 values. The functional necessity of 
the hydrogen bonds linking loops A and B suggests that proper positioning of E129 is 
critical for mCPBG channel gating. 
There are two other important ways in which mCPBG responds to mutations in a 
qualitatively distinct way from serotonin. First, the single mutation E129Q also converts 
mCPBG into an antagonist. Second, activation or block by mCPBG is not affected by 
fluorination of the W183 side chain, although serotonin and many agonists at other 
Cys-loop receptors are affected by such fluorination. (5) Substituting W183 with 5-F-Trp 
does produce a 10-fold increase in EC50, but further fluorination does not produce the 
progressive increases in EC50 that are indicative of a cation-π interaction. This suggests 
that the 5-F-Trp effect could reflect a steric interaction, so we incorporated 4-F-Trp 
(Figure 2.3). This should produce an equivalent response if we are probing a cation-π 
interaction but a different response if steric interactions are important. The EC50 value for 
4-F-Trp was close to wild-type. Increased fluorination, avoiding the 5 position, also 
resulted in near wild-type behavior. Greatly increasing the steric bulk at the 5 position via 
5-Br-Trp led to a larger increase in EC50, further supporting the idea of a steric 
interaction. This lack of fluorination effect could be due to a slight positioning difference, 
or it could be that the positive charge of mCPBG is so diffuse that it cannot pick up an 
energetically significant electrostatic interaction with the side chain of W183. 
2.3.3 mCPG 
The guanide analogue of mCPBG, termed mCPG (Figure 2.3, 2.8), is also an 
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agonist at 5-HT3 receptors with an efficacy relative to serotonin of 0.31. Compared with 
mCPBG, the smaller mCPG contains a less delocalized positive electrostatic potential 
that would seemingly be more capable of forming a cation−π interaction. As with the 
biguanide however, mCPG shows wild-type behavior with the 4-F-Trp mutant at W183 
and increasing losses of function as increasing steric bulk is introduced at the 5 position. 
mCPG also forms a crucial interaction at E129. Mutation to glutamine results in 
the conversion of mCPG to an antagonist with an IC50 comparable to that of mCPBG. 
mCPG behaves uniquely in one regard, however (Table 2.3). E129D, which is only 
mildly disruptive for both serotonin and mCPBG, converts mCPG to an antagonist with 
an IC50 in the low nanomolar range, or 100-fold stronger inhibition than that observed for 
any other converted agonist. 
2.3.4 Conclusions 
Together these results suggest an interesting cycle of interactions that mutually 
reinforce each other. The essential role of TrpB for the natural agonist serotonin is clear, 
making a cation-π interaction to the positive charge of the neurotransmitter. Loop A 
residue D124 makes two hydrogen bonds to loop B that no doubt serve to position TrpB, 
an effect that has been seen in the nAChR. Also on loop A, E129 interacts strongly with 
serotonin, and we propose that this interaction is a hydrogen bond to the OH of the 
agonist. The interconnectedness of these interactions suggested in Figure 2.2 is supported 
by mutant cycle analyses. Several pairwise interactions are significant, and the triple 
mutant cycle analysis of Figure 2.6 is especially compelling. In particular, we find that 
mutating any one of the trio of residues D124, E129, or L184 (backbone) decouples the 
other two from each other. This suggests that this cyclic array acts as a single unit, with 
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an important functional role in the 5-HT3 receptor. 
We have also found that the structurally distinct agonist mCPBG displays some 
differences from serotonin. In particular, activating the 5-HT3A receptor, the cation-π 
interaction to TrpB that is seen for serotonin and many other agonists at Cys-loop 
receptors is not present for mCPBG. 
 
2.4 METHODS 
2.4.1 Mutagenesis and Preparation of cRNA and Oocytes 
Mutant 5-HT3A receptor subunits, within the complete coding sequence for the 
mouse 5-HT3A receptor subunit (accession number Q6J1J7), were cloned into pcDNA3.1 
(Invitrogen, Abingdon, U.K.). Mutagenesis reactions were performed using the 
QuikChange mutagenesis kit (Stratagene) and confirmed by DNA sequencing. For 
unnatural mutagenesis, a stop codon, TAG, was made at the site of interest. Harvested 
stage V–VI Xenopus oocytes were washed in four changes of Ca2+-free OR2 buffer 
(82.5 mM NaCl, 2 mM KCl, 1 mM MgCl
2
, 5 mM HEPES, pH = 7.5), defolliculated in 
1 mg/mL collagenase for approximately 1 h, washed again in four changes of Ca2+-free 
OR2 and transferred to ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl
2
, 1 mM MgCl
2
, 
5 mM HEPES, pH = 7.5) supplemented with 0.28 mg/mL pyruvate, 0.05 mg/mL 
Gentamicin, and 0.12 mg/mL theophylline. Oocytes were injected with 5–25 ng of 
mRNA produced by in vitro transcription using the mMESSAGE mMACHINE kit 
(Ambion, Austin, Texas, USA) from cDNA subcloned into pGEMHE as previously 
described. (13) For unnatural amino acid experiments, a 1:1 mixture of mRNA and 
THG73 tRNA charged with an unnatural amino acid was injected (5–25 ng each). 
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Electrophysiological measurements were performed after incubation for 24–72 h 
postinjection at 18 °C. Wild-type recovery experiments (injection of tRNA appended to 
the natural amino acid) were performed to evaluate the fidelity of the unnatural 
suppression experiments. The 76-mer THG73 was also injected with mRNA as a control. 
2.4.2 Synthesis of tRNA and dCA Amino Acids 
This was as described previously. (13) Briefly, unnatural amino acids were 
chemically synthesized as nitroveratryloxycarbonyl (NVOC)-protected cyanomethyl 
esters and coupled to the dinucleotide dCA, which was then enzymatically ligated to 
74-mer THG73 tRNACUA. Immediately prior to coinjection with cRNA, aminoacyl tRNA 
was deprotected by photolysis. Typically 5–10 ng of total cRNA was injected with 25–
50 ng of tRNA-aa in a total volume of 50 nL. For a control, cRNA was injected with 
THG 76-mer tRNA (no unnatural amino acid attached). 
2.4.3 Characterization of Mutant Receptors 
Agonist-induced currents were recorded at 22–25 °C from individual oocytes 
using the OpusXpress system (Molecular Devices Axon Instruments, Union City, CA). 
5-HT, m-chlorophenylbiguanide (mCPBG), m-chlorophenylguanide (mCPG), and 
5-fluorotryptamine (5-FT) (Sigma) were stored as 25 mM aliquots at −20 °C, diluted in 
Ca-free ND96 buffer (96 mM NaCl, 2 mM KCl, 1 mM MgCl
2
, 5 mM HEPES, pH = 7.5) 
and delivered to cells via the automated perfusion system of the OpusXpress. Glass 
microelectrodes were backfilled with 3 M KCl and had a resistance of 1 MΩ. The 
holding potential was −60 mV. Agonist doses in Ca2+-free ND96 were applied for 15 s 
followed by a 116 s wash with the running buffer. Dose-response data were obtained for 
≥8 agonist concentrations on ≥6 cells. To determine EC50 values, concentration-response 
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data were fitted to the four-parameter logistic equation, I = Imax/[1 + (EC50/[A])nH] where 
Imax is the maximal response plateau, [A] is the log concentration of agonist, and nH is the 
Hill coefficient, using KaleidaGraph v3.6 software (Synergy Software, Reading, PA). A 
detailed error analysis of nonsense suppression experiments shows that data are 
reproducible to ±50% in EC50. (24) Relative efficacies (ε) of the partial agonists mCPBG, 
mCPG, and 5-fluorotryptamine (5-FT) are reported as ε = Imax-drug/Imax-5-HT. Efficacy was 
calculated for individual cells and then averaged and reported as mean ± SEM. 
The coupling coefficient, Ω, is defined as 
 
and the coupling energy of the double mutation, ΔΔG = RT ln(Ω). 
For receptor antagonist experiments, antagonist doses in Ca2+-free ND96 were 
applied to the oocyte for 15 s and incubated for a further 45 s. An identical dose of 
antagonist was then applied in a concentration of serotonin equal to 2-fold the mutant 
EC
50
 for 15 s before a 124 s wash with the running buffer. To ensure that current 
decreases result from antagonist alone, consistency of cell responses was determined by 
applying serotonin of concentration equal to 2-fold mutant EC50 for 15 s followed by a 
124 s wash with the running buffer prior to the first antagonist dose and following a 
5 min washout with running buffer after every fourth subsequent antagonist dose. Dose–
response data were obtained for ≥8 agonist concentrations on ≥6 cells. To determine IC50 
values, concentration–response data were fitted to the four-parameter logistic equation, 
I = Imax/[1 + (IC50/[A])nH] where Imax is the maximal response plateau, [A] is the log 
concentration of agonist, and nH is the Hill coefficient, using KaleidaGraph v4.1.2 
software (Synergy Software, Reading, PA). 
! 
EC50(wt,wt) * EC50(mut,mut)
EC50(wt,mut) * EC50(mut,wt)
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2.4.4 Computation 
Calculations were performed with the program SPARTAN. (25) 
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Chapter 3 
 
The 5-HT3AB Receptor Shows an A3B2 Stoichiometry at the Plasma Membrane* 
 
3.1 ABSTRACT 
 The 5-HT3AB receptor is the best-characterized heteropentameric 5-HT3 receptor. 
Under conditions of heterologous expression, the 5-HT3AB receptor shows a single 
functionally resolvable population, suggesting the presence of a unique subunit 
stoichiometry; however, conflicting previous reports have suggested two different 
possible stoichiometries. Here we isolate plasma membrane sheets containing assembled 
receptors from individual HEK293T cells. We then determine the stoichiometry of 
5-HT3AB receptors on the plasma membrane by fluorescence methods, employing 
meCFP- and meYFP-labeled A and B subunits. Over a wide range of cDNA transfection 
ratios, fluorescence intensity ratios are closest to values that correspond to a subunit ratio 
of A3B2. Förster resonance energy transfer (family FRET) efficiencies provide minor 
corrections (3–6%) to the subunit ratios and provide independent support for a 
predominantly A3B2 stoichiometry on the plasma membrane sheets. Twin FRET 
efficiencies support these data, also suggesting that the two B subunits are nonadjacent in 
most of the heteropentamers. The high-frequency variant HTR3B p.Y129S (c.386A>C, 
rs11767445), linked to psychiatric disease, also forms A3B2 receptors on the plasma 
membrane. The 5-HT3B Y129S subunit incorporates in a slightly (11–14%) more 
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efficient manner than the common variant. For the wild type and mutant receptors, most 
expressed subunits reside within the cell, rather than on the surface. In contrast to the 
findings for the plasma membrane, the relative abundances and FRET characteristics of 
intracellular subunits depend strongly on the transfection ratio. The straightforward and 
unambiguous combination of plasma membrane-sheet isolation, fluorescence intensity 
ratios, and FRET is a generally promising procedure for determining stoichiometry of 
proteins on the plasma membrane. 
 
3.2 INTRODUCTION 
 Recognition of serotonin (5-HT) is accomplished by the various proteins 
(including enzymes, transporters, and receptors) that regulate its fundamental role in 
neurotransmission. Among the seven families of serotonin receptor, only one is an ion 
channel. The 5-HT3 receptor, as a member of the Cys-loop superfamily of ligand-gated 
ion channels, is composed of five subunits that arrange symmetrically around a central 
pore (1 and 2). Found in both the peripheral and central nervous systems, 5-HT3 receptors 
have been implicated in numerous salutary and pathological processes including emesis, 
nociception, cognition, and depression (3 and 4). 
Once believed to consist of only one member (5-HT3A), the known 5-HT3 
receptor family has recently been expanded by identification of four additional subunits 
(B–E) (4, 5, and 6). Unlike 5-HT3A, which is capable of forming functional 
homopentameric receptors, the B–E subunits convey function only in the presence of the 
A subunit as heteromers. The best studied of these, 5-HT3AB, differs greatly from the 
homomeric receptor (7). For 5-HT, the AB receptor shows an increased EC50 and rate of 
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desensitization coupled with decreased cooperativity, inward rectification, and calcium 
permeability (5, 8, 9, and 10). Major differences in pharmacological selectivity at 
allosteric sites have also been observed (7, 11, and 12). Moreover, only the markedly 
higher conductance of the 5-HT3AB receptor agrees with that observed in native tissue 
(13, 14, 15, and 16). Heteromeric receptors containing 5-HT3C, D, or E subunits, on the 
other hand, are as yet functionally indistinguishable from the homomeric receptor 
(17 and 18). 
As heteropentamers, functional 5-HT3AB receptors may exhibit numerous 
potential subunit stoichiometries. Unlike other members of the Cys-loop superfamily, 
however, the 5-HT3AB receptor shows a single functionally resolvable population in 
heterologous expression systems. In an early study aimed at determining the 
stoichiometry of this population, purified 5-HT3AB receptors were antibody-labeled at 
epitope tags specific to the A and B subunits (19). AFM was then used to observe the 
angle between adjacent antibodies. For the 5-HT3AB receptor, two inter-antibody angles 
were observed: one that is unique to the heteromer and one that is also seen in the 
homomer. Based on the pattern of these angles, the authors proposed that receptors are 
composed of two A subunits and three B subunits arranged B-B-A-B-A. 
Because the orthosteric ligand-binding site of Cys-loop receptors spans the 
interface of two adjoining subunits, this finding suggested that the B subunit must 
successfully contribute to the gating of 5-HT3AB receptors. Recent studies, however, 
have called this conclusion into question. While conversion of critical A subunit residues 
to the corresponding residue of the B subunit is strongly deleterious to orthosteric ligand 
binding, the analogous mutations from B to A exhibit no effect (20). Furthermore, 
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introduction of double cysteine mutants (placed one per face on a potential binding site) 
in the A subunit displayed no response in either homo- or heteromeric receptors until 
exposed to a reducing agent. Finally, it was shown that cysteine labeling near the 
postulated AB orthosteric site hinders ligand binding only for A subunit residues (21). 
Together these findings suggested, contrary to the AFM data (19), the presence of at least 
one A-A subunit interface in the 5-HT3AB receptor. 
In this study, we have sought to resolve the stoichiometry of functional membrane 
5-HT3AB receptors using various fluorescence methods on isolated membrane sheets 
from whole cells expressing fluorescent protein fusions of the 5-HT3A and B subunits. 
 
3.3 MATERIALS AND METHODS 
3.3.1 Materials 
 The pcDNA3.1(+) expression vector and fetal bovine serum reagents 
were purchased from Invitrogen (Carlsbad, CA). TransIT transfection reagent was 
purchased from Mirus (Madison, WI). Penicillin/streptomycin (100×) solution was 
purchased from Mediatech (Herndon, VA). Culture dishes (35 mm, with 14 mm, No. 0 
thickness, glass coverslip microwells) were purchased from Mattek (Ashland, MA). 
Coverslips (25 mm, No. 1 thickness glass) were purchased from VWR (Radnor, PA). 
Other tissue-culture plasticware was purchased from Greiner Bio-One (Monroe, CA). 
3.3.2 Molecular Biology 
 Monomeric-enhanced (me) CFP and YFP were introduced in frame into the 
M3-M4 loops of the human 5HT3A and 5HT3B subunits, taking care to avoid known 
signaling and trafficking motifs. The forward primer 
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5′-AAG ACT GAT GAC TGC TCA GCC ATG GGA AAC CAC TGC AGC 
CAC ATG GGA GCT GGC GCC ATG GTG AGC AAG GGC GAG GAG-3′ 
and the reverse primer 
5′-GGG AGG GCT ACA TCT GTC CCT CGG GCT CTT CTC GAA GTC CTG 
GGG TCC GGC GCC TGC CTT GTA CAG CTC GTC CAT GCC-3′ 
were used in PCR to add overlapping regions homologous to the M3-M4 region of 
h5-HT3A to meCFP and meYFP. The forward primer 
5′- GCT AAG TCC ATC GTG TTG GTC AAA TTC CTC CAT GAT GAG CAG 
CGT GGT GCT GGC GCC ATG GTG AGC AAG GGC GAG GAG-3′ 
and the reverse primer 
5′-GGT TCC TGG CTG GGC CAG GTG CTC TCC ATA CAG CGA GGA CTC 
TGT TAC GGC GCC TGC CTT GTA CAG CTC GTC CAT GCC-3′ 
were used in PCR to add overlapping regions homologous to the M3-M4 region of 
h5-HT3B to meCFP and meYFP. These products were then isolated and used as inserts in 
a second PCR reaction with the corresponding full-length subunit to generate the receptor 
subunit-fluorescent protein fusion constructs. The fluorescent protein insertion point for 
the A subunit is between Gly-421 and Gly-422. The insertion point for the B subunit 
is between Gly-333 and Gly-334. All constructs were verified by sequencing. 
3.3.3 Cell Culture and Transfection 
 Human embryonic kidney (HEK) 293T cells, bearing T-antigen, were maintained 
on 100 mm culture plates at 37°C and 5% CO2 in a humidified atmosphere. They were 
cultured in Dulbecco’s modified Eagle’s medium/nutrient mix F12 (1:1) with 
GlutaMAX I media (Invitrogen) containing 10% fetal calf serum and 
49 
penicillin/streptomycin. Cells at 60–80% confluency within 35 mm dishes were 
transfected with a total of 2 µg of plasmid DNA using the TransIT transient transfection 
kit (Mirus). For FlexStation studies (Molecular Devices, Eugene, OR), cells were 
transfected and then plated in 96 well plates. Cells were incubated 1–2 days before assay. 
For whole-cell fluorescence studies, cells were plated in 35 mm glass-bottomed dishes 
and imaged one day after transfection. For membrane isolation studies, cells were 
prepared four days after transfection. 
3.3.4 Flexstation Analysis  
The FlexStation (Molecular Devices) analysis technique uses fluorescent 
voltage-sensitive dyes to detect changes in the membrane potential. It has been used to 
examine various ion channels, including those of the 5-HT3 receptors (22). In brief, 
fluorescent membrane potential dye (Molecular Devices) was diluted in the Flex buffer 
(10 mM HEPES, 115 mM NaCl, 1 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM 
glucose, pH = 7.4) and added to transfected cells grown on a 96 well plate. The cells were 
incubated at room temperature for 30 min and then fluorescence was measured in a 
FlexStation (Molecular Devices) at 2 s intervals for 200 s. Serotonin (5-HT) was added to 
each well after 20 s. The percentage change in fluorescence was calculated as 
 
 
where F is peak fluorescence for the current agonist dose, Fmax is peak fluorescence at 
saturating agonist, and Fmin is baseline fluorescence at 20 s. 
To determine EC50 values, concentration-response data were fitted to the 
four-parameter logistic equation, 
either homo- or heteromeric receptors until exposed to a
reducing agent. Finally, it was shown that cysteine labeling
near the postulated AB orthosteric site hinders ligand
binding only for A subunit residues (21). Together these
findings suggested, contrary to the AFM data (19), the pres-
ence of at least one A-A subunit interface in the 5-HT3AB
receptor.
In this study, we have sought to resolve the stoichiometry
of functional membrane 5-HT3AB receptors using various
fluorescence methods on isolated membrane sheets from
whole cells expressing fluorescent protein fusions of the
5-HT3A and B subunits.
MATERIALS AND METHODS
Materials
The pcDNA3.1(þ) expression vector, and fetal bovine serum reagents,
were purchased from Invitrogen (Carlsbad, CA). TransIT transfection
reagent was purchased from Mirus (Madison, WI). Penicillin/strepto-
mycin (100") solution was purchased from Mediatech (Herndon, VA).
Culture dishes (35 mm, with 14-mm, No. 0 thickness, glass cov rslip
microwells) were purchased from Mattek (Ashland, MA). Coverslips
(25 mm, No. 1 thickness glass) were purchased from VWR (Radnor,
PA). Other tissue-culture plasticware was purchased from Greiner Bio-
One (Monroe, CA).
Molecular biology
Monomeric-enhanced (me) CFP and YFP were introduced in frame into the
M3-M4 loops of the human 5HT3A and 5HT3B subunits, taking care to
avoid known signaling and trafficking motifs. The forward primer
50-AAG ACT GAT GAC TGC TCA GCC ATG GGA AAC CAC TGC
AGC CAC ATG GGA GCT GGC GCC ATG GTG AGC AAG
GGC GAG GAG-30
and the reverse primer
50-GGG AGG GCT ACA TCT GTC CCT CGG GCT CTT CTC GAA
GTC CTG GGG TCC GGC GCC TGC CTT GTA CAG CTC GTC
CAT GCC-30
were used in PCR to add overlapping regions homologous to the M3-M4
region of h5-HT3A to meCFP and meYFP. The forward primer
50- GCT AAG TCC ATC GTG TTG GTC AAA TTC CTC CAT GAT
GAG CAG CGT GGT GCT GGC GCC ATG GTG AGC AAG
GGC GAG GAG-30
and the reverse primer
50-GGT TCC TGG CTG GGC CAG GTG CTC TCC ATA CAG CGA
GGA CTC TGT TAC GGC GCC TGC CTT GTA CAG CTC GTC
CAT GCC-30
were used in PCR to add overlapping regions homologous to the M3-M4
region of h5-HT3B to meCFP and meYFP. These products were then
isolated and used as inserts in a second PCR reaction with the correspond-
ing full-length subunit to generate the receptor subunit-fluorescent protein
fusion constructs. The fluorescent protein insertion point for the A subunit
is between Gly-421 and Gly-422. The insertion point for the B subunit
is between Gly-333 and Gly-334. All constructs were verified by
sequencing.
Cell culture and transfection
Human embryonic kidney (HEK) 293T cells, bearing T-antigen, were main-
tained on 100-mm culture plates at 37#C and 5% CO2 in a humidified atmo-
sphere. They were cultured in Dulbecco’s modified Eagle’s medium/
nutrient mix F12 (1:1) with GlutaMAX I media (Invitrogen) containing
10% fetal calf serum and penicillin/streptomycin. Cells at 60–80% conflu-
ency within 35-mm dishes were transfected with a total of 2 mg of plasmid
DNA usi g the TransIT transient transfection kit (Mirus). For FlexStation
studies (Molecular Devices, Eugene, OR), cells were transfected and then
plated in 96-well plates. Cells were ncubated 1–2 days before assay. For
whole-cell fluorescence studies, cells were plated in 35-mm glass-bottomed
dishes and imaged one d y after transfection. For membrane isolation
studies, cells were prepared four days after transfection.
FlexStation analysis
The FlexStation (Molecular Devices) analysis technique uses fluorescent
voltage-sensitive dyes to detect changes in the membrane potential. It has
been used to examine various ion channels, including those of the 5-HT3
receptors (22). In brief, fluorescent membrane potential dye (Molecular De-
vices) was diluted in the Flex buffer (10 mMHEPES, 115 mM NaCl, 1 mM
KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM glucose, pH 7.4) and added
to transfected cells grown on a 96-well plate. The cells were incubated at
room temperature for 30 min and then fluorescence was measured in a
FlexStation (Molecular Devices) at 2-s intervals for 200 s. Serotonin
(5-HT) was added to each well after 20 s. The perce tage change in fluores-
cence was calculated as
ðF% FminÞ
Fmax
;
where F is peak fluorescence for the current agonist dose, Fmax is peak fluo-
rescence at saturating agonist and Fmin is baseline fluorescence at 20 s.
To determine EC50 values, concentration-response data were fitted to the
four-parameter logistic equation,
I ¼ Imax!
1 þ
"
EC50
½A)
#
nH
$ ;
where Imax is the maximal response plateau, [A] is the log concentration of
agonist, and nH is the Hill coefficient, using KaleidaGraph v3.6 software
(Synergy Software, Reading, PA).
Membrane isolation
When one performs ensemble measurements of integral membrane proteins
on the plasma membrane, it is important to restrict the pool of observed sub-
units to only those that reside on the plasma membrane. To isolate this
restricted population, membrane was mechanically removed from the rest
of the cell as described previously in Perez et al. (23).
This is achieved by bathing HEK293T cells 72–96 h posttransfection in
deionized water to induce swelling. After 1 min, a No. 1 coverslip, sterilized
by sequential 20-min 6-M KOH and acetone baths with sonication and
stored in 20-mm filtered deionized water, was placed on top of the cells.
Pressure was applied to the coverslip with a pipette tip for 3 min ensuring
contact with the cell membrane. The coverslip was then removed, bringing
adhered membrane with it, and thoroughly rinsed with phosphate-buffered
saline (PBS) to remove remaining intracellular contents. To ensure com-
plete intracellular removal, all samples subjected to this preparation were
transfected with DsRed2-ER, which labels endoplasmic reticulum (ER).
The membrane-attached side of the coverslip was then covered in filtered
deionized water, inverted to create a hanging drop and imaged by confocal
Biophysical Journal 105(4) 887–898
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where Imax is the maximal response plateau, [A] is the log concentration of agonist, and 
nH is the Hill coefficient, using KaleidaGraph v3.6 software (Synergy Software, Reading, 
PA). 
3.3.5 Membrane Isolation  
When one performs ensemble measurements of integral membrane proteins on the 
plasma membrane, it is important to restrict the pool of observed subunits to only those 
that reside on the plasma membrane. To isolate this restricted population, membrane was 
mechanically removed from the rest of the cell as described previously in Perez et al. 
(23). 
This is achieved by bathing HEK293T cells 72–96 h posttransfection in deionized 
water to induce swelling. After 1 min, a No. 1 coverslip, sterilized by sequential 20 min 
6 M KOH and acetone baths with sonication and stored in 20 µm filtered deionized 
water, was placed on top of the cells. Pressure was applied to the coverslip with a pipette 
tip for 3 min, ensuring contact with the cell membrane. The coverslip was then removed, 
bringing adhered membrane with it, and thoroughly rinsed with phosphate-buffered 
saline (PBS) to remove remaining intracellular contents. To ensure complete intracellular 
removal, all samples subjected to this preparation were transfected with DsRed2-ER, 
which labels endoplasmic reticulum (ER). 
The membrane-attached side of the coverslip was then covered in filtered 
deionized water, inverted to create a hanging drop, and imaged by confocal microscopy 
either homo- or heteromeric receptors until exposed to a
reducing agent. Finally, it was shown that cysteine labeling
near the postulated AB orthosteric site hinders ligand
binding only for A subunit residues (21). Together these
findings suggested, contrary to the AFM data (19), the pres-
ence of at least one A-A subunit interface in the 5-HT3AB
receptor.
In this study, we have sought to resolve the stoichiometry
of functional membrane 5-HT3AB receptors using various
fluorescence methods on isolated membrane sheets from
whole cells expressing fluorescent protein fusions of the
5-HT3A and B subunits.
MATERIALS AND METHODS
Materials
The pcDNA3.1(þ) expression vector, and fetal bovine serum reagents,
were purchased from Invitrogen (Carlsbad, CA). TransIT transfection
reagent was purchased from Mirus (Madison, WI). Penicillin/strepto-
mycin (100") solution was purchased from Mediatech (Herndon, VA).
Culture dishes (35 mm, with 14-mm, No. 0 thickness, glass coverslip
microwells) were purchased from Mattek (Ashland, MA). Coverslips
(25 mm, No. 1 thickness glass) were purchased from VWR (Radnor,
PA). Other tissue-culture plasticware was purchased from Greiner Bio-
One (Monroe, CA).
Molecular biology
Monomeric-enhanced (me) CFP and YFP were introduced in frame into the
M3-M4 loops of the human 5HT3A and 5HT3B subunits, taking care to
avoid known signaling and trafficking motifs. The forward primer
50-AAG ACT GAT GAC TGC TCA GCC ATG GGA AAC CAC TGC
AGC CAC ATG GGA GCT GGC GCC ATG GTG AGC AAG
GGC GAG GAG-30
and the reverse primer
50-GGG AGG GCT ACA TCT GTC CCT CGG GCT CTT CTC GAA
GTC CTG GGG TCC GGC GCC TGC CTT GTA CAG CTC GTC
CAT GCC-30
were used in PCR to add overlapping regions homologous to the M3-M4
region of h5-HT3A to meCFP and meYFP. The forward primer
50- GCT AAG TCC ATC GTG TTG GTC AAA TTC CTC CAT GAT
GAG CAG CGT GGT GCT GGC GCC ATG GTG AGC AAG
GGC GAG GAG-30
and the reverse primer
50-GGT TCC TGG CTG GGC CAG GTG CTC TCC ATA CAG CGA
GGA CTC TGT TAC GGC GCC TGC CTT GTA CAG CTC GTC
CAT GCC-30
were used in PCR to add overlapping regions homologous to the M3-M4
region of h5-HT3B to meCFP and meYFP. These products were then
isolated and used as inserts in a second PCR reaction with the correspond-
ing full-length subunit to generate the receptor subunit-fluorescent protein
fusion constructs. The fluorescent protein insertion point for the A subunit
is between Gly-421 and Gly-422. The insertion point for the B subunit
is between Gly-333 and Gly-334. All constructs were verified by
sequencing.
Cell culture and transfection
Human embryonic kidney (HEK) 293T cells, bearing T-antigen, were main-
tained on 100-mm culture plates at 37#C and 5% CO2 in a humidified atmo-
sphere. They were cultured in Dulbecco’s modified Eagle’s medium/
nutrient mix F12 (1:1) with GlutaMAX I media (Invitrogen) containing
10% fetal calf serum and penicillin/streptomycin. Cells at 60–80% conflu-
ency within 35-mm dishes were transfected with a total of 2 mg of plasmid
DNA using the TransIT transient transfection kit (Mirus). For FlexStation
studies (Molecular Devices, Eugene, OR), cells were transfected and then
plated in 96-well plates. Cells were incubated 1–2 days before assay. For
whole-cell fluorescence studies, cells were plated in 35-mm glass-bottomed
dishes and imaged one day after transfection. For membrane isolation
studies, cells were prepared four days after transfection.
FlexStation analysis
The FlexStation (Molecular Devices) analysis technique uses fluorescent
voltage-sensitive dyes to detect changes in the membrane potential. It has
been used to examine various ion channels, including those of the 5-HT3
receptors (22). In brief, fluorescent membrane potential dye (Molecular De-
vices) was diluted in the Flex buffer (10 mMHEPES, 115 mM NaCl, 1 mM
KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM glucose, pH 7.4) and added
to transfected cells grown on a 96-well plate. The cells were incubated at
room temperature for 30 min and then fluorescence was measured in a
FlexStation (Molecular Devices) at 2-s intervals for 200 s. Serotonin
(5-HT) was added to each well after 20 s. The percentage change in fluores-
cence was calculated as
ðF% FminÞ
Fmax
;
where F is peak fluorescence for the current agonist dose, Fmax is peak fluo-
rescence at saturating agonist and Fmin is baseline fluorescence at 20 s.
To determine EC50 values, concentration-response data were fitted to the
four-parameter logistic equation,
I ¼ Imax!
1 þ
"
EC50
½A)
#
nH
$ ;
where Imax is the maximal response plateau, [A] is the log concentration of
agonist, and nH is the Hill coeffici nt, using KaleidaGraph v3.6 software
(Synergy Software, Reading, PA).
Membrane isolation
When one performs ensemble measurements of integral membrane proteins
on the plasma membrane, it is important to restrict the pool of observed sub-
units to only those that reside on the plasma membrane. To isolate this
restricted population, me brane was mechanically removed fro the rest
of the cell as described previously in Perez et al. (23).
This is ach eved by b thing HEK293T c lls 72–96 h posttransfectio in
deionized water to induce swelling. After 1 min, a No. 1 coverslip, sterilized
by sequential 20- in 6-M KOH and ac tone baths with sonication and
stored in 20-mm filtered deionized water, was placed on top of the cells.
Pressure was applied to the coverslip with a pipette tip for 3 min ensuring
contact with the cell membrane. The coverslip was then removed, bringing
adhered membrane with it, and thoroughly rinsed with phosphate-buffered
saline (PBS) to remove remaining intracellular contents. To ensure com-
plete intracellular removal, all samples subjected to this preparation were
transfected with DsRed2-ER, which labels endoplasmic reticulum (ER).
The membrane-attached side of the coverslip was then covered in filtered
deionized water, inverted to create a hanging drop and imaged by confocal
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as detailed below, using a 63×, 1.2 NA violet-corrected Plan Apochromatic 
water-immersion objective (Nikon Instruments, Melville, NY). 
3.3.6 Confocal Microscopy 
Live cells grown on 14 mm glass-bottomed 35 mm dishes (Mattek) precoated 
with poly-d-lysine were washed with PBS and observed in the same solution. Imaging 
was performed at room temperature on an Eclipse C1si laser-scanning confocal 
microscope (Nikon Instruments) equipped with a 63×, 1.4 NA, violet-corrected plan 
Apochromatic oil objective and a multianode photomultiplier tube with 32 channels (both 
by Nikon Instruments). The meCFP, meYFP, and DsRed2 fluorescence signals were 
acquired by 439, 514, and 561 nm excitation, respectively. Where required, images were 
linearly unmixed with the EZ-C1 software (Nikon Instruments) for the emission spectra 
of the fluorophores of interest, using reference spectra individually compiled for each 
fluorophore expressed in the same cell type. 
3.3.7 Donor Recovery After Acceptor Photobleach FRET 
 A series of λ-stack X-Y images were collected with the Eclipse C1si 
laser-scanning confocal microscope (Nikon Instruments). Dequenching of meCFP 
fluorescence during incremental photobleaching of meYFP was performed and analyzed 
as described previously in Son et al. (24) and Nashmi et al. (25). Donor recovery after 
acceptor photobleach (DRAP) Förster resonance energy transfer (FRET) efficiency (E) 
was calculated as 
      (Equation 3.1) 
 
microscopy as detailed below, using an 63! 1.2 NA violet-corrected
Plan Apochromatic water-immersion objective (Nikon Instruments,
Melville, NY).
Confocal microscopy
Live cells grown on 14-mm glass-bottomed 35-mm dishes (Mattek) pre-
coated with poly-d-lysine were washed with PBS and observed in the
same solution. Imaging was performed at room temperature on an Eclipse
C1si laser-scanning confocal microscope (Nikon Instruments) equipped
with a 63!, 1.4 NA, violet-corrected plan Apochromatic oil objective
and a multianode photomultiplier tube with 32 channels (both by Nikon
Instruments). The meCFP, meYFP, and DsRed2 fluorescence signals were
acquired by 439-, 514-, and 561-nm excitation, respectively. Where
required, images were linearly unmixed with the EZ-C1 software (Nikon
Instruments) for the emission spectra of the fluorophores of interest, using
reference spectra individually co piled for each fluorophore expressed in
the same cell type.
Donor recovery after acceptor photobleach FRET
A series of l-stack X-Y images were collected with the Eclipse C1si laser-
scanning confocal microscope (Nikon Instruments). Dequenching of
meCFP fluorescence during incremental photobleaching of meYFP was
performed and analyzed as described previously in Son et al. (24) and
Nashmi et al. (25). Donor recovery after acceptor photobleach (DRAP)
Fo¨rster resonance energy transfer (FRET) efficiency (E) was calculated as
E ¼ 1#
!
IDA
ID
"
: (1)
Here, IDA represents the normalized fluorescence intensity of meCFP
(100%) in the presence of nonbleached acceptor. ID represents the normal-
ized fluorescence intensity of meCFP after 100% photobleach of IA, the
acceptor meYFP. The ID value was extrapolated from a scatter plot of the
percentage increase of meCFP fluorescence versus the percentage decrease
of meYFP fluorescence for each cell (as seen later in Figs. 4 and 5 C) (25).
Fluorescence intensity ratio
First described by Zheng and Zagotta (26) in 2004, fluorescence intensity
ratios (FIR) allow the pairwise determination of the relative abundance of
proteins (27,28). This is achieved by labeling both proteins of interest
with each of two fluorescent reporters. Given reporter requirements for
complete and stoichiometric labeling and the desire to minimize fluoro-
phore-specific changes in target expression, fluorescent protein fusions uti-
lizing the highly homologous meCFP and meYFP are typically chosen.
In FIR, all of the photophysical particularities of the instrumental setup
and the chosen fluorescent proteins reside within a coefficient (C) that
relates observed fluorescence intensities to the relative abundance of the
receptor subunits to which they are fused.
For AmeCFP BmeYFP, this relationship is
k1 ¼ ImeCFP
ImeYFP
¼ C !
!½A%
½B%
"
; (2)
and for AmeYFP BmeCFP, this relationship is
k2 ¼ ImeCFP
ImeYFP
¼ C!½A%
½B%
": (3)
Having determined the fluorescence intensity ratios for fluorescent protein-
receptor subunit fusion pairs, one rearranges the above equations to yield
both [A]/[B] and C as follows:!½A%
½B%
"
¼
ffiffiffiffiffiffi
k1
k2
;
r
(4)
C ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
k1 ! k2
p
: (5)
One complication resides in the ability of meCFP and meYFP to FRET.
However, as a ratiometric method, donor intensity loss via FRET is
expected to affect FIR only to the extent that FRET efficiency differs
between the two fluorescent protein fusion pairs. When such a difference
in FRET efficiency occurs, and before the acceptor is photobleached, a
correction factor (d0) to predict the direction and degree of change in sub-
unit ratio can be calculated by Eqs. 6 and 7, where E1 is the FRETefficiency
for AmeCFPBmeYFP and E2 is that for AmeYFPBmeCFP:
d0 ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi$
1=1# E2
%
$
1=1# E1
%
vuuut ; (6)
Corrected
!½A%
½B%
"
0
¼ d0 !
!!½A%
½B%
"
0
"
: (7)
To calculate FIR, we always used the acceptor intensity at the beginning of
the experiment, before any acceptor photobleaching (shown later in Tables
4 and 5, ImeYFP ¼ 1). Note that these later-appearing tables, Tables 4 and 5,
contain experimental values for d0. Figs. 4 and 5 B, also shown later, pro-
vide examples of this progression.
The constant C varied by 520% among our experiments performed on
different days. This was determined both through calculation of C in FIR
measurements and tests of the predictive power of that value, including
one using equal mole fractions of 5-HT3A-meYFP and 5-HT3A-meCFP
cDNA and unlabeled 5-HT3B, and another using unlabeled 5-HT3A and
equal mole fractions of 5-HT3B-meYFP and 5-HT3B-meCFP cDNA.
Possible bases for this variation include uncontrolled, small changes in
oxygenation, temperature, or the cell cycle, any of which may change the
fraction of immature (i.e., dark) fluorophores.
RESULTS
Fusion constructs of the human 5-HT3A and 5-HT3B
subunits with fluorescent proteins were generated. Both
meCFP and meYFP were individually added to the 5-HT3A
and 5-HT3B subunits, allowing both combinations of the
two fluorescent proteins to be probed. As with previous
Cys-loop receptor subunits, the fluorescent protein was
introduced into the M3-M4 intracellular loop, taking care
to avoid known phosphorylation and trafficking motifs
(2,25,29). These constructs were then transiently expressed
in HEK293T cells, and their functional response to serotonin
was assayed using a voltage-sensitive dye. The 5-HT3AB
receptors formed from the fluorescent protein fusion con-
structs show maximal responses, EC50 values, and Hill
coefficients essentially equivalent to the unlabeled receptor
(Fig. 1; Table 1). This suggests that neither fluorescent label
perturbs the expression level or function of the hetero-pen-
tameric 5-HT3 receptor. The characteristic shifts in EC50
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Here, IDA represents the normalized fluorescence intensity of meCFP (100%) in 
the presence of nonbleached acceptor. ID represents the normalized fluorescence intensity 
of meCFP after 100% photobleach of IA, the acceptor meYFP. The ID value was 
extrapolated from a scatter plot of the percentage increase of meCFP fluorescence versus 
the percentage decrease of meYFP fluorescence for each cell (as seen later in 
Figures 3.4 and 3.6, C) (25). 
3.3.8 Fluorescence Intensity Ratio 
First described by Zheng and Zagotta (26) in 2004, fluorescence intensity ratios 
(FIR) allow the pairwise determination of the relative abundance of proteins (27 and 28). 
This is achieved by labeling both proteins of interest with each of two fluorescent 
reporters. Given reporter requirements for complete and stoichiometric labeling and the 
desire to minimize fluorophore-specific changes in target expression, fluorescent protein 
fusions utilizing the highly homologous meCFP and meYFP are typically chosen. 
In FIR, all of the photophysical particularities of the instrumental setup and the 
chosen fluorescent proteins reside within a coefficient (C) that relates observed 
fluorescence intensities to the relative abundance of the receptor subunits to which they 
are fused. 
For AmeCFP BmeYFP, this relationship is 
      
    (Equation 3.2) 
 
 
microscopy as detailed below, using an 63! 1.2 NA violet-corrected
Plan Apochromatic water-immersion objective (Nikon Instruments,
Melville, NY).
Confocal microscopy
Live cells grown on 14-mm glass-bottomed 35-mm dishes (Mattek) pre-
coated with poly-d-lysine were washed with PBS and observed in the
same solution. Imaging was performed at room temperature on an Eclipse
C1si laser-scanning confocal microscope (Nikon Instruments) equipped
with a 63!, 1.4 NA, violet-corrected plan Apochromatic oil objective
and a multianode photomultiplier tube with 32 channels (both by Nikon
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meCFP fluorescence during incremental photobleaching of meYFP was
performed and analyzed as described previously in Son et al. (24) and
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Fo¨rster resonance energy transfer (FRET) efficiency (E) was calculated as
E ¼ 1#
!
IDA
ID
"
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Here, IDA represents the normalized fluorescence intensity of meCFP
(100%) in the presence of nonbleached acceptor. ID represents the normal-
ized fluorescence intensity of meCFP after 100% photobleach of IA, the
acceptor meYFP. The ID value was extrapolated from a scatter plot of the
percentage increase of meCFP fluorescence versus the percentage decrease
of meYFP fluorescence for each cell (as seen later in Figs. 4 and 5 C) (25).
Fluorescence intensity ratio
First described by Zheng and Zagotta (26) in 2004, fluorescence intensity
ratios (FIR) allow the pairwise determination of the relative abundance of
proteins (27,28). This is achieved by labeling both proteins of interest
with each of two fluorescent reporters. Given reporter requirements for
complete and stoichiometric labeling and the desire to minimize fluoro-
phore-specific changes in target expression, fluorescent protein fusions uti-
lizing the highly homologous meCFP and meYFP are typically chosen.
In FIR, all of the photophysical particularities of the instrumental setup
and the chosen fluorescent proteins reside within a coefficient (C) that
relates observed fluorescence intensities to the relative abundance of the
receptor subunits to which they are fused.
For AmeCFP BmeYFP, this relationship is
k1 ¼ ImeCFP
ImeYFP
¼ C !
!½A%
½B%
"
; (2)
and for AmeYFP BmeCFP, this relationship is
k2 ¼ ImeCFP
ImeYFP
¼ C!½A%
½B%
": (3)
Having determined the fluorescence intensity ratios for fluorescent protein-
receptor subunit fusion pairs, one rearranges the above equations to yield
both [A]/[B] and C as follows:!½A%
½B%
"
¼
ffiffiffiffiffiffi
k1
k2
;
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(4)
C ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
k1 ! k2
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One complication resides in the ability of meCFP and meYFP to FRET.
However, as a ratiometric method, donor intensity loss via FRET is
expected to affect FIR only to the extent that FRET efficiency differs
between the two fluorescent protein fusion pairs. When such a difference
in FRET efficiency occurs, and before the acceptor is photobleached, a
correction factor (d0) to predict the direction and degree of change in sub-
unit ratio can be calculated by Eqs. 6 and 7, where E1 is the FRETefficiency
for AmeCFPBmeYFP and E2 is that for AmeYFPBmeCFP:
d0 ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi$
1=1# E2
%
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1=1# E1
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Corrected
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To calculate FIR, we always used the acceptor intensity at the beginning of
the experiment, before any acceptor photobleaching (shown later in Tables
4 and 5, ImeYFP ¼ 1). Note that these later-appearing tables, Tables 4 and 5,
contain experimental values for d0. Figs. 4 and 5 B, also shown later, pro-
vide examples of this progression.
The constant C varied by 520% among our experiments performed on
different days. This was determined both through calculation of C in FIR
measurements and tests of the predictive power of that value, including
one using equal mole fractions of 5-HT3A-meYFP and 5-HT3A-meCFP
cDNA and unlabeled 5-HT3B, and another using unlabeled 5-HT3A and
equal mole fractions of 5-HT3B-meYFP and 5-HT3B-meCFP cDNA.
Possible bases for this variation include uncontrolled, small changes in
oxygenation, temperature, or the cell cycle, any of which may change the
fraction of immature (i.e., dark) fluorophores.
RESULTS
Fusion constructs of the human 5-HT3A and 5-HT3B
subunits with fluorescent proteins were generated. Both
meCFP and meYFP were individually added to the 5-HT3A
and 5-HT3B subunits, allowing both combinations of the
two fluorescent proteins to be probed. As with previous
Cys-loop receptor subunits, the fluorescent protein was
introduced into the M3-M4 intracellular loop, taking care
to avoid known phosphorylation and trafficking motifs
(2,25,29). These constructs were then transiently expressed
in HEK293T cells, and their functional response to serotonin
was assayed using a voltage-sensitive dye. The 5-HT3AB
receptors formed from the fluorescent protein fusion con-
structs show maximal responses, EC50 values, and Hill
coefficients essentially equivalent to the unlabeled receptor
(Fig. 1; Table 1). This suggests that neither fluorescent label
perturbs the expression level or function of the hetero-pen-
tameric 5-HT3 receptor. The characteristic shifts in EC50
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and for AmeYFP BmeCFP this relationship is 
        
   (Equation 3.3) 
 
Having determined the fluorescence intensity ratios for fluorescent 
protein-receptor subunit fusion pairs, one rearranges the above equations to yield both 
[A]/[B] and C as follows: 
(Equation 3.4) 
 
    (Equation 3.5) 
 
One complication resides in the ability of meCFP and meYFP to FRET. However, 
as a ratiometric method, donor intensity loss via FRET is expected to affect FIR only to 
the extent that FRET efficiency differs between the two fluorescent protein fusion pairs. 
When such a difference in FRET efficiency occurs, and before the acceptor is 
photobleached, a correction factor (d0) to predict the direction and degree of change in 
subunit ratio can be calculated by Equations 3.6 and 3.7, where E1 is the FRET efficiency 
for AmeCFPBmeYFP and E2 is that for AmeYFPBmeCFP: 
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microscopy as detailed below, using an 63! 1.2 NA violet-corrected
Plan Apochromatic water-immersion objective (Nikon Instruments,
Melville, NY).
Confocal microscopy
Live cells grown on 14-mm glass-bottomed 35-mm dishes (Mattek) pre-
coated with poly-d-lysine were washed with PBS and observed in the
same solution. Imaging was performed at room temperature on an Eclipse
C1si laser-scanning confocal microscope (Nikon Instruments) equipped
with a 63!, 1.4 NA, violet-corrected plan Apochromatic oil objective
and a multianode photomultiplier tube with 32 channels (both by Nikon
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required, images were linearly unmixed with the EZ-C1 software (Nikon
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Here, IDA represents the normalized fluorescence intensity of meCFP
(100%) in the presence of nonbleached acceptor. ID represents the normal-
ized fluorescence intensity of meCFP after 100% photobleach of IA, the
acceptor meYFP. The ID value was extrapolated from a scatter plot of the
percentage increase of meCFP fluorescence versus the percentage decrease
of meYFP fluorescence for each cell (as seen later in Figs. 4 and 5 C) (25).
Fluorescence intensity ratio
First described by Zheng and Zagotta (26) in 2004, fluorescence intensity
ratios (FIR) allow the pairwise determination of the relative abundance of
proteins (27,28). This is achieved by labeling both proteins of interest
with each of two fluorescent reporters. Given reporter requirements for
complete and stoichiometric labeling and the desire to minimize fluoro-
phore-specific changes in target expression, fluorescent protein fusions uti-
lizing the highly homologous meCFP and meYFP are typically chosen.
In FIR, all of the photophysical particularities of the instrumental setup
and the chosen fluorescent proteins reside within a coefficient (C) that
relates observed fluorescence intensities to the relative abundance of the
receptor subunits to which they are fused.
For AmeCFP BmeYFP, this relationship is
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One complication resides in the ability of meCFP and meYFP to FRET.
However, as a ratiometric method, donor intensity loss via FRET is
expected to affect FIR only to the extent that FRET efficiency differs
between the two fluorescent protein fusion pairs. When such a difference
in FRET efficiency occurs, and before the acceptor is photobleached, a
correction factor (d0) to predict the direction and degree of change in sub-
unit ratio can be calculated by Eqs. 6 and 7, where E1 is the FRETefficiency
for AmeCFPBmeYFP and E2 is that for AmeYFPBmeCFP:
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To calculate FIR, we always used the acceptor intensity at the beginning of
the experiment, before any acceptor photobleaching (shown later in Tables
4 and 5, ImeYFP ¼ 1). Note that these later-appearing tables, Tables 4 and 5,
contain experimental values for d0. Figs. 4 and 5 B, also shown later, pro-
vide examples of this progression.
The constant C varied by 520% among our experiments performed on
different days. This was determined both through calculation of C in FIR
measurements and tests of the predictive power of that value, including
one using equal mole fractions of 5-HT3A-meYFP and 5-HT3A-meCFP
cDNA and unlabeled 5-HT3B, and another using unlabeled 5-HT3A and
equal mole fractions of 5-HT3B-meYFP and 5-HT3B-meCFP cDNA.
Possible bases for this variation include uncontrolled, small changes in
oxygenation, temperature, or the cell cycle, any of which may change the
fraction of immature (i.e., dark) fluorophores.
RESULTS
Fusion constructs of the human 5-HT3A and 5-HT3B
subunits with fluorescent proteins were generated. Both
meCFP and meYFP were individually added to the 5-HT3A
and 5-HT3B subunits, allowing both combinations of the
two fluorescent proteins to be probed. As with previous
Cys-loop receptor subunits, the fluorescent protein was
introduced into the M3-M4 intracellular loop, taking care
to avoid known phosphorylation and trafficking motifs
(2,25,29). These constructs were then transiently expressed
in HEK293T cells, and their functional response to serotonin
was assayed using a voltage-sensitive dye. The 5-HT3AB
receptors formed from the fluorescent protein fusion con-
structs show maximal responses, EC50 values, and Hill
coefficients essentially equivalent to the unlabeled receptor
(Fig. 1; Table 1). This suggests that neither fluorescent label
perturbs the expression level or function of the hetero-pen-
tameric 5-HT3 receptor. The characteristic shifts in EC50
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microscopy as detailed below, using an 63! 1.2 NA violet-corrected
Plan Apochromatic water-immersion objective (Nikon Instruments,
Melville, NY).
Confocal microscopy
Live cells grown on 14-mm glass-bottomed 35-mm dishes (Mattek) pre-
coated with poly-d-lysine were washed with PBS and observed in the
same solution. Imaging was performed at room temperature on an Eclipse
C1si laser-scanning confocal microscope (Nikon Instruments) equipped
with a 63!, 1.4 NA, violet-corrected plan Apochromatic oil objective
and a multianode photomultiplier tube with 32 channels (both by Nikon
Instruments). The meCFP, meYFP, and DsRed2 fluorescence signals were
acquired by 439-, 514-, and 561-nm excitation, respectively. Where
required, images were linearly unmixed with the EZ-C1 software (Nikon
Instruments) for the emission spectra of the fluorophores of interest, using
reference spectra individually compiled for each fluorophore expressed in
the same cell type.
Donor recovery after acceptor photobleach FRET
A series of l-stack X-Y images were collected with the Eclipse C1si laser-
scanning confocal microscope (Nikon Instruments). Dequenching of
meCFP fluorescence during incremental photobleaching of meYFP was
performed and analyzed as described previously in Son et al. (24) and
Nashmi et al. (25). Donor recovery after acceptor photobleach (DRAP)
Fo¨rster resonance energy transfer (FRET) efficiency (E) was calculated as
E ¼ 1#
!
IDA
ID
"
: (1)
Here, IDA represents the normalized fluorescence intensity of meCFP
(100%) in the presence of nonbleached acceptor. ID represents the normal-
ized fluorescence intensity of meCFP after 100% photobleach of IA, the
acceptor meYFP. The ID value was extrapolated from a scatter plot of the
percentage increase of meCFP fluorescence versus the percentage decrease
of meYFP fluorescence for each cell (as seen later in Figs. 4 and 5 C) (25).
Fluorescence intensity ratio
First described by Zheng and Zagotta (26) in 2004, fluorescence intensity
ratios (FIR) allow the pairwise determination of the relative abundance of
proteins (27,28). This is achieved by labeling both proteins of interest
with each of two fluorescent reporters. Given reporter requirements for
complete and stoichiometric labeling and the desire to minimize fluoro-
phore-specific changes in target expression, fluorescent protein fusions uti-
lizing the highly homologous meCFP and meYFP are typically chosen.
In FIR, all of the photophysical particularities of the instrumental setup
and the chosen fluorescent proteins reside within a coefficient (C) that
relates observed fluorescence intensities to the relative abundance of the
receptor subunits to which they are fused.
For AmeCFP BmeYFP, this relationship is
k1 ¼ ImeCFP
ImeYFP
¼ C !
!½A%
½B%
"
; (2)
and for AmeYFP BmeCFP, this relationship is
k2 ¼ ImeCFP
ImeYFP
¼ C!½A%
½B%
": (3)
Having determined the fluorescence intensity ratios for fluorescent protein-
receptor subunit fusion pairs, one rearranges the above equations to yield
both [A]/[B] and C as follows:!½A%
½B%
"
¼
ffiffiffiffiffiffi
k1
k2
;
r
(4)
C ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
k1 ! k2
p
: (5)
One complication resides in the ability of meCFP and meYFP to FRET.
However, as a ratiometric method, donor intensity loss via FRET is
expected to affect FIR only to the extent that FRET efficiency differs
between the two fluorescent protein fusion pairs. When such a difference
in FRET efficiency occurs, and before the acceptor is photobleached, a
correction factor (d0) to predict the direction and degree of change in sub-
unit ratio can be calculated by Eqs. 6 and 7, where E1 is the FRETefficiency
for AmeCFPBmeYFP and E2 is that for AmeYFPBmeCFP:
d0 ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi$
1=1# E2
%
$
1=1# E1
%
vuuut ; (6)
Corrected
!½A%
½B%
"
0
¼ d0 !
!!½A%
½B%
"
0
"
: (7)
To calculate FIR, we always used the acceptor intensity at the beginning of
the experiment, before any acceptor photobleaching (shown later in Tables
4 and 5, ImeYFP ¼ 1). Note that these later-appearing tables, Tables 4 and 5,
contain experimental values for d0. Figs. 4 and 5 B, also shown later, pro-
vide examples of this progression.
The constant C varied by 520% among our experiments performed on
different days. This was determined both through calculation of C in FIR
measurements and tests of the predictive power of that value, including
one using equal mole fractions of 5-HT3A-meYFP and 5-HT3A-meCFP
cDNA and unlabeled 5-HT3B, and another using unlabeled 5-HT3A and
equal mole fractions of 5-HT3B-meYFP and 5-HT3B-meCFP cDNA.
Possible bases for this variation include uncontrolled, small changes in
oxygenation, temperature, or the cell cycle, any of which may change the
fraction of immature (i.e., dark) fluorophores.
RESULTS
Fusion constructs of the human 5-HT3A and 5-HT3B
subunits with fluorescent proteins were generated. Both
meCFP and meYFP were individually added to the 5-HT3A
and 5-HT3B subunits, allowing both combinations of the
two fluorescent proteins to be probed. As with previous
Cys-loop receptor subunits, the fluorescent protein was
introduced into the M3-M4 intracellular loop, taking care
to avoid known phosphorylation and trafficking motifs
(2,25,29). These constructs were then transiently expressed
in HEK293T cells, and their functional response to serotonin
was assayed using a voltage-sensitive dye. The 5-HT3AB
receptors formed from the fluorescent protein fusion con-
structs show maximal responses, EC50 values, and Hill
coefficients essentially equivalent to the unlabeled receptor
(Fig. 1; Table 1). This suggests that neither fluorescent label
perturbs the expression level or function of the hetero-pen-
tameric 5-HT3 receptor. The characteristic shifts in EC50
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microscopy as detailed below, using an 63! 1.2 NA violet-corrected
Plan Apochromatic water-immersion objective (Nikon Instruments,
Melville, NY).
Confocal microscopy
Live cells grown on 14-mm glass-bottomed 35-mm dishes (Mattek) pre-
coated with poly-d-lysine were washed with PBS and observed in the
same solution. Imaging was performed at room temperature on an Eclipse
C1si laser-scanning confocal microscope (Nikon Instruments) equipped
with a 63!, 1.4 NA, violet-corrected plan Apochromatic oil objective
and a multianode photomultiplier tube with 32 channels (both by Nikon
Instruments). The meCFP, meYFP, and DsRed2 fluorescence signals were
acquired by 439-, 514-, and 561-nm excitation, respectively. Where
required, images were linearly unmixed with the EZ-C1 software (Nikon
Instruments) for the emission spectra of the fluorophores of interest, using
reference spectra individually compiled for each fluorophore expressed in
the same cell type.
Dono recovery after acceptor pho obleach FRET
A series of l-stack X-Y images were collected with the Eclipse C1si laser-
scanning confocal microscope (Nikon Instruments). Dequenching of
meCFP fluorescence during incremental photobleaching f meYFP was
performed and alyzed as described previously in Son et al. (24) and
Nashmi et al. (25). Donor recovery after acceptor photobleach (DRAP)
Fo¨rster resonance energy transfer (FRET) efficiency (E) was calculated as
E ¼ 1#
!
IDA
ID
"
: (1)
Here, IDA represents the normalized fluorescence intensity of meCFP
(100%) in the presence of nonbleached acceptor. ID represents the normal-
ized fluorescence intensity of meCFP after 100% photobleach of IA, the
acceptor meYFP. The ID value was extrapolated from a scatter plot of the
percentage increase of meCFP fluorescence versus the percentage decrease
of meYFP fluorescence for each cell (as seen later in Figs. 4 and 5 C) (25).
Fluorescence intensity ratio
First described by Zheng and Zagotta (26) in 2004, fluorescence intensity
ratios (FIR) allow the pairwise determination of the relative abundance of
proteins (27,28). This is achieved by labeling both proteins of interest
with each of two fluorescent reporters. Given reporter requirements for
complete and stoichiometric labeling and the desire to minimize fluoro-
phore-specific changes in target expression, fluorescent protein fusions uti-
lizing the highly homologous meCFP and meYFP are typically chosen.
In FIR, all of the photophysical particularities of the instrumental setup
and the chosen fluorescent proteins reside within a coefficient (C) that
relates observed fluorescence intensities to the relative abundance of the
receptor subunits to which they are fused.
For AmeCFP BmeYFP, this relationship is
k1 ¼ ImeCFP
ImeYFP
¼ C !
!½A%
½B%
"
; (2)
and for AmeYFP BmeCFP, this relationship is
k2 ¼ ImeCFP
ImeYFP
¼ C!½A%
½B%
": (3)
Having determined the fluorescence intensity ratios for fl orescent protein-
receptor subunit fusion pairs, one rearranges the above equations to yield
both [A]/[B] and C as follows:!½A%
½B%
"
¼
ffiffiffiffiffiffi
k1
k2
;
r
(4)
C ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
k1 ! k2
p
: (5)
One complication resides in the ability of meCFP and meYFP to FRET.
However, as a ratiometric method, donor intensity loss via FRET is
expected to affect FIR only to the extent that FRET efficiency differs
between the two fluorescent protein fusion pairs. When such a difference
in FRET efficiency occurs, and before the acceptor is photobleached, a
correction factor (d0) to predict the direction and degree of change in sub-
u it ratio can be calculated by Eqs. 6 and 7, wher E1 is the FRETefficiency
for AmeCFPBmeYFP and E2 is that for AmeYFPBmeCFP:
d0 ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi$
1=1# E2
%
$
1=1# E1
%
vuuut ; (6)
Corrected
!½A%
½B%
"
0
¼ d0 !
!!½A%
½B%
"
0
"
: (7)
To calculate FIR, we always used the acce tor intensity at the begin ing of
the experim nt, before any acceptor photobleaching (shown later in Tables
4 and 5, ImeYFP ¼ 1). Note that these later-appearing tables, Tables 4 and 5,
contain experiment l values for d0. Figs. 4 and 5 B, also hown later, pro-
vide examples of this progr ssion.
The constant C varied by 520% among our experiments performed on
different days. This was determined both through calculation of C in FIR
measurements and tests of the predictive power of that value, including
one using equal mole fractions of 5-HT3A-meYFP and 5-HT3A-meCFP
cDNA and unlabeled 5-HT3B, and another using unlabeled 5-HT3A and
equal mole fractions of 5-HT3B-meYFP and 5-HT3B-meCFP cDNA.
Possible bases for this variation include uncontrolled, small changes in
oxygenation, temperature, or the cell cycle, any of which may change the
fraction of immature (i.e., dark) fluorophores.
RESULTS
Fusion constructs of the hum n 5-HT3A and 5-HT3B
subunits with fl orescent proteins were generated. Both
meCFP and meYFP were individually added to the 5-HT3A
and 5-HT3B subunits, allowing both combinations of the
two fluorescent proteins to be probed. As with previous
Cys-loop receptor subunits, the fluorescent protein was
introduced into the M3-M4 intracellular loop, taking care
to avoid known phosphorylation and trafficking motifs
(2,25,29). These constructs were then transiently expressed
in HEK293T cells, and their functional response to serotonin
was assayed using a voltage-sensitive dye. The 5-HT3AB
receptors formed from the fluorescent protein fusion con-
structs show maximal responses, EC50 values, and Hill
coefficients essentially equivalent to the unlabeled receptor
(Fig. 1; Table 1). This suggests that neither fluorescent label
perturbs the expression level or function of the hetero-pen-
tameric 5-HT3 receptor. The characteristic shifts in EC50
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microscopy as detailed b low, using an 63! 1.2 NA violet-corrected
Plan Apochrom tic water-immersion objective (Nikon Instruments,
Melville, NY).
Confocal microscopy
Liv cells grown on 14- m glass-bottomed 35-mm dishes (Mattek) pre-
coated with poly-d-lysine were washed with PBS and observed in the
same solution. Imaging was performed at room temperature on an Eclipse
C1si laser-scanning confocal microscope (Nikon Instruments) equipped
with a 63!, 1.4 NA, violet-corrected plan Apochromatic oil objective
and a multianode photomultiplier tube with 32 channels (both by Nik n
Instruments). The meCFP, meYFP, and DsRed2 fluorescence signals were
acquired by 439-, 514-, and 561-nm excitation, respectively. Where
required, images were linearly unmixed with the EZ-C1 software (Nikon
Instruments) for the emission spectra of the fluorophores of interest, using
reference spectra individually compiled for each fluorophore expressed in
the same cell type.
Donor recovery after acceptor photobleach FRET
A series of l-stack X-Y images were collected with the Eclipse C1si laser-
scanning confocal microscope (Nikon Instruments). Dequenching of
meCFP fluorescence during incremental photobleaching of meYFP was
performed and analyzed as described previously in Son et al. (24) and
Nashmi et al. (25). Donor recove y after acceptor photobleach (DRAP)
Fo¨rst r resonance energy transfer (FRET) efficiency (E) was calculated as
E ¼ 1#
!
IDA
ID
"
: (1)
Here, IDA represents the normalized fluorescence intensity of meCFP
(100%) in the presence of nonbleached acceptor. ID represents the normal-
ized fluorescence intensity of meCFP after 100% photobleach of IA, the
acceptor meYFP. The ID value was extrapolated from a scatter plot of the
percentage i crease of meCFP fluorescence versus th perce age decrease
of meYFP fluorescence for each cell (as se n later in Figs. 4 d 5 C) (25).
Flu rescence intensity ratio
First described by Zheng a d Zagotta (26) in 2004, fluorescence intensity
ratios (FIR) allow th pairwise determination of the relative abundance of
proteins (27,28). This is achieved by labeling both proteins of interest
with each of two fluorescent reporters. Given reporter requirements for
complete and stoichiometric labeling and the desire to minimize fluoro-
phore-specifi changes in targ t expression, fluorescent protein fusions uti-
lizing the highly omo ogous meCFP and meYFP are typically chosen.
In FIR, all of the photophysical particularities of the instrumental setup
and the chosen fluorescent proteins reside within a coefficient (C) that
relates observed fluore cence i tensit es to the relative abundance of the
receptor subunits to which they are fused.
For AmeCFP BmeYFP, this relationship is
k1 ¼ ImeCFP
ImeYFP
¼ C !
!½A%
½B%
"
; (2)
and for AmeYFP BmeCFP, this relationship is
k2 ¼ ImeCFP
ImeYFP
¼ C!½A%
½B%
": (3)
Having determined the fluorescence intensity ratios for fluorescent protein-
receptor subunit fusion pairs, one rearranges the above equations to yield
both [A]/[B] and C as follows:!½A%
½B%
"
¼
ffiffiffiffiffiffi
k1
k2
;
r
(4)
C ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
k1 ! k2
p
: (5)
One complication resides in the ability of meCFP and meYFP to FRET.
However, as a ratiometric method, donor intensity loss via FRET is
expected to affect FIR nly to he extent that FRET efficie cy differs
between the two fluorescent protein fusion pairs. When such a difference
in FRET efficiency occurs, and before the acceptor is photobleached, a
correction factor (d0) to predict the direction and degree of change in sub-
unit ratio can be calculated by Eqs. 6 and 7, where E1 is the FRETefficiency
for AmeCFPBmeYFP and E2 is that for AmeYFPBmeCFP:
d0 ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi$
1=1# E2
%
$
1=1# E1
%
vuuu
; (6)
Correct d
!½A%
½B%
"
0
¼ d0 !
!!½A%
½B%
"
0
"
: (7)
To calculate FIR, we always used the acceptor intensity at the beginning of
the experiment, before any acceptor photobleaching (shown later in Tables
4 and 5, ImeYFP ¼ 1). Note that these later-appearing tables, Tables 4 and 5,
contain experimental values for d0. Figs. 4 and 5 B, also shown later, pro-
vide examples of this progression.
The constant C varied by 520% among our experiments performed on
different days. This was determined both through calculation of C in FIR
measurements and tests of the predictive power of that value, including
one using equal mole fractions of 5-HT3A-meYFP and 5-HT3A-meCFP
cDNA and unlabeled 5-HT3B, and another using unlabeled 5-HT3A and
equal mole fractions of 5-HT3B-meYFP and 5-HT3B-meCFP cDNA.
Possible bases for this variation include uncontrolled, small changes in
oxygenation, temperatur , or the cell cyc e, any of which may change the
fraction of immature (i.e., dark) fluorophores.
RESULTS
Fusion constructs of the human 5-HT3A and 5-HT3B
subunits with fluorescent proteins were generated. Both
meCFP and meYFP were individually added to the 5-HT3A
and 5-HT3B subunits, allowing both combinations of the
two fluorescent protein to b probed. As with previous
Cys-loop r ceptor subunits, the fluoresce t protein was
introduced into the M3-M4 intracellular loop, taking care
to avoid known phosphorylation and trafficking motifs
(2,25,29). These constructs were then transiently expressed
in HEK293T cells, and their functional response to seroto in
was assayed using a voltage-sensi ive dye. The 5-HT3AB
receptors formed from the fluorescent protein fusion con-
structs show maximal responses, EC50 values, and Hill
coefficients essentially equivalent to the unlabeled receptor
(Fig. 1; Table 1). This suggests that neither fluorescent label
perturbs the expression level or function of the hetero-pen-
tameric 5-HT3 receptor. The characteristic shifts in EC50
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microscopy as detailed below, using an 63! 1.2 NA violet-corrected
Plan Apochromatic water-immersion objective (Nikon Instruments,
Melville, NY).
Confocal microscopy
Live cells grown on 14-mm glass-bottomed 35-mm dishes (Mattek) pre-
coated with poly-d-lysine were washed with PBS and observed in the
same solution. Imaging was performed at room temperature on an Eclipse
C1si laser-scanning confocal microscope (Nikon Instruments) equipped
with a 63!, 1.4 NA, violet-corrected plan Apochromatic oil objective
and a multianod photomultiplier tube with 32 channels (both by Nikon
Instruments). The meCFP, meYFP, and DsRed2 fluorescenc signals were
a quired by 439-, 514-, and 561-nm excitation, respectiv ly. Where
equired, imag s were li early unmixed with the EZ-C1 software (Nikon
Instruments) for the emission s ectra f the fluor phores of interest, using
reference spectra individually compiled for each fluorophore expressed in
the same cell type.
Donor recovery after acceptor photobleach FRET
A series of l-stack X-Y images were collected with the Eclipse C1si laser-
scanning confocal microscope (Nikon Instruments). Dequenching of
meCFP fluoresce ce during in remental photobleaching f eYFP was
performed and analyzed as described previ usly in S n et al. (24) and
Nashmi t al. (25). Donor recovery after acceptor photobleac (DRAP)
Fo¨rster resonance energy transfer (FRET) efficiency (E) was calculated as
E ¼ 1#
!
IDA
ID
"
: (1)
Here, IDA represents the normalized fluorescence intensity of meCFP
(100%) in the presence of nonbleached acceptor. ID represents the normal-
ized fluorescence intensity of meCFP after 100% photobleach of IA, the
acceptor meYFP. The ID value was extrapolated from a scatt plot of the
percentage incr ase of meCFP fluorescence v sus the percentage decrease
of meYFP fluo escence for each cell (as se n later in Figs. 4 and 5 C) (25).
Fluorescence intensity rati
First described by Zheng and Zagotta (26) in 2004, fluorescence intensity
ratios (FIR) allow the pairwise determination of the relative abundance of
proteins (27,28). This is achieved by labeling both proteins of interest
with each of two fluorescent reporters. Given reporter requirements for
complete and stoichiometric labeling and the desire to minimize fluoro-
phore-specific changes in target expression, fluorescent protein fusions uti-
lizing the highly homologous meCFP and meYFP are typically chosen.
In FIR, all of the photophysical particularities of the instrumental setup
and the chosen fluorescent proteins reside within a coefficient (C) that
relates observed fluorescence intensities to the relative abundance of the
receptor subunits to which they are fused.
For AmeCFP BmeYFP, this relationship is
k1 ¼ ImeCFP
ImeYFP
¼ C !
!½A%
½B%
"
; (2)
and for AmeYFP BmeCFP, this relationship is
k2 ¼ ImeCFP
ImeYFP
¼ C!½A%
½B%
": (3)
Having determined the fluorescence intensity ratios for fluorescent protein-
receptor subunit fusion pairs, one rearranges the above equations to yield
both [A]/[B] and C as follows:!½A%
½B%
"
¼
ffiffiffiffiffiffi
k1
k2
;
r
(4)
C ¼
ffiffiffiffiffiffiffiffiffiffi ffiffiffiffi
k1 ! k2
p
: (5)
One complication resides in the ability of meCFP and meYFP to FRET.
However, as a ratiometric method, onor intensity l ss via FRET is
exp cted to affect FIR only to the extent that FRET efficiency differs
between the two fluorescent protein fusion pairs. When such a diff rence
in FRET efficiency ccurs, and before the acceptor is photobleached, a
correction factor (d0) to predict the direction and degre of change n sub-
unit ratio can be calculated by Eqs. 6 and 7, wh re E1 is the FRETefficiency
for AmeCFPBmeYFP and E2 is that for AmeYFPBmeCFP:
d0 ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi$
1=1# E2
%
$
1=1# E1
%
vuuut ; (6)
Corrected
!½A%
½B%
"
0
¼ d0 !
!!½A%
½B%
"
0
"
: (7)
To calculate FIR, we always used the acceptor intensity at the beginning of
the experiment, before any acceptor photobleaching (shown later in Tables
4 and 5, ImeYFP ¼ 1). Note that these later-appearing tables, Tables 4 and 5,
contain experimental values for d0. Figs. 4 and 5 B, also shown later, pro-
vide examples of this progression.
The constant C varied by 520% among our experiments performed on
different days. This was determined both through calculation of C in FIR
measurements and tests of the predictive power of that value, including
one using equal mole fractions of 5-HT3A-meYFP and 5-HT3A-meCFP
cDNA and unlabeled 5-HT3B, and a other using unl beled 5- T3A and
equal mole fractions of 5-HT3B-meYFP and 5-HT3B-meCFP cDNA.
Possible bases for this variation include uncontrolled, small changes in
oxygenation, temperature, or the cell cycle, any of which may change the
fraction of immatur (i.e., dark) fluorophores.
RESULTS
Fusion co struct of the hum 5-HT3A and 5-HT3B
subunits with fluorescent proteins were generated. Both
meCFP and meYFP were individually added to the 5-HT3A
and 5-HT3B subunits, allowing both combinations of the
two fluorescent proteins to be probed. As with previous
Cys-loop receptor subunits, the fluorescent protein was
introduced into the M3-M4 intracellular loop, taking care
to av id known phosphorylation and trafficking motifs
(2,25,29). These constructs were then transiently expressed
in HEK293T cells, and their functional response to serotonin
was assayed using a voltage-sensitive dye. The 5-HT3AB
receptors formed from the fluorescent protein fusion con-
structs show maximal responses, EC50 values, and Hill
coefficients essentially equivalent to the unlabeled receptor
(Fig. 1; Table 1). This su gests that neither fluorescent label
perturbs th expression level or function of the hetero-pen-
tameric 5-HT3 receptor. The characteristic shifts in EC50
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To calculate FIR, we always used the acceptor intensity at the beginning of the 
experiment, before any acceptor photobleaching (shown later in Tables 3.4 and 3.5, 
ImeYFP = 1). Note that these later-appearing tables, Tables 3.4 and 3.5, contain 
experimental values for d0. Figures 3.4 and 3.6, B, also shown later, provide examples of 
this progression. 
The constant C varied by ±20% among our experiments performed on different 
days. This was determined both through calculation of C in FIR measurements and tests 
of the predictive power of that value, including one using equal mole fractions of 
5-HT3A-meYFP and 5-HT3A-meCFP cDNA and unlabeled 5-HT3B, and another using 
unlabeled 5-HT3A and equal mole fractions of 5-HT3B-meYFP and 5-HT3B-meCFP 
cDNA. Possible bases for this variation include small, uncontrolled changes in 
oxygenation, temperature, or the cell cycle, any of which may change the fraction of 
immature (i.e., dark) fluorophores. 
 
3.4 RESULTS 
 Fusion constructs of the human 5-HT3A and 5-HT3B subunits with fluorescent 
proteins were generated. Both meCFP and meYFP were individually added to the 
5-HT3A and 5-HT3B subunits, allowing both combinations of the two fluorescent 
proteins to be probed. As with previous Cys-loop receptor subunits, the fluorescent 
protein was introduced into the M3-M4 intracellular loop, taking care to avoid known 
phosphorylation and trafficking motifs (2, 25, and 29). These constructs were then 
transiently expressed in HEK293T cells, and their functional response to serotonin was 
assayed using a voltage-sensitive dye. The 5-HT3AB receptors formed from the 
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fluorescent protein fusion constructs show maximal responses, EC50 values, and Hill 
coefficients essentially equivalent to the unlabeled receptor (Figure 3.1; Table 3.1). This 
suggests that neither fluorescent label perturbs the expression level or function of the 
hetero-pentameric 5-HT3 receptor. The characteristic shifts in EC50 and Hill coefficient 
between the homo- and heteromeric receptors would betray mixed populations of 
receptor by generating a biphasic dose-response relationship. An equal mole ratio of 
transfected 5-HT3A and 5-HT3B subunit DNA, however, yielded a pure population of 
heteromeric receptors. 
?
Figure 3.1 5-HT3 receptor agonist dose-response relations are not changed by labeling 
the fluorescent labels on the subunits. Receptors expressed in HEK293T cells were 
assayed with a voltage-sensitive dye. All heteromeric receptors were transfected with a 
1:1 ratio of A/B subunit cDNA. 
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Table 3.1 5-HT3 Receptor agonist dose-response data. All values are reported as 
mean ± standard error. 
 
Transfected fluorescent 5-HT3 receptor and ER marker showed extensive 
colocalization, demonstrating marked ER retention of the component receptor subunits, 
thereby obscuring the plasma membrane population of assembled functional receptors 
(Figure 3.2). The ER retention seen with transfected cells may be partially due to the 
addition of the large GFP proteins. To isolate plasma membrane-embedded receptors, 
plasma membranes were allowed to adhere to a coverslip before being mechanically 
sheared away from the cell body by removal of that coverslip. Extensive rinsing in PBS 
removed residual intracellular contents. Subsequent imaging of the coverslip reveals 
much lower ER marker fluorescence while retaining fragments bearing fluorescent 5-HT3 
receptor with shallow z-axis signatures. We term these “membrane sheets”. 
 
 
 
 
 
and Hill coefficient between the homo- and heteromeric re-
ceptors would betraymixed populations of receptor by gener-
ating a biphasic dose-response relationship. An equal mole
ratio of transfected 5-HT3A and 5-HT3B subunit DNA, how-
ever, yielded a pure population of heteromeric receptors.
Transfected fluorescent 5-HT3 receptor and ER marker
showed extensive colocalization, demonstrating marked
ER retention of the component receptor subunits, thereby
obscuring the plasma membrane population of assembled
functional receptors (Fig. 2). The ER retention seen with
transfected cells may be partially due to the addition of
the large GFP proteins. To isolate plasma membrane-
embedded receptors, plasma membranes were allowed to
adhere to a coverslip before being mechanically sheared
away from the cell body by removal of that coverslip. Exten-
sive rinsing in PBS removed residual intracellular contents.
Subsequent imaging of the coverslip reveals much lower ER
marker fluorescence while retaining fragments bearing fluo-
rescent 5-HT3 receptor with shallow z-axis signatures. We
term these ‘‘membrane sheets’’.
FIR measurements show A3B2 subunit ratios
FIR measurements (Fig. 3) provide direct determination of
subunit ratios. As will be shown below, these measurements
required only minimal correction for FRET. FIR were deter-
mined for membrane sheets containing both labeling
patterns (5-HT3A-meYFP/5-HT3B-meCFP and 5-HT3A-
meCFP/5-HT3B-meYFP; see Fig. S1 in the Supporting Ma-
terial). The average FIR for both pairings of subunit and
fluorescent protein were then related by Eq. 4 to yield the
relative concentration of A to B subunits (Table 2). The
membrane-sheet/subunit ratio revealed by FIR shows a
slight dependence on the cDNA transfection ratio, but in
all cases strongly suggests three A subunits for every two
B subunits (Fig. 3).
Clearly, the ratio of subunit cDNA transfected did not
strongly influence the ratio of subunit protein expressed in
the plasma membrane sheets. When similar analyses were
performed on intact cells, we found a markedly different
pattern. Although 2–3 day incubations were required for
satisfactory fluorescence signals in the membrane-sheet
samples, strong fluorescence was observed within 24 h of
transfection for whole cells. In identically treated samples
transfected with 0.75 mol fraction 5-HT3B, the whole cell
fluorescence intensity corresponding to the A subunit
increased 7.5 5 1.2-fold from membrane-sheet levels.
The fluorescence intensity corresponding to the B subunit
increased only 3.55 0.5-fold. The subunit ratios calculated
FIGURE 1 5-HT3 receptor agonist dose-response relations are not
changed by labeling the fluorescent labels on the subunits. Receptors
expressed in HEK293T cells were assayed with a voltage-sensitive dye.
All heteromeric receptors were transfected with a 1:1 ratio of A/B subunit
cDNA. See Table 1.
TABLE 1 5-HT3 Receptor agonist dose-response data
Maximal
response (AU)
5-HT EC50
(mM)
Hill
coefficient (nH) N
5-HT3A 6675 28 0.245 0.02 3.05 0.6 16
5-HT3AB 6165 23 1.15 0.2 1.85 0.3 6
5-HT3AmeYFPBmeCFP 5745 31 1.25 0.1 1.55 0.2 6
5-HT3AmeCFPBmeYFP 5715 54 1.55 0.3 1.75 0.4 6
5-HT3ABY129S 5265 23 1.35 0.1 1.85 0.3 6
All values are reported as mean5 standard error.
FIGURE 2 Fluorescence imaging of whole cells and isolated membrane
sheets. (A) Illustration of membrane-sheet preparation method. (B)
HEK293T cells transfected with 5-HT3AmeYFP and DsRed2-ER.
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Figure 3.2 Fluorescence imaging of whole cells and isolated membrane sheets. (A) 
Illustration of membrane-sheet preparation method. (B) HEK293T cells transfected with 
5-HT3AmeYFP and DsRed2-ER 
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3.4.1	  FIR	  Measurements	  Show	  A3B2	  Subunit	  Ratios	  
 FIR measurements provide direct determination of subunit ratios. As will be 
shown below, these measurements required only minimal correction for FRET. FIR were 
determined for membrane sheets containing both labeling patterns 
(5-HT3A-meYFP/5-HT3B-meCFP and 5-HT3A-meCFP/5-HT3B-meYFP). Fluorescence 
intensity ratios for individual membrane sheets display tight bunching, as demonstrated in 
Figure 3.3. The average FIR for both pairings of subunit and fluorescent protein were 
then related by Equation 3.4 to yield the relative concentration of A to B subunits 
(Table 3.2). The membrane-sheet/subunit ratio revealed by FIR shows a slight 
dependence on the cDNA transfection ratio, but in all cases strongly suggests three 
A subunits for every two B subunits (Figure 3.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Fluorescence intensity ratio (FIR) on 5-HT3AB membrane sheets: support for 
the A3B2 subunit ratio. Heteromers were expressed from a 1:9 ratio of A subunit to B 
subunit cDNA. Each point corresponds to a single membrane sheet’s FRET corrected 
FIR. Expected average values for various stoichiometries were calculated using C as 
determined by Equation 3.5. These data provide one of the data points in Figure 3.4 and 
Table 3.2. 
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Figure S1. Fluorescence intensity ratio (FIR) on 5-HT3AB membrane sheets: support for 
the A3B2 subunit ratio. Heteromers were expressed from a 1:9 ratio of A subunit to 
B subunit cDNA. Each point corresponds to a single membrane sheet’s FRET corrected 
FIR. Expected average values f r various st ichiometries were calculated using C as 
determined by Eq. 5. These data provide one of the data points in Figure 3 and Table 2. 
59 
Table 3.2 Fluorescence data, membrane sheets. All values are reported as 
mean ± standard error. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 5-HT3AB 
receptor subunit ratio is 
3:2 on the plasma 
membrane, as calculated 
by FIR at various subunit 
cDNA transfection ratios. 
Both axes are shown on a 
logarithmic scale. (see 
Table 2). Error bars 
depict the standard error.
  
 
 
by FIR were strongly dependent on the relative amount of
subunit cDNA transfected. Whereas the membrane-sheet
subunit ratios all suggest a single receptor subunit ratio, in
whole cells every condition points toward a different ratio
(Fig. 3; Table 3).
Family FRET measurements provide minor
corrections to FIR and support for A3B2
stoichiometry
Previous work with other heteromeric Cys-loop receptors,
especially a4b2 nicotinic receptors, has shown that fluores-
cently labeled heteromeric receptors of differing stoichiom-
etries can display differences in FRET efficiencies (24,30).
The FIR experiments described in Fig. 3 provide a family
FRET experiment: all the A subunits bear donor fluoro-
phores, and all the B subunits bear acceptor fluorophores
(or vice versa). To evaluate family FRET efficiencies,
DRAP time courses were determined (Fig. 4, A–C). Donor
fluorescence at complete acceptor photobleach is extrapo-
lated from this time course, allowing for the calculation of
FRET efficiency by Eq. 1. This procedure was performed
for both pairings of subunit and fluorescent protein within
the heteromeric receptor at various transfected mole ratios
of 5-HT3A and 5-HT3B subunit cDNA (Table 2). The stoi-
chiometry of donor fluorophores to acceptor fluorophores
is different in the two pairings of subunit and fluorescent
protein. This causes changes in the measured FRET effi-
ciencies of CFP- and YFP-labeled 5-HT3AB receptors in
the membrane sheets.
In a first application of these family FRET measurements,
we employed them in Eqs. 6 and 7 to calculate the correc-
tion factor (d0) to the FIR measurements.
In a second application of these family FRET measure-
ments, their comparative amplitudes provide independent
support for our conclusions about subunit stoichiometry.
A satisfactory theory for family FRET measurements
must account for several factors, including the subunit order,
dipole orientation, departures from pentameric symmetry,
and coplanarity of the fluorophores within the M3-M4 loops
(24,30). These parameters are not known for any hetero-
meric Cys-loop receptor. Importantly, a reasonable range
of assumptions about these parameters predict that FRET
for two donor subunits and three acceptor subunits exceeds
that for a receptor with three donor subunits and two
acceptor subunits (24,30). The theory accounts for pub-
lished data on transfected cells in which a4b2 stoichiome-
tries were manipulated in one of three ways:
1. By varying fluorescent subunit cDNA ratios;
2. By treating with pharmacological chaperone; or
3. By mutations that change the stoichiometry (30,31).
These experiments on 5-HT3AB showed the pattern ex-
pected from the FIR data (24,30). 5-HT3AB receptors
thought to have two donors/three acceptors from the FIR
data had greater FRET than those with three donors/two ac-
ceptors. When the A subunit was labeled with the acceptor
FIGURE 3 5-HT3AB receptor subunit ratio is 3:2 on the plasma mem-
brane, as calculated by FIR at various subunit cDNA transfection ratios.
Both axes are shown on a logarithmic scale. See Table 2. Error bars depict
the standard error.
TABLE 2 Fluorescence data, membrane sheets
Mole fraction 5-HT3A Mole fraction 5-HT3B FRET
efficiency (%)
Fluorescence intensity
ratio (meCFP/meYFP) [A]/[B] NmeCFP meYFP meCFP meYFP
0.5 0.5 26.15 0.7 0.2735 0.023 1.935 0.29 22
0.5 0.5 30.85 0.4 0.0735 0.009 16
0.25 0.75 27.65 0.6 0.2315 0.015 1.575 0.17 44
0.25 0.75 32.75 0.8 0.0945 0.008 40
0.1 0.9 25.25 0.6 0.1905 0.015 1.375 0.15 13
0.1 0.9 33.95 1.4 0.1025 0.009 21
All values are reported as mean5 standard error.
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Clearly, the ratio of subunit cDNA transfected did not strongly influence the ratio 
of subunit protein expressed in the plasma membrane sheets. When similar analyses were 
performed on intact cells, we found a markedly different pattern. Although 2–3 day 
incubations were required for satisfactory fluorescence signals in the membrane-sheet 
samples, strong fluorescence was observed within 24 h of transfection for whole cells. In 
identically treated samples transfected with 0.75 mol fraction 5-HT3B, the whole cell 
fluorescence intensity corresponding to the A subunit increased 7.5 ± 1.2 fold from 
membrane-sheet levels. The fluorescence intensity corresponding to the B subunit 
increased only 3.5 ± 0.5 fold. The subunit ratios calculated by FIR were strongly 
dependent on the relative amount of subunit cDNA transfected. Whereas the 
membrane-sheet subunit ratios all suggest a single receptor subunit ratio, in whole cells 
every condition points toward a different ratio (Figure 3.4; Table 3.3). 
 
 
Table 3.3 Fluorescence data, whole cells. All values are reported as mean ± standard 
error. 
 
 
 
3.4.2	  Family	  FRET	  measurements	  provide	  minor	  corrections	  to	  FIR	  and	  support	  
for	  A3B2	  stoichiometry	  
Previous work with other heteromeric Cys-loop receptors, especially α4β2 
nicotinic receptors, has shown that fluorescently labeled heteromeric receptors of 
(meYFP) and the B subunit with the donor (meCFP), FRET
efficiency was 1.18–1.34 times that with the opposite pair-
ing when evaluating membrane sheets. The FRET efficiency
was also independent of cDNA transfection ratio. These
data are consistent with the view of a receptor with an
A3B2 stoichiometry on the plasma membrane. In contrast,
the FRET efficiencies for whole cells were strongly depen-
dent on cDNA transfection ratio (Fig. 4, D and E; Table 3).
In the absence of a correction for the higher FRET effi-
ciency when the A subunit has meYFP, the ratio of A/B
subunits derived from FIR (detailed previously) varies at
different degrees of acceptor photobleaching. Furthermore,
TABLE 3 Fluorescence data, whole cells
Mole fraction 5-HT3A Mole fraction 5-HT3B FRET
efficiency (%)
Fluorescence intensity
ratio (meCFP/meYFP) [A]/[B] NmeCFP meYFP meCFP meYFP
0.5 0.5 15.75 0.5 0.6185 0.047 3.715 0.41 23
0.5 0.5 57.85 5.0 0.0455 0.003 24
0.25 0.75 26.85 1.2 0.4245 0.025 2.045 0.27 25
0.25 0.75 47.55 2.2 0.1025 0.012 17
0.1 0.9 32.55 0.7 0.1355 0.011 0.735 0.07 20
0.1 0.9 21.75 1.2 0.2525 0.017 24
All values are reported as mean5 standard error.
FIGURE 4 Family FRET measurements are consistent with A3B2 stoichiometry. Donor recovery after acceptor photobleaching (DRAP) on 5-HT3AB
membrane sheets. (A) Representative membrane-sheet images before and after photobleaching for AmeCFPBmeYFP transfected with a 1:1 ratio of A/B subunit
cDNA. (B) The corresponding plot of fluorescence during the acceptor photobleaching time course. (C) Extrapolation of the photobleaching time course in B
to donor fluorescence intensity at complete acceptor bleach. (D) FRET efficiency of 5-HT3AmeYFPBmeCFP at various subunit cDNA transfection ratios. The X
axis is shown on a logarithmic scale. (E) FRET efficiency of 5-HT3AmeCFPBmeYFP at various subunit cDNA transfection ratios. The X axis is shown on a
logarithmic scale. See Table 2. Error bars depict the standard error.
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differing stoichiometries can display differences in FRET efficiencies (24 and 30). The 
FIR experiments described in Figure 4.4 provide a family FRET experiment: all the 
A subunits bear donor fluorophores, and all the B subunits bear acceptor fluorophores (or 
vice versa). To evaluate family FRET efficiencies, DRAP time courses were determined 
(Figure 3.5, A–C). Donor fluorescence at complete acceptor photobleach is extrapolated 
from this time course, allowing for the calculation of FRET efficiency by Equation 3.1. 
This procedure was performed for both pairings of subunit and fluorescent protein within 
the heteromeric receptor at various transfected mole ratios of 5-HT3A and 5-HT3B 
subunit cDNA (Table 3.2). The stoichiometry of donor fluorophores to acceptor 
fluorophores is different in the two pairings of subunit and fluorescent protein. This 
causes changes in the measured FRET efficiencies of CFP- and YFP-labeled 5-HT3AB 
receptors in the membrane sheets. 
In a first application of these family FRET measurements, we employed them in 
Equations 3.6 and 3.7 to calculate the correction factor (d0) to the FIR measurements. 
In a second application of these family FRET measurements, their comparative 
amplitudes provide independent support for our conclusions about subunit stoichiometry. 
A satisfactory theory for family FRET measurements must account for several 
factors, including the subunit order, dipole orientation, departures from pentameric 
symmetry, and coplanarity of the fluorophores within the M3-M4 loops (24 and 30). 
These parameters are not known for any heteromeric Cys-loop receptor. Importantly, a 
reasonable range of assumptions about these parameters predict that FRET for two donor 
subunits and three acceptor subunits exceeds that for a receptor with three donor subunits 
and two acceptor subunits (24 and 30). The theory accounts for published data on 
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transfected cells in which α4β2 stoichiometries were manipulated in one of three ways: 
1. By varying fluorescent subunit cDNA ratios; 
2. By treating with pharmacological chaperone; or 
3. By mutations that change the stoichiometry (30 and 31) 
 
 
Figure 3.5 Family FRET measurements are consistent with A3B2 stoichiometry. Donor 
recovery after acceptor photobleaching (DRAP) on 5-HT3AB membrane sheets. (A) 
Representative membrane-sheet images before and after photobleaching for AmeCFPBmeYFP 
transfected with a 1:1 ratio of A/B subunit cDNA. (B) The corresponding plot of 
fluorescence during the acceptor photobleaching time course. (C) Extrapolation of the 
photobleaching time course in B to donor fluorescence intensity at complete acceptor 
bleach. (D) FRET efficiency of 5-HT3AmeYFPBmeCFP at various subunit cDNA transfection 
ratios. The X-axis is shown on a logarithmic scale. (E) FRET efficiency of 
5-HT3AmeCFPBmeYFP at various subunit cDNA transfection ratios. The X-axis is shown on 
a logarithmic scale (see Table 3.2). Error bars depict the standard error. 
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These experiments on 5-HT3AB showed the pattern expected from the FIR data 
(24 and 30). 5-HT3AB receptors thought to have two donors/three acceptors from the FIR 
data had greater FRET than those with three donors/two acceptors. When the A subunit 
was labeled with the acceptor (meYFP) and the B subunit with the donor (meCFP), 
FRET efficiency was 1.18–1.34 times that with the opposite pairing when evaluating 
membrane sheets. The FRET efficiency was also independent of cDNA transfection ratio. 
These data are consistent with the view of a receptor with an A3B2 stoichiometry on the 
plasma membrane. In contrast, the FRET efficiencies for whole cells were strongly 
dependent on cDNA transfection ratio (Figure 3.5, D and E; Table 3.3). 
In the absence of a correction for the higher FRET efficiency when the A subunit 
has meYFP, the ratio of A/B subunits derived from FIR (detailed previously) varies at 
different degrees of acceptor photobleaching. Furthermore, if both measures are 
exclusively the result of assembled receptors, the difference in FRET efficiencies should 
predict the direction and degree of change in the subunit ratio, according to Equations 3.6 
and 3.7. For membrane sheets, the changes in subunit ratios derived from FIR during 
photobleaching agree with the corrected FIR at all cDNA transfection ratios (Table 3.4). 
 
Table 3.4 Effect of acceptor photobleaching on subunit ratio, membrane sheets. All 
values are reported as mean ± standard error. 
 
For whole cells, the d0-corrected subunit ratio is markedly different from that 
observed at complete acceptor photobleach for two of three transfection ratios 
if both measures are exclusively the result of assembled
receptors, the difference in FRET efficiencies should predict
the direction and degree of change in the subunit ratio
according to Eqs. 6 and 7. For membrane sheets, the
changes in subunit ratios derived from FIR during photo-
bleaching agree with the corrected FIR at all cDNA trans-
fection ratios (Table 4).
For whole cells, the d0-corrected subunit ratio is markedly
different from that observed at complete acceptor photo-
bleach for two of three transfection ratios (Table 5). T is in-
dicates that additional complexities contribute to the FRET
efficiencies and subunit ratios for whole cells.
Twin FRET measurements support the inference
of A3B2 stoichiometry
We also employed another FRET-based method for probing
stoichiometry—twin FRET analysis—in which receptors
are composed of one subunit subtype that is unlabeled and
another that is an equal mixture of CFP and YFP constructs
(24) (Fig. 5, A–D). Previous theory and experiments show
that twin FRET data for (a4)3(b2)2 versus (a4)2(b2)3
nAChRs are dominated by the fact that the former stoichi-
ometry has two adjacent a4 subunits and no adjacent b2
subunits; but the latter stoichiometry has the contrasting
patter of adjacency. The differences ar se from the steep
distance-dependence of FRET (24).
Membrane sheets transfected with 0.75 mol fraction
5-HT3B with the A subunit doubly labeled have a FRET
efficiency of 33.2 5 1.2% (N ¼ 19) (Fig. 5 D). This is
generally compatible with a structure containing at least
two A subunits. The rather high efficiency suggests that
two of the A subunits are adjacent in most receptors; this
is required if there are three A subunits in a pentamer.
Twin FRET between the labeled B subunits is also detect-
able, at an efficiency of 18.35 0.7% (N¼ 9) (Fig. 5D). This
shows that there are also at least twoB subunits. As discussed
below, the lower FRETefficiency for the B subunits indicates
that probably there are only two, nonadjacent B subunits in
most receptors. Thus, these twin FRETexperiments also sup-
port the conclusion of predominantly A3B2 stoichiometry.
The 5-HT3B Y129S subunit assembles into
receptors like the B subunit
The B subunit studied in the experiments above contains
tyrosine at position 129. A single-nucleotide non-
synonymous polymorphism HTR3B p.Y129S (c.386A>C,
rs11767445) has been associated with several diseases,
including major depression and bipolar affective disorder
(4,32–34). This residue is located on a b-strand beneath
the orthosteric binding site, and the side chain is modeled
to project into the inter-subunit interface. We constructed
and studied Y129S subunits containing both fluorophores.
To investigate the possibility that Y129S might affect
receptor assembly and stoichiometry, the subunit ratio deter-
mined by FIR was measu ed on membrane sheets tra s-
fected with 0.75 mol fraction 5-HT3BY129S. The FRET
efficiencies and subunit ratio calculated by FIR were largely
unchanged from that of the Y129 B subunit (which we usu-
ally term B) receptor, suggesting a receptor stoichiometry of
three A subunits and two B subunits for the variant receptor
(Tables 2 and 6; Fig. 3; Fig. 4, D and E).
Because heterozygotes for the B subunit allele (one 129Y,
one 129S) occur in >30% of many human populations (32),
we investigated the relative efficiency of incorporating the
two variant B subunits, when both are expressed simulta-
neously. In the conceptually simplest experiments (Table 7),
we directly compared the plasma membrane subunit ratios
of tagged Y129 B (also called simply, B) subunits and
tagged BY129S subunits when those cDNAs were transfected
at equal amounts, along with labeled A subunit cDNAs.
We found a [B]/BY129S ratio of 0.86 5 0.12. Twin FRET
efficiencies between coassembled B and BY129S subunits
(17–19%) are near those between coassembled B and B sub-
units (18%) (Fig. 5 D and Table 7).
In another experiment (Table 8), untagged B subunits and
tagged BY129S subunits were expressed at equal cDNA
amounts, along with tagged A subunits. We measured a
plasma membrane [A]/BY129S subunit ratio of 2.66 5
0.37, implying that BY129S subunits are 1.11-fold more
abundant than the value of 3 expected if the two B subunit
variants incorporated with equal efficiency in A3B2 recep-
tors. Family FRETexperiments gave additional information.
With BY129S-meYFP as acceptor, we measured a FRET
efficiency of 12.4 5 0.2%, as expected if each receptor
has roughly half as many B-acceptors. With BY129S-meCFP
as donor, we measured a FRET efficiency like that in
previous experiments, suggesting that, as usual, each
B subunit donor resides in a receptor with three A subunit
acceptors.
Thus the FIR experiments show a consistent pattern.
When the two subunit variants are expressed simulta-
neously, the BY129S subunit incorporates into assembled
TABLE 4 Effect of acceptor photobleaching on subunit ratio, membrane sheets
Mole fraction 5-HT3B ImeYFP ¼ 1 ImeYFP ¼ 0.6 ImeYFP ¼ 0.25 ImeYFP ¼ 0 d0 ImeYFP ¼ 1 corrected by d0
0.5 1.965 0.31 1.955 0.29 1.975 0.28 1.935 0.29 0.97 1.90
0.75 1.605 0.19 1.585 0.19 1.565 0.17 1.575 0.17 0.96 1.54
0.9 1.415 0.20 1.385 0.18 1.365 0.15 1.375 0.15 0.94 1.33
All values are reported as mean5 standard error.
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(Table 3.5). This indicates that additional complexities contribute to the FRET 
efficiencies and subunit ratios for whole cells. 
Table 3.5 Effect of acceptor photobleaching on subunit ratio, whole cells. All values are 
reported as mean ± standard error. 
 
 
3.4.3	  Twin	  FRET	  measurements	  support	  the	  inference	  of	  A3B2	  stoichiometry	  
We also employed another FRET-based method for probing stoichiometry—twin 
FRET analysis—in which receptors are composed of one subunit subtype that is 
unlabeled and another that is an equal mixture of CFP and YFP constructs (24) 
(Figure 4.6, A–D). Previous theory and experiments show that twin FRET data for 
(α4)3(β2)2 versus (α4)2(β2)3 nAChRs are dominated by the fact that the former 
stoichiometry has two adjacent α4 subunits and no adjacent β2 subunits; but the latter 
stoichiometry has the contrasting pattern of adjacency. The differences arise from the 
steep distance-dependence of FRET (24). 
Membrane sheets transfected with 0.75 mol fraction 5-HT3B with the A subunit 
doubly labeled have a FRET efficiency of 33.2 ± 1.2% (N = 19) (Figure 3.6, D). This is 
generally compatible with a structure containing at least two A subunits. The rather high 
efficiency suggests that two of the A subunits are adjacent in most receptors; this is 
required if there are three A subunits in a pentamer. 
 
plasma membrane 5-HT3AB receptors in a manner slightly
(1.11–1.14-fold) more efficient than that of the B subunit.
DISCUSSION
These measurements provide a robust determination of sub-
unit stoichiometry for a Cys-loop receptor in the plasma
membrane. The data arise from combining several tech-
niques, including isolation of plasma membrane sheets
(23), FIR measurements (26–28), FRET measurements,
and the placement of fluorescent proteins in the M3-M4
loop of Cys-loop receptors while conserving most aspects
of receptor function (24,25). Heteromeric receptors formed
from subunits containing fluorescent proteins display mini-
mally perturbed serotonin EC50 values and Hill coefficients
in HEK293T cells (Fig. 1; Table 1).
In whole cells, retention of the receptor subunits in the
endoplasmic reticulum complicated the characterization of
assembled receptors on the plasma membrane. In particular,
subunit ratios determined by various approaches are strongly
dependent on cDNA transfection ratios. This suggests that un-
assembled and partially assembled subunits in the ER domi-
nate the calculation, as might be expected given the observed
subunit ER retention (Fig. 2). We also observe an overabun-
dance of the A subunit relative to its cDNA proportion, which
is likely due to the previously reported endoplasmic reticu-
lum-associated degradation of the B subunit (35).
To circumvent this problem, the membrane was isolated
by glass adhesion and mechanical shearing (Fig. 2)
(35,36). Following this procedure, appearance of ER marker
is sharply reduced, while patches of membrane-containing
receptor termed ‘‘membrane sheets’’ remain. All efforts to
characterize the stoichiometry of receptors employed mem-
brane sheets.
FIR were constructed for each membrane sheet using
FRET-corrected fluorescence intensities. Average values
were calculated for each pairing of fluorescent protein and
receptor subunit at each cDNA transfection ratio (Tables 2
and 3; Fig. 3). The relative amount of each subunit was
then extracted by Eq. 4. Studies of membrane sheets are
TABLE 5 Effect of acceptor photobleaching on subunit ratio, whole cells
Mole fraction 5-HT3B ImeYFP ¼ 1 ImeYFP ¼ 0.6 ImeYFP ¼ 0.25 ImeYFP ¼ 0 d0 ImeYFP ¼ 1 corrected by d0
0.5 4.845 0.68 4.095 0.53 3.595 0.50 3.715 0.41 0.71 3.42
0.75 2.175 0.37 2.095 0.31 2.055 0.27 2.045 0.27 0.85 1.84
0.9 0.685 0.07 0.715 0.08 0.725 0.08 0.735 0.07 1.08 0.73
All values are reported as mean5 standard error.
FIGURE 5 Twin FRET measurements are
consistent with A3B2 stoichiometry and with
nonadjacent B subunits. Donor recovery after
acceptor photobleaching (DRAP) on 5-HT3AB
membrane sheets. (A) Representative membrane-
sheet images before and after photobleaching for
AmeCFPAmeYFPB transfected with a 1:1:6 ratio of
AmeCFP/AmeYFP to untagged B subunit cDNA. (B)
Plot of fluorescence during the acceptor photo-
bleaching time course for both tagged A or tagged
B subunit 5-HT3AB twin FRET experiments. (C)
Extrapolation of the photobleaching time courses
in B to donor fluorescence intensity at complete
acceptor bleach. (D) Twin FRET efficiencies of
tagged A or tagged B subunit 5-HT3AB receptors.
Error bars depict the standard error.
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Figure 3.6 Twin FRET measurements are consistent with A3B2 stoichiometry and with 
nonadjacent B subunits. Donor recovery after acceptor photobleaching (DRAP) on 
5-HT3AB membrane sheets. (A) Representative membrane-sheet images before and after 
photobleaching for AmeCFPAmeYFPB transfected with a 1:1:6 ratio of AmeCFP/AmeYFP to 
untagged B subunit cDNA. (B) Plot of fluorescence during the acceptor photobleaching 
time course for both tagged A or tagged B subunit 5-HT3AB twin FRET experiments. 
(C) Extrapolation of the photobleaching time courses in B to donor fluorescence intensity 
at complete acceptor bleach. (D) Twin FRET efficiencies of tagged A or tagged 
B subunit 5-HT3AB receptors. Error bars depict the standard error. 
 
Twin FRET between the labeled B subunits is also detectable, at an efficiency of 
18.3 ± 0.7% (N = 9) (Figure 3.6, D). This shows that there are also at least two 
B subunits. As discussed below, the lower FRET efficiency for the B subunits indicates 
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that there are probably only two nonadjacent B subunits in most receptors. Thus, these 
twin FRET experiments also support the conclusion of predominantly A3B2 
stoichiometry. 
3.4.4	  The	  5-­HT3B	  Y129S	  subunit	  assembles	  into	  receptors	  like	  the	  B	  subunit	  
The B subunit studied in the experiments above contains tyrosine at position 129. 
A single-nucleotide nonsynonymous polymorphism HTR3B p.Y129S (c.386A>C, 
rs11767445) has been associated with several diseases, including major depression and 
bipolar affective disorder (4, 32, 33, and 34). This residue is located on a β-strand 
beneath the orthosteric binding site, and the side chain is modeled to project into the 
inter-subunit interface. We constructed and studied Y129S subunits containing both 
fluorophores. 
To investigate the possibility that Y129S might affect receptor assembly and 
stoichiometry, the subunit ratio determined by FIR was measured on membrane sheets 
transfected with 0.75 mol fraction 5-HT3BY129S. The FRET efficiencies and subunit ratio 
calculated by FIR were largely unchanged from that of the Y129 B subunit (which we 
usually term B) receptor, suggesting a receptor stoichiometry of three A subunits and two 
B subunits for the variant receptor (Tables 3.2 and 3.6; Figure 3.4; Figure 3.5, D and E). 
 
Table 3.6 5-HT3ABY129S membrane-sheet fluorescence data for A and B subunits. All 
values are reported as mean ± standard error. 
 
rather consistent in their support for an A3B2 subunit ratio
(Fig. 3 A). The FIR at 0.5 mol fraction 5-HT3A is, however,
significantly different from the expected value for this stoi-
chiometry. There are two possible explanations:
1. This deviation could arise from a small population of
homomeric 5-HT3A receptors. This is supported by the
whole-cell subunit ratio at this transfection condition,
which shows nearly four A subunits per B subunit
expressed. While a monophasic dose-response curve
for serotonin is seen at this transfection ratio (Fig. 1),
the markedly higher single channel conductance of the
5-HT3AB receptor (16–30 pS versus sub-pS for
5-HT3A) allows it to obscure even moderate proportions
of homomeric receptor (7).
2. The membrane-sheet preparation could retain a small
amount of intracellular receptors, perhaps in organelles,
again distorting the measurements (Fig. 1).
FIR measurements do not formally rule out the possibility
that the data arise in part from isolated groups of A subunits
and B subunits, because the groups would be separated by
less than the resolution of the microscope. FRET measure-
ments, however, present the advantage that the FRET effi-
ciencies depend on donor-acceptor interactions within
assembled pentamers.
The family FRET efficiencies between receptor subunits
within these membrane sheets were determined for various
ratios of transfected subunit cDNA by monitoring DRAP
(Fig. 4, A–C). Unlike those in whole cells, the FRET effi-
ciencies in membrane sheets are nearly independent of sub-
unit cDNA transfection ratio (Table 2; Fig. 4, D and E). This
supports the contention of the FIR measurements that
membrane sheets are enriched in a single population of
assembled membrane receptors, evidenced as loose donor
subunits generated by biased transfection-decrease FRET
efficiency.
The FRET efficiency of 5-HT3AmeYFPBmeCFP was 1.18–
1.34-fold (average of 1.24-fold) greater than that for the
opposite pairing of fluorescent protein and receptor subunit.
Previous theoretical and experimental studies on other
members of the Cys-loop receptor family have determined
that this difference in FRET efficiency is consistent with a
receptor stoichiometry of A3B2 (24,30). These analyses,
summarized in the Supporting Material (see Fig. S2),
depend on the ratio of donors/acceptors imposed by a pen-
tameric receptor and the proportion of couplings between
adjacent/nonadjacent receptor subunits.
The FRET measurements present the disadvantage that
conclusions cannot be made about the actual physical
distance between the fluorophores, because one does not
know many factors, including the subunit order, dipole
orientation, departures from pentameric symmetry, and
coplanarity of the fluorophores within the M3–M4 loops.
The measured FRET efficiencies would be compatible
with a wide range of assumptions about these parameters,
if adjacent subunits have a fluorophore separation of 30–
45 A˚. This distance is broadly consistent with known Cys-
loop receptor structures (30).
Further support that the membrane sheets correspond to
purified plasma membrane containing assembled receptors
is found by analyzing the effect of acceptor photobleaching
on the calculated subunit ratios. The observed difference in
FRET efficiencies between the two pairs of fluorescent pro-
teins and receptor subunits described earlier can be used to
generate a correction factor, d0 (Eq. 6). The value d0 can
then be used to predict the direction and magnitude of the
change in calculated subunit ratio upon acceptor photo-
bleaching (Eq. 7). This prediction will fail if loose or
partially assembled subunits sway the subunit ratio without
FRET, or if they contribute inordinately to FRET by aggre-
gating, as is observed in whole cells (Table 4). In membrane
sheets the correction factor correctly predicts subunit ratios
under every condition (Table 5).
Additional information about stoichiometry and subunit
order is found in twin FRET experiments on membrane
sheets (Fig. 5). With this technique, the FRET between
two subunits of the same subtype is monitored. The exis-
tence of twin FRET between A subunits, and in another
TABLE 6 5-HT3ABY129S membrane-sheet fluorescence data for A and B
Mole fraction 5-HT3A Mole fraction 5-HT3BY129S Family FRET
efficiency (%)
Fluorescence intensity
ratio (meCFP/meYFP) [A]/[BY129S] NmeCFP meYFP meCFP meYFP
0.25 0.75 25.45 0.3 0.3095 0.083 1.765 0.51 13
0.25 0.75 37.25 0.9 0.1005 0.010 20
All values are reported as mean5 standard error.
TABLE 7 5-HT3ABY129S membrane-sheet FIR data for A and B
Mole fraction 5-HT3A Mole fraction 5-HT3BY129S Family FRET
efficiency (%)
Fluorescence intensity
ratio (meCFP/meYFP) [A]/[BY129S] NmeCFP meYFP meCFP meYFP
0.25 0.375 12.45 0.2 0.4665 0.049 2.665 0.37 19
0.25 0.375 36.05 0.5 0.0665 0.006 20
All values are reported as mean5 standard error. All conditions contain 0.375 mol fraction unlabeled 5-HT3B.
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Because heterozygotes for the B subunit allele (one 129Y, one 129S) occur in 
>30% of many human populations (32), we investigated the relative efficiency of 
incorporating the two variant B subunits, when both are expressed simultaneously. In the 
conceptually simplest experiments (Table 3.7), we directly compared the plasma 
membrane subunit ratios of tagged Y129 B (also called simply B) subunits and tagged 
BY129S subunits when those cDNAs were transfected at equal amounts, along with labeled 
A subunit cDNAs. We found a [B]/BY129S ratio of 0.86 ± 0.12. Twin FRET efficiencies 
between coassembled B and BY129S subunits (17–19%) are near those between 
coassembled B and B subunits (18%) (Figure 3.6, D and Table 3.7). 
 
 
 
 
 
Table 3.7 5-HT3ABY129S membrane-sheet FIR data for A and B subunits. All values are 
reported as mean ± standard error. All conditions contain 0.375 mol fraction unlabeled 
5-HT3B. 
 
 
 
In another experiment (Table 4.8), untagged B subunits and tagged 
BY129S subunits were expressed at equal cDNA amounts, along with tagged A subunits. 
We measured a plasma membrane [A]/BY129S subunit ratio of 2.66 ± 0.37, implying that 
BY129S subunits are 1.11 fold more abundant than the value of 3 expected if the two 
B subunit variants incorporated with equal efficiency in A3B2 receptors. Family FRET 
experiments gave additional information. With BY129S-meYFP as acceptor, we measured 
rather consistent in their support for an A3B2 subunit ratio
(Fig. 3 A). The FIR at 0.5 mol fraction 5-HT3A is, however,
significantly different from the expected value for this stoi-
chiometry. There are two possible explanations:
1. This deviation could arise from a small population of
homomeric 5-HT3A receptors. This is supported by the
whole-cell subunit ratio at this transfection condition,
which shows nearly four A subunits per B subunit
expressed. While a monophasic dose-response curve
for serotonin is seen at this transfection ratio (Fig. 1),
the markedly higher single channel conductance of the
5-HT3AB receptor (16–30 pS versus sub-pS for
5-HT3A) allows it to obscure even moderate proportions
of homomeric receptor (7).
2. The membrane-sheet preparation could retain a small
amount of intracellular receptors, perhaps in organelles,
again distorting the measurements (Fig. 1).
FIR measurements do not formally rule out the possibility
that the data arise in part from isolated groups of A subunits
and B subunits, because the groups would be separated by
less than the resolution of the microscope. FRET measure-
m nts, however, present the advantage that the FRET effi-
ciencies depend on donor-acceptor interactions within
assembled pentamers.
The family FRET efficiencies between receptor subunits
within these membrane sheets were determined for various
ratios of transfected subunit cDNA by monitoring DRAP
(Fig. 4, A–C). Unlike those in whole cells, the FRET effi-
ciencies in membrane sheets are nearly independent of sub-
unit cDNA transfection ratio (Table 2; Fig. 4, D and E). This
supports the contention of the FIR measurements that
membrane sheets are enriched in a single population of
assembled membrane receptors, evidenced as loose donor
subunits generated by biased transfection-decrease FRET
efficiency.
The FRET efficiency of 5-HT3AmeYFPBmeCFP was 1.18–
1.34-fold (average of 1.24-fold) greater than that for the
opposite pairing of fluorescent protein and receptor subunit.
Previous theoretical and experimental studies on other
members of the Cys-loop receptor family have determined
that this difference in FRET efficiency is consistent with a
receptor stoichiometry of A3B2 (24,30). These analyses,
summarized in the Supporting Material (see Fig. S2),
depend on the ratio of donors/acceptors imposed by a pen-
tameric receptor and the proportion of couplings between
adjacent/nonadjacent receptor subunits.
The FRET measurements present the disadvantage that
conclusions cannot be made about the actual physical
distance between the fluorophores, because one does not
know many factors, including the subunit order, dipole
orientation, departures from pentameric symmetry, and
coplanarity of the fluorophores within the M3–M4 loops.
The measured FRET efficiencies would be compatible
with a wide range of assumptions about these parameters,
if adjacent subunits have a fluorophore separation of 30–
45 A˚. This distance is broadly consistent with known Cys-
loop receptor structures (30).
Further support that the membrane sheets correspond to
purified plasma membrane containing assembled receptors
is found by analyzing the effect of acceptor photobleaching
on the lculated subunit ratios. The observed difference in
FRET efficiencies between the two pairs of fluorescent pro-
teins and receptor subunits described earlier can be used to
generate a correction factor, d0 (Eq. 6). The value d0 can
then be used to predict the direction and magnitude of the
change in calculated subunit ratio upon acceptor photo-
bleaching (Eq. 7). This prediction will fail if loose or
partially assembled subunits sway the subunit ratio without
FRET, or if they contribute i ordinately to FRET by aggre-
gating, as is observed in whole cells (Table 4). In membrane
sheets the correction factor correctly predicts subunit ratios
under every condition (Table 5).
Additional information about stoichiometry and subunit
order is found in twin FRET experiments on membrane
sheets (Fig. 5). With this technique, the FRET between
two subunits of the same subtype is monitored. The exis-
tence of twin FRET between A subunits, and in another
TABLE 6 5-HT3ABY129S membrane-sheet fluorescence data for A and B
Mole fraction 5-HT3A Mole fraction 5-HT3BY129S Family FRET
efficiency (%)
Fluorescence intensity
ratio (meCFP/meYFP) [A]/[BY129S] NmeCFP meYFP meCFP meYFP
0.25 0.75 25.45 0.3 0.3095 0.083 1.765 0.51 13
0.25 0.75 37.25 0.9 0.1005 0.010 20
All values are reported as mean5 standard error.
TABLE 7 5-HT3ABY129S membrane-sheet FIR data for A and B
Mole fraction 5-HT3A Mole fraction 5-HT3BY129S Family FRET
efficiency (%)
Fluorescence intensity
ratio (meCFP/meYFP) [A]/[BY129S] NmeCFP meYFP meCFP meYFP
0.25 0.375 12.45 0.2 0.4665 0.049 2.665 0.37 19
0.25 0.375 36.05 0.5 0.0665 0.006 20
All values are reported as mean5 standard error. All conditions contain 0.375 mol fraction unlabeled 5-HT3B.
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a FRET efficiency of 12.4 ± 0.2%, as expected if each receptor has roughly half as many 
B-acceptors. With BY129S-meCFP as donor, we measured a FRET efficiency like that in 
previous experiments, suggesting that, as usual, each B subunit donor resides in a 
receptor with three A subunit acceptors. 
 
Table 3.8 5-HT3A(BY129 and BS129) membrane-sheet fluorescence data. All values are 
reported as mean ± standard error. All conditions contain 0.25 mol fraction unlabeled 
5-HT3A. 
 
Thus, the FIR experiments show a consistent pattern. When the two subunit 
variants are expressed simultaneously, the BY129S subunit incorporates into assembled 
plasma membrane 5-HT3AB receptors in a manner slightly (1.11–1.14 fold) more 
efficient than that of the B subunit. 
 
3.5 DISCUSSION 
 These measurements provide a robust determination of subunit stoichiometry for 
a Cys-loop receptor in the plasma membrane. The data arise from combining several 
techniques, including isolation of plasma membrane sheets (23), FIR measurements 
(26, 27, and 28), FRET measurements, and the placement of fluorescent proteins in the 
M3-M4 loop of Cys-loop receptors while conserving most aspects of receptor function 
(24 and 25). Heteromeric receptors formed from subunits containing fluorescent proteins 
display minimally perturbed serotonin EC50 values and Hill coefficients in HEK293T 
preparation between B subunits, is consistent with a receptor
stoichiometry containing at least two A subunits and at least
two B subunits. The markedly higher efficiency of the FRET
between A subunits, compared to that between B subunits,
suggests that most individual 5-HT3AB receptor molecules
have an A-A subunit interface but no adjacent B subunits.
Pentameric receptors with an A3B2 stoichiometry, as sug-
gested by FIR and FRET experiments, must contain at least
one A-A subunit interface.
We can provide a more-quantitative interpretation of the
twin FRET efficiencies in light of previous theoretical and
experimental studies on a4b2 nicotinic acetylcholine recep-
tors (24). In a4b2 receptors, known subunit stoichiometries
and known subunit orders on the plasma membrane can be
generated by varying cDNA transfection ratios. In a receptor
with two a4 subunits, they are nonadjacent; and in a receptor
with two b2 subunits, they too are nonadjacent. The twin
FRET ratio between adjacent and nonadjacent subunits is
1.80 5 0.21, nearly identical to that found here (1.81 5
0.10) for A twin FRET versus B twin FRET efficiencies.
The agreement between these two analogous experiments
on Cys-loop receptors suggests that the 5-HT3AB receptor
has subunit order of A-A-B-A-B, that is, one lacking a B-
B interface and analogous to an a4-a4-b2-a4-b2 nAChR.
This order, in which A-B assembly precludes B-B interac-
tions, is intuitively consistent with previous knowledge
that B subunits assemble and traffic to the membrane only
upon coexpression with the A subunit.
A synonymous polymorphism in the HTR3B gene results
in either the more common allele, encoding tyrosine-129,
or a modestly less common allele encoding serine. The
serine allele is linked to several disorders, including major
depression and bipolar affective disorder (32–34). While
the serine allele increases 5-HT-induced responses by
extending the duration of channel opening (32–34), its
complete effects on channel function remain poorly
defined. Because the polymorphic residue lies on a b-
strand just below the proposed orthosteric ligand-binding
site where it may project into the inter-subunit space, we
considered the possibility that the side chain affects hetero-
meric receptor assembly. The 5-HT3AB receptors contain-
ing onl the BY129S subunit, however, display a subunit
ratio and FRET efficiencies consistent with those observed
for the more common B subunit variant (Fig. 3; Fig. 4, D
and E). Thus the BY129S subunit’s profoundly altered gating
characteristics (32–34) occur within the usual A3B2 recep-
tor structure.
Heterozygotes for the B subunit common allele (one
129Y, one 129S) occur in >30% of many human popula-
tions (32), prompting additional experiments to study the
5-HT3AB receptors that would be produced in a heterozy-
gote. We directly compared the efficiency of incorporation
of the common and minor variant B subunit by transfecting
cells with the A subunit cDNA plus a mixture of cDNAs for
these two B subunits. Under the conditions of our experi-
ments, two types of FIR data show that 5-HT3B-Y129S sub-
unit incorporates slightly (1.11–1.14-fold) more efficiently
than the 5-HT3B-Y129 subunit (Table 4). In an individual
pentamer containing both B subunit alleles, FRET effi-
ciencies between the two B subunits suggest that this hetero-
zygote pentamer has the same stoichiometry and subunit
order as a pentamer containing only major alleles of the B
subunit (Fig. 5 D and Table 7).
Our experiments perform a quantitative analysis of heter-
opentameric receptors with only two types of subunits. They
require modest equipment and minimal assumptions. The
methods do require moderately high levels of plasma mem-
brane protein density, probably>100/mm2. In future studies,
the membrane-sheet isolation procedure will allow more-
precise information on Cys-loop receptors with more com-
plex compositions in the plasma membrane; such receptors
would include nAChR, GABAA, and some invertebrate Cys-
loop receptors. This can be accomplished through the accu-
mulation of pairwise subunit relative abundances or through
employing modern available fluorophores, and modern
spectrally resolved microscopes, that enable one to detect
three fluorophores in a given membrane sample. One can
readily permute fluorophores among three subunit types,
leading to six FIR experiments. This would provide redun-
dant, consistent determinations of subunit ratios.
Previous reports have shown how pairwise family FRET
experiments provide qualitative proof that individual pen-
tameric receptors contain three types of nAChR subunits
(a4b2b3, a4a6b2, a6b2b3) or four types of nAChR sub-
units (a4, a6, b2, b3) (37). In twin FRET experiments, the
b3 subunit, where present, displays near-zero twin FRET
and therefore exists as only one copy per pentamer.
In contrast, the other tested subunits have>1 copy in at least
some individual nAChR molecules (37). It would therefore
be possible to determine subunit ratios, stoichiometry, and
order in pentameric Cys-loop receptors containing three,
four, or even five (38) subunit types. Thus, the straightfor-
ward combination of membrane-sheet isolation, FIR, family
FRET, and twin FRET is a generally promising procedure
TABLE 8 5-HT3A(BY129 and BS129) membrane-sheet fluorescence data
Mole fraction 5-HT3B Mole fraction 5-HT3BY129S Twin FRET
efficiency (%)
Fluorescence intensity
ratio (meCFP/meYFP) [B]/[BY129S] NmeCFP meYFP meCFP meYFP
0.375 0.375 17.25 0.3 0.1045 0.007 0.865 0.10 16
0.375 0.375 19.45 0.5 0.1405 0.013 16
All values are reported as mean5 standard error. All conditions contain 0.25 mol fraction unlabeled 5-HT3A.
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cells (Figure 3.1; Table 3.1). 
In whole cells, retention of the receptor subunits in the endoplasmic reticulum 
complicated the characterization of assembled receptors on the plasma membrane. In 
particular, subunit ratios determined by various approaches are strongly dependent on 
cDNA transfection ratios. This suggests that unassembled and partially assembled 
subunits in the ER dominate the calculation, as might be expected given the observed 
subunit ER retention (Figure 3.2). We also observe an overabundance of the A subunit 
relative to its cDNA proportion, which is likely due to the previously reported 
endoplasmic reticulum-associated degradation of the B subunit (35). 
To circumvent this problem, the membrane was isolated by glass adhesion and 
mechanical shearing (Figure 3.2) (35 and 36). Following this procedure, the appearance 
of ER marker is sharply reduced, while patches of membrane-containing receptor termed 
“membrane sheets” remain. All efforts to characterize the stoichiometry of receptors 
employed membrane sheets. 
FIR were constructed for each membrane sheet using FRET-corrected 
fluorescence intensities. Average values were calculated for each pairing of fluorescent 
protein and receptor subunit at each cDNA transfection ratio (Tables 3.2 and 3.3; 
Figure 3.4). The relative amount of each subunit was then extracted by Equation 3.4. 
Studies of membrane sheets are rather consistent in their support of an A3B2 subunit ratio 
(Figure 3.4). The FIR at 0.5 mol fraction 5-HT3A is, however, significantly different from 
the expected value for this stoichiometry. There are two possible explanations: 
1. This deviation could arise from a small population of homomeric 5-HT3A 
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receptors. This is supported by the whole-cell subunit ratio at this 
transfection condition, which shows nearly four A subunits per B subunit 
expressed. While a monophasic dose-response curve for serotonin is seen 
at this transfection ratio (Figure 3.1), the markedly higher single channel 
conductance of the 5-HT3AB receptor (16–30 pS versus sub-pS for 
5-HT3A) allows it to obscure even moderate proportions of homomeric 
receptor (7). 
2. The membrane-sheet preparation could retain a small amount of 
intracellular receptors, perhaps in organelles, again distorting the 
measurements (Figure 3.1). 
FIR measurements do not formally rule out the possibility that the data arise in 
part from isolated groups of A subunits and B subunits, because the groups would be 
separated by less than the resolution of the microscope. FRET measurements, however, 
present the advantage that the FRET efficiencies depend on donor-acceptor interactions 
within assembled pentamers. 
The family FRET efficiencies between receptor subunits within these membrane 
sheets were determined for various ratios of transfected subunit cDNA by monitoring 
DRAP (Figure 3.5, A–C). Unlike those in whole cells, the FRET efficiencies in 
membrane sheets are nearly independent of subunit cDNA transfection ratio (Table 3.2; 
Figure 3.5, D and E). This supports the contention of the FIR measurements that 
membrane sheets are enriched in a single population of assembled membrane receptors.  
The FRET efficiency of 5-HT3AmeYFPBmeCFP was 1.18–1.34 fold (average of 
1.24 fold) greater than that for the opposite pairing of fluorescent protein and receptor 
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subunit. Previous theoretical and experimental studies on other members of the Cys-loop 
receptor family have determined that this difference in FRET efficiency is consistent with 
a receptor stoichiometry of A3B2 (Figure 3.7) (24 and 30).  
 
Figure 3.7 A schematic interpretation of family FRET measurements, based on the 
theory and simulations of Ref (30). The 5-HT3AB receptor is depicted with A3B2 
stoichiometry; the A2B3 stoichiometry is not depicted. Each A subunit has a YFP 
acceptor, and each B subunit has a CFP donor fused into the M3-M4 cytoplasmic loops. 
The average separation between adjacent (adj) fluorophores is termed R1,ave in Ref (30); 
this parameter varies along the X-axis. The Y-axis shows that family FRET efficiency, 
E(AYFPBCFP) for the A3B2 stoichiometry, always exceeds E(ACFPBYFP) for the A3B2 
stoichiometry. The Förster radius R0 is ~ 52 Å for this fluorophore pair. 
 
Figure S2.  A schematic interpretation of family FRET measurements, based on the 
theory and simulations of Ref (1).  The 5-HT3AB receptor is depicted, with A3B2 
stoichiometry; the A2B3 stoichiometry is not depicted.  Each A subunit has a YFP 
acceptor, and each B subunit has a CFP donor, fused into the M3-M4 cytoplasmic loops. 
The average separation between adjacent (adj) fluorophores is termed R1,ave in Ref (1); 
this parameter varies along the X-axis. The Y-axis shows that family FRET efficiency, 
E(AYFPBCFP) for the A3B2 stoichiometry, always exceeds E(ACFPBYFP) for the A3B2 
stoichiometry. The Förster radius R0 is ~ 52 Å for this fluorophore pair.  
 
In its simplest form, the theory simulates a regular planar pentagon that has radially 
disposed fluorophore dipoles. Departures from this structure are described by parameters 
termed geometry/coplanarity G, and asymmetry !. Ref (1) presents simulations over 
ranges of G and !; for the simulations presented here, G and ! are set to 1 and 0, 
respectively, to represent a regular planar pentagon.  
 
For all reasonable values of R1,ave, G and !, FRET efficiency for the A3B2 stoichiometry, 
E(AYFPBCFP), exceeds that for A2B3, E(AYFPBCFP), by a factor of 1.1 to 1.4. For 
fluorophore separations < 0.5R0, E approaches 1, but E for an adjacent pair only slightly 
exceeds E for a non-adjacent pair; this vitiates accurate measurements.  For fluorophore 
separations > 2R0, E for an adjacent pair >> E for a non-adjacent pair, but the E values 
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These analyses depend on the ratio of donors/acceptors imposed by a pentameric 
receptor and the proportion of couplings between adjacent/nonadjacent receptor subunits. 
In its simplest form, the theory simulates a regular planar pentagon that has radially 
disposed fluorophore dipoles. Departures from this structure are described by parameters 
termed geometry/coplanarity G, and asymmetry Δ. Ref (30) presents simulations over 
ranges of G and Δ; for the simulations presented here, G and Δ are set to 1 and 0, 
respectively, to represent a regular planar pentagon.  
For all reasonable values of R1,ave, G and Δ, FRET efficiency for the A3B2 
stoichiometry, E(AYFPBCFP), exceeds that for A2B3, E(AYFPBCFP), by a factor of 1.1 to 1.4. 
For fluorophore separations < 0.5R0, E approaches 1, but E for an adjacent pair only 
slightly exceeds E for a non-adjacent pair; this vitiates accurate measurements.  For 
fluorophore separations > 2R0, E for an adjacent pair >> E for a non-adjacent pair, but the 
E values become unmeasurably small. This again vitiates accurate data. Therefore FRET 
measurements can distinguish the two stoichiometries, if 0.6R0 < the fluorophore 
separation < 1.4R0. The structures of cytoplasmic loops are not known. Structural data for 
the extracellular binding domains and transmembrane domains of Cys-loop receptor 
shows that homologous residues on adjacent subunits are separated by 5 to 40 Å. 
Fluorescent proteins have a diameter of 25 Å, precluding a closer approach of the 
fluorophores. Because we do not know G and Δ, more specific inferences cannot be made 
about the size / shape of the M3-M4 loops, or about the fluorophore separation R1,ave. 
The heavy horizontal line in Figure 4.7 shows the average ratio determined in this 
study, 1.24 (Figure 3.5). Because this value exceeds 1, the data are compatible with a 
stoichiometry of A3B2. This compatibility, not a value for the fluorophore separation, is 
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the major conclusion of this section. 
The FRET measurements present the disadvantage that conclusions cannot be 
made about the actual physical distance between the fluorophores, because one does not 
know many factors, including the subunit order, dipole orientation, departures from 
pentameric symmetry, and coplanarity of the fluorophores within the M3–M4 loops. The 
measured FRET efficiencies would be compatible with a wide range of assumptions 
about these parameters, if adjacent subunits have a fluorophore separation of 30–45 Å. 
This distance is broadly consistent with known Cys-loop receptor structures (30). 
Further support that the membrane sheets correspond to purified plasma 
membrane containing assembled receptors is found by analyzing the effect of acceptor 
photobleaching on the calculated subunit ratios. The observed difference in FRET 
efficiencies between the two pairs of fluorescent proteins and receptor subunits described 
earlier can be used to generate a correction factor, d0 (Equation 3.6). The value d0 can 
then be used to predict the direction and magnitude of the change in calculated subunit 
ratio upon acceptor photobleaching (Equation 3.7). This prediction will fail if loose or 
partially assembled subunits sway the subunit ratio without FRET, or if they contribute 
inordinately to FRET by aggregating, as is observed in whole cells (Table 3.4). In 
membrane sheets the correction factor correctly predicts subunit ratios under every 
condition (Table 3.5). 
Additional information about stoichiometry and subunit order is found in twin 
FRET experiments on membrane sheets (Figure 3.6). With this technique, the FRET 
between two subunits of the same subtype is monitored. The existence of twin FRET 
between A subunits, and in another preparation between B subunits, is consistent with a 
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receptor stoichiometry containing at least two A subunits and at least two B subunits. The 
markedly higher efficiency of the FRET between A subunits, compared to that between 
B subunits, suggests that most individual 5-HT3AB receptor molecules have an A-A 
subunit interface but no adjacent B subunits. Pentameric receptors with an A3B2 
stoichiometry, as suggested by FIR and FRET experiments, must contain at least one 
A-A subunit interface. 
We can provide a more-quantitative interpretation of the twin FRET efficiencies 
in light of previous theoretical and experimental studies on α4β2 nicotinic acetylcholine 
receptors (24). In α4β2 receptors, known subunit stoichiometries and known subunit 
orders on the plasma membrane can be generated by varying cDNA transfection ratios. In 
a receptor with two α4 subunits, they are nonadjacent, and in a receptor with two 
β2 subunits, they too are nonadjacent. The twin FRET ratio between adjacent and 
nonadjacent subunits is 1.80 ± 0.21, nearly identical to that found here (1.81 ± 0.10) for 
A twin FRET versus B twin FRET efficiencies. The agreement between these two 
analogous experiments on Cys-loop receptors suggests that the 5-HT3AB receptor has 
subunit order of A-A-B-A-B, that is, one lacking a B-B interface and analogous to an 
α4-α4-β2-α4-β2 nAChR. This order, in which A-B assembly precludes B-B interactions, 
is intuitively consistent with previous knowledge that B subunits assemble and traffic to 
the membrane only upon coexpression with the A subunit. 
A synonymous polymorphism in the HTR3B gene results in either the more 
common allele, encoding tyrosine 129, or a modestly less common allele encoding serine. 
The serine allele is linked to several disorders, including major depression and bipolar 
affective disorder (32, 33, and 34). While the serine allele increases 5-HT-induced 
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responses by extending the duration of channel opening (32, 33, and 34), its complete 
effects on channel function remain poorly defined. Because the polymorphic residue lies 
on a β-strand just below the proposed orthosteric ligand-binding site where it may project 
into the inter-subunit space, we considered the possibility that the side chain affects 
heteromeric receptor assembly. The 5-HT3AB receptors containing only the 
BY129S subunit, however, display a subunit ratio and FRET efficiencies consistent with 
those observed for the more common B subunit variant (Figure 3.4; Figure 3.5, D and E). 
Thus, the BY129S subunit’s profoundly altered gating characteristics (32, 33, and 34) occur 
within the usual A3B2 receptor structure. 
Heterozygotes for the B subunit common allele (one 129Y, one 129S) occur in 
>30% of many human populations (32), prompting additional experiments to study the 
5-HT3AB receptors that would be produced in a heterozygote. We directly compared the 
efficiency of incorporation of the common and minor variant B subunit by transfecting 
cells with the A subunit cDNA plus a mixture of cDNAs for these two B subunits. Under 
the conditions of our experiments, two types of FIR data show that 5-HT3B-Y129S 
subunit incorporates slightly (1.11–1.14 fold) more efficiently than the 5-HT3B-Y129 
subunit (Table 3.4). In an individual pentamer containing both B subunit alleles, FRET 
efficiencies between the two B subunits suggest that this heterozygote pentamer has the 
same stoichiometry and subunit order as a pentamer containing only major alleles of the 
B subunit (Figure 3.6, D and Table 3.7). 
Our experiments perform a quantitative analysis of heteropentameric receptors 
with only two types of subunits. They require modest equipment and minimal 
assumptions. The methods do require moderately high levels of plasma membrane 
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protein density, probably >100/µm2. In future studies, the membrane-sheet isolation 
procedure will allow more precise information on Cys-loop receptors with more complex 
compositions in the plasma membrane; such receptors would include nAChR, GABAA, 
and some invertebrate Cys-loop receptors. This can be accomplished through the 
accumulation of pairwise subunit relative abundances or through employing modern 
available fluorophores, and modern spectrally resolved microscopes, that enable one to 
detect three fluorophores in a given membrane sample. One can readily permute 
fluorophores among three subunit types, leading to six FIR experiments. This would 
provide redundant, consistent determinations of subunit ratios. 
Previous reports have shown how pairwise family FRET experiments provide 
qualitative proof that individual pentameric receptors contain three types of nAChR 
subunits (α4β2β3, α4α6β2, α6β2β3) or four types of nAChR subunits (α4, α6, β2, β3) 
(37). In twin FRET experiments, the β3 subunit, where present, displays near-zero twin 
FRET and therefore exists as only one copy per pentamer. In contrast, the other tested 
subunits have >1 copy in at least some individual nAChR molecules (37). It would 
therefore be possible to determine subunit ratios, stoichiometry, and order in pentameric 
Cys-loop receptors containing three, four, or even five (38) subunit types. Thus, the 
straightforward combination of membrane-sheet isolation, FIR, family FRET, and twin 
FRET is a generally promising procedure for determining subunit ratios, stoichiometry, 
and subunit order of proteins on the plasma membrane. 
3.5.1 C onclusions 
 Previous reports have supported two different possible stoichiometries for the 
5-HT3AB receptor. In this work, we have utilized a method to isolate plasma membrane 
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sheets containing assembled receptors and used this to determine the stoichiometry of the 
5-HT3AB receptor by fluorescence methods: FIR, family FRET, and twin FRET. Our 
strongest, non-model-dependent conclusion arises from FIR, which shows an A3B2 
subunit ratio. Family FRET and twin FRET efficiencies are also consistent with an A3B2 
stoichiometry. 
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* This work was done in collaboration with Matthew Davis, who performed computations 
to generate interaction energies between guanidinium and fluorinated benzenes.  
Chapter 4 
 
Allosteric Activation of the 5-HT3AB Receptor by mCPBG* 
 
4.1 ABSTRACT 
The 5-HT3AB receptor contains three A and two B subunits, likely in an A-A-B-
A-B order. However serotonin function at the 5-HT3AB receptor has been shown to 
depend solely on the A-A interface present in the homomeric receptor. Using mutations 
at sites on both the primary (E122) and complementary (Y146) faces of the B subunit, we 
demonstrate that mCPBG, a 5-HT3 selective agonist, is capable of binding and activating 
the 5-HT3AB receptor at all five subunit interfaces of the heteromer. Further, mCPBG is 
capable of allosterically modulating the activity of serotonin from these sites. While these 
five binding sites appear functionally degenerate in terms of mCPBG EC50, we uncover 
subtle differences in heteromeric binding site sensitivity to mutation. We also find that 
the A-A interface appears to contribute disproportionately to the efficacy of 5-HT3AB 
receptor activation. We also investigate a potential cation-π interaction between mCPBG 
and F226 of the B subunit in the 5-HT3AB receptor. 
 
4.2 INTRODUCTION   
5-HT3 receptors are excitatory ligand-gated ion channels of the Cys-loop 
(pentameric) receptor super-family that also includes nicotinic acetylcholine (nAChR), 
glycine and GABAA receptors (1). The 5-HT3 family is principally composed of 
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homomeric 5-HT3A, and heteromeric receptors containing some combination of the 
A subunit and either B, C, D, or E subunits (2-4). The best studied heteromeric receptor is 
5-HT3AB. In addition to contributing to the fundamental role of 5-HT3 in the gut, the 
5-HT3AB receptor is widely expressed in the brain and has been implicated in numerous 
salutary and pathological processes (5, 6).  
As ligand binding occurs at the interface of adjacent subunits, heteromeric 
receptors present the opportunity for novel ligand binding sites. This potential complexity 
might afford one signaling molecule, serotonin (5-HT), the ability to elicit diverse 
responses depending on the repertoire of receptors present (7). The 5-HT3AB receptor 
contains three A and two B subunits, likely in an A-A-B-A-B order (8). Thus, there are 
three potential types of binding sites in the 5-HT3AB receptor: I., the single A-A interface 
also found in the homomeric receptor, II., the two heteromeric binding sites with the B 
subunit as the primary face, and III., the two heteromeric binding sites with the B subunit 
as the complementary face (Figure 1). 
 
Figure 4.1 Top-down view of 5-HT3AB 
receptor based on GluCl crystal structure 
(PDB: 3RHW). Three types of binding 
sites are present in the heteromeric 
receptor: I., A subunit as both principal 
and complementary faces, II., B subunit 
as principal and A subunit as 
complementary, and III., A subunit as 
principal and B subunit as 
complementary. 	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However, serotonin function at the 5-HT3AB receptor depends solely on the 
type I binding site present in the homomeric receptor (9-11). Multiple studies have 
capitalized on the wealth of mutagenic data on homomeric receptors to identify crucial, 
non-conserved residues at both the principal and complementary faces of the B subunit 
that impact 5-HT function (9, 11). Combined, these studies demonstrate that only one 
serotonin molecule binds to and activates the 5-HT3AB receptor, a finding predicted by 
modeling of receptor kinetic parameters (12). This makes the 5-HT3AB receptor unusual 
in the Cys-loop super-family, where multiple binding sites predominate.  
m-chlorophenyl biguanide (mCPBG) is a 5-HT3 selective agonist (13). Unlike 
5-HT, whose amine forms a cation-π interaction at W178 (human subunit numbering, 
akin to W183 in the mouse numbering of Chapter 1, and aligning with TrpB in the 
nAChR) (14) and whose hydroxyl forms a hydrogen bond at E124 (E129 in mouse 
numbering, and aligning with TyrA in the nAChR) (15), a satisfactory binding model of 
mCPBG has not been enumerated. While mCPBG forms no interaction at W178, it does 
rely upon E124 for the initiation of channel gating (16). In the face of this relative paucity 
of binding information, it is not readily apparent that mCPBG should be incapable of 
acting at type II and type III binding sites. Indeed, a molecule has already been identified 
that is functional at type III binding sites (17, 18).  
Here we demonstrate that, unlike serotonin, mCPBG is capable of binding and 
activating the 5-HT3AB receptor at all three types of binding site present in the 
heteromer.  Through mutagenesis, we identify crucial residues on the B subunit, 
corresponding to both principle and complementary faces, and thus bind site types II and 
III, on which this activity is dependent. Further, we show that mCPBG is capable of 
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allosterically modulating the activity of serotonin from type II binding sites, 
demonstrating the potential for future development of 5-HT3AB ligands with 
benzodiazapine-like properties.  
 
4.3 RESULTS & DISCUSSION 
4.3.1 5-HT and mCPBG behave differently at wild type 5-HT3AB receptors 
Serotonin activates 5-HT3A receptors with a 3.4 µM EC50 and a high Hill 
coefficient (nH), indicating a high level of cooperativity (Table 4.1). Though it need not 
be the case, this measure of cooperativity has tracked with the level of ligand binding in 
other Cys-loop receptors (19, 20). At the heteromeric AB receptor, both the EC50 and Hill 
coefficient markedly change, with a 7 fold decrease in ligand sensitivity and a loss of 
cooperativity reflected in a decreased Hill coefficient from 2.8 to 1.1 (Figure 4.2A). 
These data are consistent with the finding that 5-HT likely acts at only the single type I 
binding site in the AB receptor.  
 mCPBG has a similar potency to 5-HT (3.8 µM) at the homomeric receptor along 
with a similarly high Hill coefficient (nH = 3.0) (Table 4.2). Unlike 5-HT, both of these 
measures remain practically unchanged in the AB receptor (EC50 = 2.8µM, nH  = 2.5), 
suggesting that mCPBG may retain the ability to bind the receptor at type II and type III 
binding sites (Figure 4.2B). Meanwhile, the relative efficacy (ε) of mCPBG surges from 
0.85 to 2.75, as it transitions from a strong partial agonist to a super-agonist (Table 4.3; 
Figure 4.2C). This is consistent with a drop in the absolute efficacy of 5-HT due to its 
reduction to a single binding site in the heteromeric receptor.  
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Figure 4.2 5-HT and mCPBG dose-response data for wild type 5-HT3A and 5-HT3AB 
receptors. (A) 5-HT dose-response data  for wild type 5-HT3A and 5-HT3AB receptors 
with current normalized to the maximum elicited 5-HT current. (B) mCPBG dose-
response data for wild type 5-HT3A and 5-HT3AB receptors with current normalized to 
the maximum elicited mCPBG current. (C) mCPBG dose-response data for wild type 
5-HT3A and 5-HT3AB receptors with current normalized to the maximum elicited 5-HT 
current. 5-HT3A data are shown in red and 5-HT3AB data are shown in blue.  
 
4.3.2 The 5-HT3B subunit contributes to mCPBG activation of the 5-HT3AB receptor 
E124 of loop A on the principle side of the 5-HT3A binding site plays a critical 
role in mCPBG activation. Mutation of E124 to glutamine has been shown to selectively 
ablate the ability of mCPBG to activate the 5-HT3A receptor, converting mCPBG to a 
competitive antagonist (16). However, we find that the E124Q mutation in the A subunit 
of the heteromeric receptor, while highly deleterious, does not eliminate the ability of 
mCPBG to activate the 5-HT3AB receptor (Figure 4.3). Relative efficacy drops sharply to 
0.35 (Figure 4.3A, Table 4.3) and the Hill coefficient falls precipitously from 2.6 to 1.2 
(Figure 4.3B, Tables 4.2), suggesting the elimination of functional ligand binding sites. 
As this mutation disrupts type I and type III binding sites, this remaining activation by 
mCPBG suggests that mCPBG acts at type II binding sites. 
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Figure 4.3 mCPBG dose-response data for 5-HT3AB receptors bearing the E124Q 
mutation in the A subunit. (A) mCPBG dose-response data normalized to the maximum 
elicited 5-HT current. (B) mCPBG dose-response data normalized to the maximum 
elicited mCPBG current. 5-HT3A data are shown in red and 5-HT3AB data are shown in 
blue. 
 
To determine if this difference in response between the A and AB receptors was 
due to ligand binding at the type II binding sites or to allosteric effects of the B subunit 
on the type I binding site, an experiment in which both agonists were applied was 
devised. First, an Imax dose of 5-HT was applied to AB receptors bearing the E124Q 
mutation in the A subunit. After 5-HT maximally opened the channel and saturated its 
binding sites, mCPBG was co-applied at its EC50. Upon mCPBG addition a second wave 
of receptor opening corresponding to an additional 60 % beyond the 5-HT Imax was 
observed (ΔImax = +60 ± 9 %, n = 18) (Figure 4.4A). This effect is only possible if 
mCPBG binds allosterically, increasing 5-HT efficacy. When the same experiment is 
performed with an Imax concentration of mCPBG, upon co-application the current sharply 
declines to approximately the relative efficacy of mCPBG  alone (ΔImax = -72 ± 2 %, 
!" #"
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n = 20) (Figure 4.4B). This is consistent with mCPBG displacement of 5-HT at the type I 
binding site at higher concentrations.  
 
 
Figure 4.4 Dual Agonist Experiment on 5-HT3AB receptors bearing the E124Q mutation 
in the A subunit. (A) Model of receptor binding by 5-HT and mCPBG and representative 
electrophysiology trace showing maximal 5-HT response followed by an additional 
60 ± 9 % (n = 18) response upon addition of EC50 mCPBG. (B) Model of receptor 
ligation by 5-HT and mCPBG and representative electrophysiology trace showing 
maximal 5-HT response followed by a reduction in current by 72 ± 2 % (n = 20) upon 
addition of saturating mCPBG, whereupon mCPBG outcompetes 5-HT for binding at the 
A-A interface.  
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A Subunit B subunit EC50 (µM) Fold Shift nH # Cells 
WT - 3.4 ± 0.1 - 2.8 ± 0.1 10 
E124Q - 165 ± 9 48.5 1.9 ± 0.1 6 
Y148A - 185 ± 14 54.4 2.4 ± 0.3 5 
WT WT 24.1 ± 2.9 - 1.1 ± 0.1 7 
E124Q WT 141 ± 16 5.9 1.6 ± 0.2 6 
Y148A WT 300 ± 14 12.4 1.8 ± 0.1 7 
WT E122Q 15.5 ± 1.6 0.6 1.2 ± 0.1 5 
WT E122A 16.1 ± 2.5 0.7 1.0 ± 0.1 5 
WT Y146A 14.9 ± 0.9 0.6 1.2 ± 0.1 5 
WT E122Q Y146A 8.2 ± 0.6 0.3 1.4 ± 0.1 6 
E124Q E122Q 117 ± 10 4.9 1.5 ± 0.1 5 
E124Q E122A 197 ± 3 8.2 1.9 ± 0.1 5 
E124Q Y146A 178 ± 8 7.4 1.5 ± 0.1 9 
E124Q F236 F1-Phe 150 ± 3 6.2 1.8 ± 0.1 5 
E124Q F236 F3-Phe 139 ± 5 5.8 2.2 ± 0.1 5 
 
Table 4.1 Serotonin functional data for 5-HT3A and 5-HT3AB receptors. Hill coefficient 
(nH). Values are reported as mean ± standard error. Wild type (WT). No subunit supplied 
(-). Fold shift is reported relative to the wild type receptor of the same subunit 
composition. 
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A Subunit B subunit EC50 (µM) Fold Shift nH # Cells 
WT - 3.8 ± 0.2 - 3.0 ± 0.4 5 
E124Q - NR     12 
Y148A - 24.7 ± 0.9 6.5 1.9 ± 0.1 6 
WT WT 2.8 ± 0.1 - 2.5 ± 0.3 7 
E124Q WT 3.0 ± 0.7 1.1 1.0 ± 0.2 10 
Y148A WT 11.2 ± 0.6 4 2.8 ± 0.4 7 
WT E122Q 2.3 ± 0.1 0.8 2.6 ± 0.4 5 
WT E122A 2.4 ± 0.1 0.9 2.2 ± 0.2 5 
WT Y146A 4.3 ± 0.3 1.5 2.1 ± 0.2 5 
WT F226 F3-Phe 3.5 ± 0.3 1.3 1.6 ± 0.2 10 
WT E122Q Y146A 3.5 ± 0.1 1.3 2.2 ± 0.2 6 
E124Q E122Q 2.4 ± 0.4 0.9 1.2 ± 0.2 5 
E124Q E122A SR     5 
E124Q Y146A 4.8 ± 0.7 1.7 1.5 ± 0.3 9 
E124Q F226 F1-Phe 3.8 ± 0.2 1.4 1.5 ± 0.1 5 
E124Q F226 F2-Phe 3.7 ± 0.3 1.3 1.5 ± 0.1 5 
E124Q F226 F3-Phe 4.4 ± 0.3 1.6 1.4 ± 0.1 4 
 
Table 4.2 mCPBG functional data for 5-HT3A and 5-HT3AB receptors. Hill coefficient 
(nH) , Small Response (SR) refers to Imax < 100nA. No Response (NR) refers to 
Imax < 30nA. Values are reported as mean ± standard error. Wild type (WT). No subunit 
supplied (-). Fold shift is reported relative to the wild type receptor of the same subunit 
composition. 
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A Subunit B Subunit ε # Cells 
WT - 0.85 ± 0.17 10 
E124Q - < 0.01 10 
Y148A - 3.79 ± 0.37 7 
WT WT 2.75 ± 0.19 22 
E124Q WT 0.36 ± 0.04 10 
Y148A WT 10.6 ± 0.9 14 
WT E122Q 1.94 ± 0.12 19 
WT E122A 1.60 ± 0.14 11 
WT Y146A 2.18 ± 0.17 13 
WT F226 F3-Phe 1.74 ± 0.23 12 
WT E122Q Y146A 1.58 ± 0.09 13 
E124Q E122Q 0.24 ± 0.02 13 
E124Q E122A < 0.01 8 
E124Q Y146A 0.18 ± 0.03 9 
E124Q F226 F1-Phe 0.13 ± 0.05 10 
E124Q F226 F2-Phe 0.06 ± 0.01 5 
E124Q F226 F3-Phe 0.05 ± 0.02 10 
 
Table 4.3 5-HT3A and 5-HT3AB receptor relative efficacies of mCPBG (ε). Values are 
reported as mean ± standard error. Wild type (WT). No subunit supplied (-).   
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4.3.3 mCPBG binds to all five interfaces of the 5-HT3AB receptor 
Given the ability of mCPBG to compete at the orthosteric type I binding site, it 
was presumed that allosteric binding occurs at the equivalent location on B subunit-
containing type II and type III binding sites. To determine if the B subunit could 
functionally contribute to the principal, complementary, or both faces of the potential 
binding site, mutants found to disrupt function in A subunits were introduced at the 
corresponding sites in the B subunit. E122Q (equivalent to E124 in the A subunit) was 
chosen for the principal face to probe type II binding sites.  
Unfortunately, fewer crucial ligand interactions to the complementary face to 
probe type III binding are known (21). Previous studies demonstrated that Y148 on loop 
E of the A subunit (Y153 in mouse subunit numbering) is critical for both serotonin 
binding and gating of the homomeric receptor (22). Mutation of Y148 to alanine displays 
a loss of function for mCPBG as well, though less than that observed for 5-HT (Tables 
4.1 and 4.2). The relative efficacy of mCPBG increases over 4 fold, suggesting that while 
this mutation affects mCPBG, it is more deleterious for serotonin function (Table 4.3). 
5-HT3AB receptors bearing Y148A in the A subunits show a similar pattern of effects. In 
the B subunit, serotonin is oblivious to mutation, leaving only the perturbation of 
mCPBG function, if mCPBG acts at type III binding sites.  
5-HT3AB receptors containing type II or type III binding site disrupting mutations 
were then assessed with both 5-HT and mCPBG. As 5-HT is found to be largely 
insensitive to B subunit mutations (Table 4.1), serotonin response serves as a control for 
proper folding and trafficking of the receptors.  
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While mCPBG EC50 remains unchanged for both mutant receptors, relative 
efficacy is significantly affected. mCPBG remains a super-agonist of slightly lower 
efficacy, 1.94 for E122Q  (Type II disrupted) and 2.18 for Y146A (Type III disrupted) 
(Figure 4.5; Table 4.3). The lack of effect on mCPBG EC50 is expected if the mutations 
completely disrupt the binding sites that contain them while mCPBG is capable of 
opening the receptor, though less effectively, through the unaffected binding sites that 
remain. It is also possible that the apparent agonist efficacy at the receptor is decreased 
because the fraction of the response corresponding to the disrupted binding sites is shifted 
outside the observable window for mCPBG. Unfortunately, this would not take an 
enormous loss of function, as mCPBG appears to be a quite effective open channel 
blocker at concentrations above 100 µM (12).  
The decrease in relative efficacy for the two mutations indicates that the B subunit 
is capable of functionally contributing to both faces of heteromeric binding sites. The 
similarity of the magnitude of the effect is consistent with the loss of two out of five 
possible binding sites in each case. As the number of remaining binding sites in either 
mutant receptor would still outnumber that of serotonin, it might be expected that 
mCPBG remains a super-agonist at the mutant receptors.  
5-HT3AB receptors containing both mutations in its B subunits show a relative 
efficacy that is still further decreased to 1.66, demonstrating that the two mutations are 
additive (Figure 4.5; Table 4.3). mCPBG is still a super-agonist at this receptor however, 
suggesting either that function is not completely disrupted at the binding sites that contain 
the mutations, or that the presence of the B subunit allosterically improves the relative 
efficacy of mCPBG activation through the A-A interface. In either case, the disruption of 
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all four B subunit containing binding sites is nearly an order of magnitude less disruptive 
than the disruption of three binding sites including the A-A interface. This suggests that 
the five binding sites do not contribute equally to mCPBG efficacy and that the A-A 
interface has a special importance.  
Figure 4.5 Relative Efficacies of mCPBG at 5-HT3AB Receptor Mutants. All 
5-HT3AB receptors bearing mutations in the B subunits are significantly different 
(p < 0.05) than both the wild type receptor and 5-HT3AB containing E124Q in the A 
subunit. 5-HT3AB bearing both E122Q and Y146A is significantly different (p < 0.05) 
from both single mutants. Values are depicted as the mean ± standard error. 
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4.3.4 Evidence for differences in heteromeric binding site organization 
To test that the mutations are, in fact, completely disrupting function at the 
binding sites that contain them, heteromeric receptors in which the critical glutamate in 
every subunit (E124 in the A subunits and E122 in the B subunits) is mutated to 
glutamine were probed (disrupting all three binding site types). Unexpectedly, this 
quintuple mutant receptor is still responsive to mCPBG, with a relative efficacy only 
slightly worse than that of receptors with the mutation in the A subunit alone (disrupting 
types I and III) (Figure 4.6 and Table 4.3). Thus, it appears that there are subtle 
differences in the type II binding sites of the heteromeric receptor.  
 It may be puzzling why mutation to glutamine at E124 has such drastic effects, as 
glutamine retains a side chain oxygen capable of forming a hydrogen bond to the ligand. 
It may be that the glutamate to glutamine mutation has such drastic effects because the 
remaining side chain oxygen is pre-complexed with another residue in the homomeric 
receptor and thus unable to reposition to form ligand interactions. This might not be the 
case in a heteromeric receptor however, so the more drastic alanine mutation was made. 
5-HT3AB receptors with E122A in the B subunits (disrupting type I and type III binding 
sites) again showed no change in mCPBG EC50 but a large decrease in relative efficacy to 
1.60, slightly worse than that for E122Q (ε = 1.94) (Figure 4.6; Tables 4.2 and 4.3). 
Heteromeric receptors bearing E124Q in the A subunits and E122A in the B subunits 
(disrupting all three binding site types) now show the expected destruction of mCPBG 
agonist activity (ε < 0.01), akin to E124Q mutation in the homomeric 5-HT3A receptor 
(Figure 4.6; Table 4.3).  
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It appears that the type III binding site also behaves slightly differently with 
regard to mutation of E124. It would be expected based on the homomeric receptor that 
E124Q would destroy both the type I and type III binding sites. If so, the addition of 
Y146A in the B subunits (type III disrupting) should have no additional effect. This is not 
the case, however, as relative efficacy decreases from 0.36 to 0.18, suggesting that 
E124Q in the A subunit is not completely destroying the type III binding sites 
(Figure 4.6; Table 4.3).  
Figure 4.6 Relative efficacies of 5-HT3AB receptors bearing mutations in both subunits. 
Addition of E122Q, E122A, or Y146A mutations to the B subunits show significant 
(p < 0.05) reductions in relative efficacy. Values are depicted as the mean ± standard 
error.  
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4.3.5 F226 of the B subunit (TyrC2) is important for mCPBG activation 
mCPBG differs from serotonin in its interactions with the 5-HT3A receptor. 
Unlike serotonin, it forms no cation-π interaction with W178 (TrpB) (16). Thus, it is not 
surprising that, unlike serotonin, mCPBG is not negatively affected by the absence of 
TrpB in the B subunit (I176). Given the ability of mCPBG to bind effectively at 
B subunit containing interfaces, the B subunit was scanned for residues capable of 
binding the positive charge of mCPBG. Of the five residues that constitute the “aromatic 
box” in the binding site of the prototypical Cys-loop receptor, only two remain in the 
B subunit: those that align with TrpD (W83) and TyrC2 (F226). As TrpD aromaticity has 
been found not to contribute to mCPBG or serotonin activation in the homomeric 
receptor, efforts were focused on TyrC2 (23).  
F226 of the B subunit was considered promising, as previous studies of the 
5-HT3A receptor had suggested that TyrC2 (Y228) aromaticity was important for ligand 
binding; however, steric effects at the 4-position of the residue complicated interpretation 
(22). It was hoped that the phenylalanine present in the B subunit would simplify 
interpretation.  
Fluorination of aromatic amino acids results in the depletion of electron density 
from the face of the side chain that may weaken or ablate the ability to form aromatic 
interactions (24). 5-HT3AB receptors containing wild type A subunits and highly 
fluorinated phenylalanine residues at F226 of the B subunits show a loss of relative 
efficacy (ε = 1.74) and cooperativity (nH  = 1.6) as strong as that for any single mutation 
of the B subunit, including E122A (Table 4.2 and 4.3).  
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In order to simplify analysis, the E124Q mutation was introduced to the A subunit 
of the 5-HT3AB receptor so that the intact binding sites would consist solely of B-A. 
Surprisingly, increasing fluorination of F226 does not affect mCPBG EC50, suggesting 
that the site is not necessary for ligand binding (Table 4.2). Relative efficacy, however, is 
responsive to fluorination at F226, with F1-Phe showing a large loss in efficacy (ε = 0.13) 
that is further weakened in F2- and F3-Phe, which are equivalent to each other (ε = 0.06; 
ε = 0.05, respectively) (Figure 4.7; Table 4.3). This loss of relative efficacy suggests that 
this site is important for activation of the receptor. This role is consistent with the 
residue’s location on loop C, whose dynamics are thought to be critical for receptor 
activation (25, 26).  
Unfortunately the lack of effect in EC50, and the lack of further effect progressing 
from F2- to F3-Phe, is inconsistent with the trend in cation-π interaction energies 
computed using sodium as the positive charge (27). It may be that the large delocalized 
positive biguanide moiety of mCPBG behaves differently than sodium with regard to the 
changing electron density of the ring system upon higher fluorination, however, it is also 
possible that the effects observed are not electrostatic in nature.  
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Figure 4.7 F226 (aligning with TyrC2) on the B subunit is important for mCPBG 
activation of 5-HT3AB receptor. (A) Structures of the unnatural amino acids incorporated 
at F226 of the B subunit. (B) mCPBG dose-response data for sequential fluorination of 
F226 in the B subunit of 5-HT3AB receptors containing the E124Q mutation in the A 
subunit and normalized to the maximal elicited 5-HT current. 
 
Ab initio calculations of cation-π interaction energies between fluorinated 
benzenes and guanidinium were performed. Interpretation of the resulting interaction 
energies was precluded, however, as it became apparent that, unlike sodium, the 
guanidinium ion repositions itself to form direct interactions with the fluorine 
substituents (Figure 4.8).  
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Figure 4.8 Ab initio calculations of benzene fluorination effects on sodium and 
guanidinium ions. (A) Top-down view of the geometry-minimized stacked binding pose 
of sodium and benzene or its fluorinated analogues. (B) Top-down view of the geometry-
minimized stacked binding pose of guanidinium and benzene or its fluorinated analogues. 
Structures and were generated at HF 6-31G** and MP2/6-311+G** levels, with similar 
results (HF 6-31G** shown). 
 
4.3.6 Conclusions 
Unlike serotonin, which is only capable of activating 5-HT3AB through its A-A 
interface, mCPBG is capable of binding the receptor at all five subunit interfaces. E124 
(TyrA) and F226 (TyrC2) of the B subunit contribute to receptor activation in the 
principle face of the binding site and Y146 of Loop E contributes from the 
complementary face. mCPBG is capable of allosterically modulating the serotonin 
response through its binding at these additional interfaces. This highlights the potential 
A 
B 
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for the development of allosteric modulators of heteromeric 5-HT3 receptors akin to the 
benzodiazepine actions at GABAA receptors.  
4.4 METHODS  
4.4.1 Mutagenesis and Preparation of cRNA and Oocytes 
Mutant 5-HT3A and 5-HT3B receptor subunits, within the complete coding 
sequence for the human 5-HT3A and 5-HT3B receptor subunit (accession numbers 
P46098-1; NP_006019), were cloned into pGEMhe. Mutagenesis reactions were 
performed using the QuikChange mutagenesis kit (Stratagene), and confirmed by DNA 
sequencing. For unnatural mutagenesis, a stop codon, TAG, was made at the site of 
interest. Harvested stage V-VI Xenopus oocytes were washed in four changes of Ca2+-
free OR2 buffer (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.5), de-
folliculated in 1 mg/ml collagenase for approximately 1 h, washed again in four changes 
of Ca2+-free OR2, and transferred to ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 
mM MgCl2, 5 mM HEPES, pH 7.5) supplemented with 0.28 mg/ml pyruvate, 0.05 mg/ml 
Gentamicin, and 0.12 mg/ml theophylline.  Oocytes were injected with 5-25 ng mRNA 
produced by in vitro transcription using the mMESSAGE MACHINE kit (Ambion, 
Austin, Texas, USA) from cDNA subcloned into pGEMhe as previously described (28). 
For unnatural amino acid experiments a 1:1 mixture of mRNA and tRNA was injected (5-
25 ng each). Electrophysiological measurements were performed after incubation for 24 - 
72 h post-injection at 18o C. Wild-type recovery experiments (injection of tRNA 
appended to the natural amino acid) were performed to evaluate the fidelity of the 
unnatural suppression experiments. 76-mer THG73 was also injected with mRNA as a 
control.  
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4.4.2 Synthesis of tRNA and dCA amino acids 
This was as described previously (28). Briefly, unnatural amino acids were 
chemically synthesized as nitroveratryloxycarbonyl (NVOC)-protected cyanomethyl 
esters and coupled to the dinucleotide dCA, which was then enzymatically ligated to 74-
mer THG73 tRNACUA. Immediately prior to coinjection with cRNA, aminoacyl tRNA 
was deprotected by photolysis. Typically 5-10 ng total cRNA was injected with 25-50 ng 
of tRNA-aa in a total volume of 50 nl. For a control cRNA was injected with THG 76-
mer tRNA (no unnatural amino acid attached). 
4.4.3 Characterization of mutant receptors 
Agonist-induced currents were recorded at 22-25o C from individual oocytes 
using the OpusXpress system (Molecular Devices Axon Instruments, Union City, CA). 
5-HT, and m-chlorophenylbiguanide (mCPBG) (Sigma) were stored as 25 mM aliquots at 
-20o C, diluted in Ca2+-free ND96 buffer (96 mM NaCl, 2 mM KCl, 1 mM MgCl2,, 5 mM 
HEPES, pH 7.5), and delivered to cells via the automated perfusion system of the 
OpusXpress. Glass microelectrodes were backfilled with 3 M KCl and had a resistance of 
~1 MΩ. The holding potential was -60 mV. Agonist doses in Ca2+-free ND96 were 
applied for 15 s followed by a 116 s wash with the running buffer. Dose-response data 
were obtained for ≥ 8 agonist concentrations on ≥ 5 cells. To determine EC50 values, 
concentration-response data were fitted to the four-parameter logistic equation, I = Imax/[1 
+ (EC50/[A])nH] where Imax is the maximal response plateau, [A] is the log concentration 
of agonist, and nH is the Hill coefficient, using KaleidaGraph v3.6 software (Synergy 
Software, Reading, PA). A detailed error analysis of nonsense suppression experiments 
shows that data are reproducible to ±50% in EC50 (29). Relative efficacies (ε) of mCPBG, 
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are reported as ε = Imax-mCPBG/Imax-5-HT. Efficacy was calculated for individual cells and 
then averaged and reported as mean ± S.E.M.  
4.4.4 Computation 
 All calculations were performed with the program SPARTAN (30).  
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Chapter 5 
 
Efforts Toward the Application of  
Unnatural Amino Acid Mutagenesis in Ligand-Gated Transcription Factors 
 
5.1 ABSTRACT 
 Nuclear receptors are a broad class of ligand-gated transcription factors. This 
family of receptors is responsible for sensing steroids, sterols, fatty acids, and retinoids, 
and their function has been implicated in diverse physiological processes such as 
metabolism, inflammation, and immunity. RARα/RXRα heterodimeric nuclear receptor 
activation requires more than simply ligand binding and is surprisingly complex. The 
process of activation terminates in phosphorylation at S77 of RARα. Interestingly, S77 is 
immediately succeeded by a proline residue. This constitutes the minimal known 
recognition motif for the prolyl-isomerase Pin1. Unnatural amino acid mutagenesis with 
proline analogues of varying cis preference would be an elegant proof of this activation 
mechanism. Here, I describe progress toward the reconstitution of a RARα/RXRα 
pathway in Xenopus laevis oocytes and the detection of reporter mRNA by quantitative 
reverse transcription PCR as a functional assay for the detection of unnatural amino acid 
bearing transcription factors.  
 
5.2 INTRODUCTION 
 Given that a multicellular organism contains the same DNA in its genome across 
all of its cells, the specialization required by multicellularity is generated through the 
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differential selection of subsets of that genome to be transcribed into RNA. This selection 
is enacted by a broad class of proteins termed transcription factors. Upon becoming 
activated via either the sensation of ligand or post-translational modification, these 
proteins access the nucleus and bind to specific sequences in the genome termed 
promoters. In eukaryotes, combinatorial and cooperative action by collections of 
transcription factors bound at promoters recruit the RNA polymerase and its associated 
cofactors, enabling them to generate functional RNA.  
 While crystallography has elucidated the structures of a multitude of transcription 
factors, the structural logic of what constitutes an activated transcription factor, and in 
turn an activated promoter capable of recruiting RNA polymerase, is largely unknown.  
Transcription factors display a high degree of intrinsic disorder and complex dependent 
structure (1). Thus, even for proteins in which structures of certain domains exist, much 
of their function may lie in more fluid regions that orient those structured domains. 
Unfortunately, it is precisely these variable regions on which crystallography is void.  
 Nuclear receptors are a broad class of ligand-gated transcription factors, with 48 
unique receptors identified in humans thus far (2). This family of receptors is responsible 
for sensing steroids, sterols, fatty acids, and retinoids, and their function has been 
implicated in diverse physiological processes such as metabolism, inflammation, and 
immunity. Nuclear receptors have two conserved domains, a ligand-binding domain and 
a DNA-binding domain. The two domains are linked by variable hinge domains. These 
receptors also possess a highly variable N-terminal domain.  
Nuclear receptors are generally grouped into three classes: I, those that act as 
monomers, such as Nur77, and steroidogenic factor 1 (SF1), II, those that homodimerize, 
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such as the androgen receptor, the estrogen receptor (ER), and the glucocorticoid receptor 
(GR), and III, those that form heterodimers with the retinoid receptor (RXR), such as 
peroxisome proliferator-activated receptors (PPAR) and retinoic acid receptors (RAR) 
(2).  
Each nuclear receptor subunit binds to a unique six base consensus DNA 
sequence and dimers have a receptor-specific distance between each of their six base 
sequences. This combined stretch of bases is referred to as the receptor’s response 
element (2). While DNA-binding domains are capable of binding their consensus 
sequences in isolation, there is ample evidence of allosteric communication between the 
domains (3, 4). Recently, full-length crystal structures of dimeric nuclear receptors have 
been reported (5-7). These suggest a critical role for the hinge region in conveying 
allostery by controlling the relative orientation of the ligand-binding and DNA-binding 
domains. This communication is further modulated by the binding of one of the over 150 
co-activators of nuclear receptors (2). These co-activators bind at one of two sites: 
activating factor 1 (AF1) in the ligand-binding domain or AF2 in the N-terminal domain. 
The RARα/RXRα heterodimeric nuclear receptor has been thoroughly 
biochemically characterized, and many structures exist for each of its domains in 
isolation (8, 9). Upon binding of retinoic acid, RARα dimerizes with RXRα, migrates to 
the nucleus where it binds its response element, and recruits the transcriptional 
machinery. The process of receptor activation requires more than simply ligand binding 
however and is surprisingly complex (Figure 5.1). Retinoic acid, in addition to being 
bound by RAR, activates the p38MAPK pathway (10). This, coupled with RAR/RXR 
ligand binding, allows MSK1 to phosphorylate RAR at S369 of the ligand-binding 
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domain adjacent to AF1 (10). S369 phosphorylation, in turn, allows Cyclin H and cdk7 of 
the TFIIH complex to phosphorylate S77 of the N-terminal domain near AF2 (11). This 
latter phosphorylation is necessary and sufficient for transcription factor activation and 
results in higher DNA binding efficiency at the response element (11, 12).  
Figure 5.1 The RAR/RXR activation pathway. Adapted from reference 10.  
 
The exact structural mechanism of how phosphorylation in the N-terminal domain 
affects the adjacent DNA-binding domain remains to be explored. Interestingly, S77 is 
immediately succeeded by a proline residue. This constitutes the minimal known 
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recognition motif for the enzyme Pin1 (13, 14). Pin1 is a phospho-directed proline 
isomerase. Proline is the only natural amino acid that is capable of existing to any 
appreciable extent (about five percent) in a cis conformation (15). Isomerization is still 
disfavored, however, and is exceedingly slow. Augering the hypothesis that S77 marks a 
recognition site is the finding that Pin1 interacts with other nuclear receptors (16-18). 
Pin1 is capable of catalyzing both the trans to cis and cis to trans reactions (13, 
14, 19). Most kinases, however, are only capable of phosphorylation adjacent to trans 
substrates. Phosphorylation has been found to raise the energetic barrier between the 
trans and cis conformations, essentially locking the backbone in its set conformation 
unless acted upon by Pin1. Therefore, in vivo, Pin1 is likely to predominantly catalyze the 
proline backbone from trans to cis.  
Assays for detecting Pin1 activity are crude however. The best and most used 
method is to reconstitute the system in question and dope in peptides containing Pin1 
recognition sequences (20, 21). These peptides are expected to outcompete the 
endogenous substrate for catalysis, resulting in the diminishment of the ultimate 
functional output. Such an assay is both indirect and difficult to accomplish for complex 
systems such as RAR/RXR activation.  
 Here we hope to establish a system in which we can perform a more direct and 
elegant test of Pin1 function. A number of unnatural proline analogues have been created 
that show a diverse range of cis preferences (Figure 5.2) (22, 23). If mutation to a heavily 
cis biased unnatural amino acid at P78 can rescue an otherwise inactive S77A RAR/RXR, 
it is likely that proline isomerization at P78 is crucial for activation.  
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Figure 5.2 Unnatural proline analogues of varying cis preference. 
  
Unnatural amino acid mutagenesis brings complications of its own. First, to date 
there are a limited variety of amenable systems for heterologous expression in which 
unnatural amino acid incorporation is well tolerated (24, 25). The best characterized and 
most precedented is the Xenopus laevis oocyte . There is precedence for the heterologous 
expression of the RAR/RXR nuclear receptor in Xenopus oocytes by introducing mRNA 
for the receptor subunits and a simple luciferase reporter plasmid containing the 
appropriate response element (26, 27). RAR/RXR function in this system was confirmed 
by detecting luciferase bioluminescence.  
A second limitation of unnatural amino acid mutagenesis is that, even in Xenopus 
oocytes, expression of unnatural amino acid containing proteins is extremely limited (28). 
Thus a supremely sensitive functional assay is required. There are reasons to be hopeful 
however, as transcription is an amplifying process, e.g., each activated transcription 
factor is capable of generating many RNA molecules.  
 Each of those RNA molecules can, in turn, be amplified and detected using 
quantitative Reverse-Transcribed PCR (qRT-PCR). In fact, qRT-PCR protocols have 
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been shown to reliably detect roughly 20 copies of target RNA (29). In this technique 
isolated RNA is reverse transcribed into DNA that is then subject to amplification by 
PCR. Oligonucleotide primers specific to the target of interest are combined with those 
for various reference genes whose expression levels are known to be unaffected by the 
target (30). After each PCR cycle a fluorescence reading is taken to detect a fluorescent 
DNA intercalator included in the reaction. The higher the copy number of the target, the 
fewer PCR cycles it will take before the target fragment is amplified above the 
fluorescence background. The cycle at which the target reaches a fluorescence threshold 
can then be normalized to that of the reference genes in the same sample, allowing for 
calculation of relative abundances across experimental conditions.  
 Thus, we hope to develop an experimental system for unnatural amino acid 
mutagenesis and qRT-PCR analysis in Xenopus laevis oocytes to investigate potential 
enzyme directed proline isomerization of nuclear receptors as a structural mechanism of 
activation. We expect to see robust activation in the wild type RAR/RXR that is 
abolished by S77A mutation and rescued by the introduction of cis biased unnatural 
amino acids.  
  
5.3 RESULTS AND DISCUSSION 
5.3.1 Luciferase reporter plasmid qPCR calibration 
 A luciferase reporter plasmid containing a minimal promoter with three sites for 
RAR/RXR heterodimer binding, akin to that reported in prior studies in Xenopus laevis 
oocytes, was obtained. Primers were designed to specifically amplify a section of the 
luciferase coding region. To determine the sensitivity of the qPCR protocol and the 
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effectiveness of the luciferase primers, a calibration experiment was devised. Dilutions of 
the reporter plasmid were created at every order of magnitude from three million copies 
per µL down to three copies of the plasmid per µL. These dilutions seeded qPCR 
reactions with each condition run in triplicate. An additional condition with no reporter 
plasmid was also included.  
 The results of this experiment showed the expected pattern, with the fluorescence 
of higher copy number conditions rising above threshold at a lower number of 
amplification cycles (Cq) (Figure 5.3A). Tight grouping of replicates within each 
condition was also observed, demonstrating the precision of the qPCR technique. A 
thermal denaturation experiment was performed on the amplified product, or amplicon, 
showing a sharp characteristic melting temperature for the amplicon that is consistent 
across experimental conditions, with one exception (Figure 5.3B). The tightness of the 
melting curve peak suggests that only one DNA species is amplified during the qPCR 
procedure. The one exception shows a second peak of higher thermal stability, suggesting 
contamination or nonspecific amplification in this condition. As only one of twenty-one 
samples using the luciferase primers shows this second peak, it is likely that the primers 
are generally sound and that the thermal denaturation experiment may be used to identify 
and remove rare events of contamination from inclusion in future analysis.  
 The cycle at which fluorescence surpasses threshold for each condition shows a 
strong correlation with the plasmid copy number of the condition, as expected 
(Figure 5.3C). The difference in number of cycles between conditions that increase an 
order of magnitude, 3.29 ± 0.35 cycles, agrees well with that expected given amplicon 
doubling during every cycle (3.32 cycles). Thus it appears that the qPCR is a reliable 
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measure of relative sample copy number within an experiment. Also, given this 
calibration experiment, the Cq value of future experiments may be related back to 
absolute copy number.  
 
Figure 5.3 Luciferase reporter plasmid qPCR calibration. (A) Fluorescence response of 
samples of varying plasmid copy number as the PCR cycle count increases. (B) Melting 
curve of luciferase primer amplicon, plotted as the rate of fluorescence change versus 
temperature. (C) The relationship between the cycle at which fluorescence surpasses 
threshold, Cq, and the plasmid copy number. The average spacing of 3.29 agrees well 
with the order of magnitude difference in sample plasmid abundance. RFU, relative 
fluorescence units.  
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The variability between replicates of the same condition does increase as copy 
number decreases below 300, suggesting a lower threshold. There eventually is 
amplification of the condition with zero plasmid, however with significant fluorescence 
from the cycle numbers in the high 30s, suggesting that Cq values in this range are not 
indicative of real signal.  
5.3.2 qRT-PCR on mRNA from uninjected oocytes  
 To ensure that the luciferase primers used above are specific to only the reporter 
plasmid, they were tested against the pool of mRNA produced by naive oocytes that have 
not been injected with any foreign constructs. To do this, the mRNA must first be 
extracted from the oocytes. Then the isolated mRNA must be reverse transcribed into 
DNA so that PCR amplification may proceed.  
 To limit the effects of cell to cell variability in expression and to ensure sufficient 
RNA isolate, four oocytes were combined for each RNA extraction sample. Extraction 
was supplemented with a half hour on column DNAse I digestion at room temperature to 
ensure RNA purity. RNA isolate was analyzed by UV-Vis spectroscopy, showing a 
concentration of 113 ng per µL and the ratio of absorbances at 260 nm / 280nm was 2.05. 
Ratios over 2.0 are indicative of an enriched RNA sample. Lower ratios indicate mixture 
with DNA or RNA degredation.  
 Reverse transcription was performed using 1 µg of the extracted RNA in a 20 µL 
reaction. A poly-thymine primer, [dT]18, was used to selectively catalyze the reverse 
transcription of the mRNA minority within the RNA isolate. The process finishes with 
RNAse digestion. After reverse transcription the sample was again analyzed by UV-Vis 
spectroscopy. The reverse transcribed sample showed a concentration of 2222 ng per µL 
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and an A260/280 ratio of 1.84. The increase in concentration shows that the reaction 
amplified the mRNA within the sample. This is a potential source of concern as it could 
bias results if not all target mRNAs amplify with equal efficiency. The marked decrease 
to 1.8 is consistent with a relatively pure and non-degraded DNA sample.  
 As positive controls, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 
ornithine decarboxylase (ODC) were selected, as they had previously been shown to exist 
at invariant abundance in Xenopus laevis oocytes. Such general housekeeping genes are 
also of great utility as reference marks against which to interpret the luciferase reporter 
abundance so that differences in the quality and quantity of RNA extracted can be 
accounted for. qPCR primers were designed for both of these genes so that conditions 
probing their abundance could be run in parallel with the luciferase primers.  
 The reverse transcription reaction mixture was split into three replicates of each of 
the three primer sets for a total of nine qPCR reactions. GAPDH and ODC show high 
abundances in the reverse transcribed sample with Cq values of 23.2 and 24.2 cycles, 
respectively (Figure 5.4). This is roughly equivalent to ten thousand copies each in the 
fraction of the sample probed in each reaction based on the luciferase calibration 
experiment, though slight corrections may need to account for differences in amplicon 
length. The luciferase samples on the other hand have a Cq value of 36.6 cycles. This is 
equivalent to that seen for samples with three or fewer copies in the calibration 
experiment.  
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Figure 5.4 qPCR controls tested on uninjected oocytes. RFU, relative fluorescence units.  
 
Unfortunately the thermal denaturation experiment shows a sharp peak in the 
luciferase amplicon melt curve equivalent to that seen at high copy numbers in the 
calibration experiment (Figure 5.5A). This suggests that the nonspecific amplification has 
a similar thermal stability and that, unfortunately, the denaturation experiment may not 
root out all false positives. The thermal denaturation of GAPDH and ODC amplicons 
show similarly sharp peaks at 75 and 78 °C, respectively (Figure 5.5B and C).  
These results suggest that GAPDH and ODC fall within a robust region of qPCR 
detection, making them well suited as reference genes against which to evaluate 
luciferase expression levels. The lack of amplification of the luciferase amplicon in naïve 
uninjected oocytes shows that the luciferase primers are specific to that construct and 
background off-target amplification will not significantly contribute to the apparent 
abundance of luciferase in future experiments.  
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Figure 5.5 Thermal denaturation of qPCR amplicons. Plots are the rate of fluorescence 
change versus temperature for luciferase (A), GAPDH (B), and ODC (C) primers.  
 
5.3.3 Reconstitution of the RAR/RXR dependent luciferase reporter system 
 With the above controls in place, reconstitution of the RAR/RXR dependent 
luciferase reporter system in Xenopus laevis oocytes as reported previously was 
attempted. The experimental work-flow was as follows (Figure 5.6):  
 1. injection of the oocyte nuclei with luciferase reporter plasmid 
 2. injection of in vitro transcribed mRNA for RARα and RXRα 
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 3. incubation with or without retinoic acid 
 4. RNA isolation for reverse transcription and qPCR as previously described.  
Figure 5.6 Schematic of experimental work-flow.  
The first step proved to be non-trivial, with multiple methods for nuclear injection 
attempted. These methods are premised on the finding that the nucleus is fluid within the 
oocyte. Low-speed centrifiguation of oocytes individually situated animal pole down in 
conical tubes was performed to force the nucleus up against the plasma membrane of the 
animal pole. This should result in an area of reduced pigment that marks the presence of 
the nucleus into which one should inject. Centrifugation is harsh on the oocytes and 
removal of the oocytes from the tubes without disrupting the nucleus’ placement is 
delicate.  
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A second, and preferred, method is to rely on the observed relative low density of 
the nucleus relative to the cytoplasm. If left animal pole up, the nucleus will float to the 
top of the oocyte, resulting in a similar displacement of pigment in the animal pole by 
which it may be identified. The injection needle was placed perpendicular to the nucleus 
and inserted slightly deeper into the oocyte than typical cytoplasmic injections. 10 nL 
containing 2 ng of luciferase reporter plasmid was injected into each oocyte. 
 After an overnight incubation during which the oocytes were allowed to recover 
and to chromatinize the reporter construct, they received a second cytoplasmic injection. 
This contained in vitro transcribed mRNA for RARα and RXRα. 10 ng of each mRNA 
was delivered in a 50 nL shallow injection at the boundary between the  animal and 
vegetal poles of the oocytes. Following an hour incubation in which the oocytes were 
allowed to recover, the cells were randomly split into two equal groups, with one 
receiving 10 µM retinoic acid. Retinoic acid solubility was increased by supplementation 
with 0.1 percent DMSO and sonication at 37 °C for a half hour prior to addition.  
After an additional overnight incubation in a blacked out container to limit 
retinoic acid photo-degradation, total RNA was extracted from oocytes from conditions 
with and without retinoic acid exposure and mRNA was reverse transcribed into DNA as 
detailed previously. UV-Vis spectroscopy showed the sample to be of good quality 
(Table 5.1) Each reverse transcription reaction seeded qPCR reactions for luciferase, 
GAPDH and ODC. Each condition was run in triplicate.  
GAPDH and ODC reference genes show amplification at around 30 cycles 
regardless of incubation with retinoic acid (Table 5.1). The lack of meaningful change in 
Cq between the conditions confirms the validity of the targets as reference genes. The 
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lack of a significant change in Cq between GAPDH and ODC also suggests that their 
expression levels are relatively invariant. The fact that GAPDH and ODC amplify at 
roughly 6 cycles higher than observed in the experiment on uninjected oocytes may 
imply that the RNA extraction was less efficient in this experiment or that the oocyte 
repair process following puncture results in fewer housekeeping gene mRNA.  
As hoped, the luciferase sample that has been exposed to retinoic acid shows 
strong signal with a Cq of roughly 24 cycles (Table 5.1). Unfortunately, this high 
expression is also observed in the absence of retinoic acid.  
RNA 
extracted 
DNA 
reverse 
transcribed 
qPCR Cq 
 
 Conc 
A260/ 
280 Conc 
A260
/ 280 Luciferase GAPDH ODC 
No 
ligand 263 2.05 1824 1.84 22.2 ± 1.1 30.0 ± 0.8 30.0 ± 0.8 
RA 
 296 2.05 2070 1.83 23.9 ± 0.8 29.4 ± 0.8 28.5 ± 0.8 
Table 5.1 UV-Vis and qPCR data for DNA and RNA injected oocytes. Concentrations 
are in ng per µL. Cq are in cycles. RA is retinoic acid. Values are reported as mean and 
standard error.  
 
 
5.3.4 Determining the origin of luciferase reporter signal 
There are several possible explanations for this high apparent expression of 
luciferase that is unresponsive to retinoic acid exposure. The first is that the RARα and 
RXRα may be constitutively active, resulting in the production of luciferase mRNA even 
in the absence of activating ligand. It is also possible that endogenous activated nuclear 
receptors within the oocytes are stimulating the production of luciferase mRNA.  
To distinguish between these two cases, the experiment was repeated identically, 
except that the second injection containing the RARα and RXRα mRNA was skipped. If 
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the luciferase signal is due to their constitutive activation, this sample should have 
negligible luciferase response. Samples with and without retinoic acid exposure were 
again created and run in duplicate. UV-Vis spectroscopy again confirmed high sample 
quality and conversion to DNA (Table 5.2).  
RNA 
extracted 
DNA 
reverse 
transcribed qPCR Cq 
 Conc 
A260/ 
280 Conc 
A260
/ 280 Luciferase GAPDH ODC 
No 
ligand 259 2.07 2015 1.80 22.0 25.6 24.3 
RA 
 240 2.07 2245 1.82 22.1 26.7 25.7 
Table 5.2 UV-Vis and qPCR data for DNA injected oocytes. Concentrations are in ng per 
µL. Cq are in cycles. RA is retinoic acid. Cq values are the average of 2 replicates. 
 
GAPDH and ODC samples amplified at around 25 cycles and luciferase again 
showed high copy numbers with a Cq value of 22 cycles regardless of retinoic acid 
presence (Table 5.2). The difference between the Cq of luciferase and the Cq of the 
reference genes in this experiment was roughly three cycles, whereas the difference when 
the transcription factor mRNA is injected is roughly seven cycles. If real, this suggests 
that the luciferase transcript is 24 or 16 times more abundant when RARα and RXRα 
mRNA are supplied. The response is still invariant with regard to retinoic acid, 
suggesting constitutive activation.  
The high basal level of luciferase response, even when the transcription factors 
are not supplied, suggests that there may be either endogenous transcription factors that 
are acting on the reporter plasmid, or that there is contamination from undigested DNA 
plasmid that remains in the extracted RNA despite the on-column DNAse I digestion. It 
is possible that if the basal level of luciferase response could be lowered, the fold increase 
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upon expression of the transcription factors might appear much larger. This would 
provide a larger window in which to reliably observe partial recovery of function when it 
comes time to attempt unnatural amino acid mutagenesis.  
To determine whether DNA contamination persists after the DNAse I digestion, 
two different initial approaches were attempted. First, a primer was designed to amplify 
from a non-coding region of the luciferase reporter plasmid. In a calibration curve 
experiment, this primer, called pGL3, showed similar fidelity as the luciferase primer, 
with the spacing between order of magnitude dilutions of plasmid of 3.34 cycles or 10.1 
fold (Figure 5.7).  
Figure 5.7 pGL3 primer qPCR calibration. Fluorescence as a function of PCR cycle 
shows pGL3 primer to function similarly to previous luciferase primers.  
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When tested against reverse transcribed RNA isolate from naïve ununinjected 
oocytes however, the pGL3 reaction amplified at 26 cycles. This suggests that the 
primers are not specific for the luciferase reporter plasmid and amplify endogenous 
constructs. The second method attempted was to perform an additional DNAse I 
digestion for 10 min at 37 °C on the extracted total RNA prior to reverse transcription. 
Oocytes injected with only the luciferase reporter plasmid were lysed after overnight 
incubation in the absence of retinoic acid. Total RNA was extracted from two sets of four 
oocytes with equivalent yields and quality (Table 5.3) Each sample received the standard 
on-column DNAse I digestion, while one sample received the addition re-digestion. This 
re-digested sample showed marked degradation, however, with the concentration 
dropping from 230 ng per µL after the first digestion to 53 ng per µL. Additionally the 
A260/280 ratio dropped from 2.05 to 1.97, supporting the conclusion that the sample had 
degraded (Table 5.3).  
RNA 
extracted 
DNA 
reverse 
transcribed 
qPCR Cq 
 
 Conc 
A260/ 
280 Conc 
A260
/ 280 Luciferase GAPDH ODC 
Single 267 2.04 1994 1.82 23.8 ± 0.7 24.8 ± 0.2 27.4 ± 0.8 
First 
 230 2.05 - -  -   -   -  
Second 
 53 1.97 2333 1.81 24.3 ± 1.1 27.4 ± 0.4 30.4 ± 0.9 
Table 5.3 UV-Vis data for DNAse I re-digestion experiment. Single refers to the 
standard condition of a single DNAse I digestion. First refers to a sample after the first of 
two DNAse I digestions. Second refers to a sample after the second of two DNAse I 
digestions. Concentrations are in ng per µL. Cq are in cycles. Values are reported as 
mean and standard error.  
 
 When this re-digested sample was reverse transcribed and compared to a parallel 
sample that had only the standard single on-column digestion, the difference in 
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absorbance profiles disappeared with each showing high abundance and A260/280 ratios 
typtical of DNA samples. qPCR revealed that the Cq of luciferase remained unchanged 
between the two samples and that the difference in Cq between luciferase and the 
reference genes actually increased upon re-digestion (Table 5.3). This suggests that while 
the reference genes degraded during the second DNAse I digestion, the luciferase 
construct remained stable. It is possible that the heat of the re-digestion had a greater 
effect on the comparatively labile RNA than the DNAse did on the plasmid.  
The difference between luciferase and the reference genes in the single digestion 
condition is different than that observed in the prior experiment. If this sample were 
compared with the transcription factor injected condition, it would appear that there was 
no increase in luciferase abundance with the addition of transcription factor mRNA. This 
variable response may be due to imprecision of the amount of reporter plasmid delivered, 
as 10 nL is at the lower limit of detection for the standard micro-injection needles used.  
 The final and most elegant method to determine the source of the luciferase signal 
was to perform qPCR reactions on the total isolated RNA without reverse transcription. 
Leftover RNA isolate from the above singly digested sample was added directly to qPCR 
reactions for luciferase and GAPDH. Amplification should be impossible for single 
stranded RNA so neither construct should show signal unless there is DNA 
contamination in the RNA isolate with the required template sequences. Amplification 
does occur for luciferase with a Cq of 25.8 ± 0.1 cycles while the GAPDH Cq is 
38.4 ± 0.1 cycles (Figure 5.8). Thus, it appears that the luciferase signal arises nearly 
entirely from DNA contamination in the total RNA extract despite DNAse I digestion. 
The Cq of luciferase is roughly 3 cycles lower than the Cq after reverse transcription, 
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which tracks well with the roughly 10 fold increase in nucleic acid concentration 
recorded by UV-Vis after reverse transcription. The Cq of GAPDH corresponds to less 
than three copies according to the luciferase calibration curve, showing that the reference 
gene signal in prior experiments did indeed arise from reverse transcribed mRNA.  
Figure 5.8 qPCR of the total RNA isolate of luciferase reporter plasmid injected oocytes 
 
 
5.3.5 Introducing selectivity for the luciferase transcript 
 Given the high background level (equivalent to tens of thousands of copies) of 
luciferase response in qPCR experiments due to the amplification of contaminating 
plasmid DNA, it is possible that the signal from smaller retinoic acid dependent increases 
in luciferase mRNA production is swamped out. In order to see these potential effects, 
specificity of amplification for the mRNA over the DNA plasmid must be introduced. 
The conventional way in which this specificity is generated is to create amplification 
primers that span the intron-exon junction of a gene. If the primer contains only coding 
sequence from adjacent exons, it will only be able to anneal and allow amplification after 
intron excision during mRNA maturation.  
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Unfortunately, the introns of the luciferase 
gene were removed from the reporter construct. 
Therefore a short intron original to the firefly 
luciferase gene was reintroduced by PCR. The 
intron is short enough that it could be chemically 
synthesized in its entirety with overlaps into the 
adjacent exons, allowing the oligo to be used as 
one large amplification primer. qPCR primers 
were then designed that anneal across the 
intron-exon boundary, referred to as plasmid 
primer, and those that anneal only to the edges 
of the exons split by the intron, referred to as 
intron-spanning primer (Figure 5.9).  
These primers were then used in qPCR reactions to find conditions that promote 
maximal selectivity between the two. Ideally conditions would require annealing along 
the full sequence of the primer to allow amplification. The best way to regulate 
stringency of primer binding is to adjust the annealing temperature of the PCR method. 
Thus, side by side reactions of the intron-spanning and plasmid primers were performed 
at a range of annealing temperatures from 50.8 °C to 69.7 °C (Table 5.4). The largest 
difference between the efficiency of amplification of the two sets of primers while still 
allowing any amplification occurred at an annealing temperature of 63.5 °C.  
Figure 5.9 Diagram of qPCR primers 
for an intron-containing luciferase 
reporter plasmid. The black section of 
the green coding region is an intron. 
The blue primers bridge these 
sections and anneal along the whole 
length. The red primer spans the 
intron and anneals only on the two 
exons that will be brought together 
after splicing.  
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Annealing 
Temperature plasmid Cq 
intron-
spanning Cq 
69.7 - - 
66.9 - - 
63.5 16 29.3 
59.6 17.4 25.5 
56.5 17.4 23.9 
53.5 17.9 21.3 
50.8 18.4 20.3 
Table 5.4 qPCR data for intron-containing luciferase primer annealing temperature 
experiment. Temperatures are in ºC. Cq are in cycles. Values are the mean of three 
replicates. -, no amplification.  
 
This qPCR protocol was then applied to the total RNA extracted from 4 oocytes 
injected with the standard 2 ng per cell of the luciferase reporter plasmid. It was found 
that while the plasmid primers amplified as expected with a Cq of 26 cycles, the intron-
spanning primers displayed a Cq of 37.9 cycles (Figure 5.10). As this Cq reflects an 
absolute abundance of the luciferase DNA in single digit or even zero copies, this result 
suggests that the intron-spanning primers are sufficient to discriminate between mRNA 
and the DNA plasmid in the Xenopus laevis oocyte.  
Figure 5.10 qPCR using intron-spanning primers of the total RNA lysate from modified 
luciferase resporter plasmid injected oocytes.  
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Having validated the intron-spanning primers and established a true negative 
control, the full expression system was again reconstituted in hopes of establishing a 
positive response. Oocyte nuclei were injected with 2 ng per cell of the luciferase reporter 
construct, and allowed to repair and chromatinize the plasmid for 18 hours. Then the 
oocyte was cytoplasmically injected with 5 ng or 0.5 ng each of RARα and RXRα 
mRNA. After one hour for the oocytes to recover from injection, they were incubated in 
10 µM retinoic acid for an additional 18 hours. At this time, total RNA was extracted and 
reverse transcribed according to the established protocol, creating two parallel conditions 
culled from four oocytes each that are identical except in the amount of transcription 
factor mRNA injected.   
These two samples were split into qPCR reactions using the intron-primers with 
an annealing temperature of 63.5 °C, in addition to those for the reference genes with the 
standard annealing temperature of 48 °C. The results of these reactions show the expected 
abundances of the reference genes with GAPDH Cq values around 25 cycles and ODC 
Cq values around 28 cycles (Table 5.5). Unfortunately, the luciferase Cq values were 
around 35 cycles, firmly in a range that suggests there is no detectable expression. The 
amount of transcription factor mRNA injected seems to have no effect on these results.  
 
 0.5 ng mRNA 5 ng mRNA 
Intron-
Spanning 35.7 35.1 
GAPDH 28.2 29.4 
ODC 24.5 26.0 
Table 5.5 qPCR data for intron-containing DNA and RNA injected oocytes. 0.5 and 5 ng 
mRNA refers to the amount of RARα/RXRα mRNA injected per oocyte. Values are the 
average Cq for two replicates of each condition.  
 
128 
5.3.6 Future Directions 
 The lack of signal observed with the intron-spanning primers may arise from a 
number of possibilities. It is possible that the Xenopus laevis spliceosome is incapable of 
recognizing the firefly intron for excision. It is also possible that in the oocyte 
developmental state the spliceosome is not active or the mRNA is sequestered from it. In 
this case the experiment should be repeated with the intron-less luciferase reporter assay. 
The protein fraction of the cell lysate should then be subjected to the luciferase enzymatic 
luminescence assay. If luciferase mRNA is made, and that mRNA is translated to protein, 
this assay should give an observable signal.  
It is also possible that the transcription factors themselves are not being created. It 
is possible that there is an undetected defect in the coding region of the DNA for RARα 
or RXRα that precludes functional expression, or that there was a mistake in their 
subcloning into Xenopus laevis expression vectors. Western blotting of the protein 
fraction of the oocyte lysate for the transcription factors should reveal whether they are 
being produced to any appreciable extent within the oocyte.  
Alternative methods for micro-injecting the oocyte nuclei with the luciferase 
reporter plasmid must also be attempted. There appears to be some sample to sample 
heterogeneity in the amount of plasmid delivered due to the small volume injected. A 
more reliable system for such small volumes may be to use the Nano-ject II by 
Drummond, which is on hand.  
It is also worth considering that, even given a working expression system with 
retinoic acid inducible luciferase mRNA production, it may be that our unnatural proline 
analogues are ill-suited to the question at hand. It may be that the activation of the 
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receptor depends on a certain lifetime of the cis proline. The proline analogues increase 
the population percent cis bias but there is still rapid interconversion between the cis and 
trans states. Aside from the reasonableness of this particular biological question, the 
expansion of the unnatural amino acid mutagenesis methodology to an important new 
class of protein by the application of alternative highly sensitive functional assays would 
be an important step forward for this technology.  
  
5.4 MATERIALS AND METHODS 
5.4.1 Materials 
 pSV Sport RXRα (ID: 8882), pcDNA FLAG-RARα (ID: 35555), and pGL3 
RARE Luciferase (ID: 13458) constructs were obtained from Addgene. Retinoic acid was 
purchased as a powder from Sigma, suspended as a 10 mM stock in DMSO and stored at 
-80 ºC.   
5.4.2 Preparation of cRNA and Oocytes 
 Harvested stage V–VI Xenopus oocytes were washed in four changes of Ca2+-free 
OR2 buffer (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH = 7.5), 
defolliculated in 1 mg/mL collagenase for approximately 1 h, washed again in four 
changes of Ca2+-free OR2, and transferred to ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM 
CaCl2, 1 mM MgCl2, 5 mM HEPES, pH = 7.5) supplemented with 0.28 mg/mL pyruvate, 
0.05 mg/mL Gentamicin, and 0.12 mg/mL theophylline. Oocytes were injected with 
either cDNA plasmids or mRNA produced by in vitro transcription using the 
mMESSAGE mMACHINE kit (Ambion, Austin, Texas, USA) from cDNA subcloned 
into pGEMHE as previously described (28). 
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 Oocyte nuclei were injected by allowing the nucleus to rise against the animal 
pole by incubation, vegetal pole down in the ridge of the disk that sits within petri dishes 
used for micro-injection for 90 minutes at room temperature. Oocytes were injected 
deeply and directly into the center of discolored regions the animal pole that appeared 
after such incubation with 0.2 or 2 ng of reporter plasmid per oocytes. Oocyte cytoplasms 
were injected shallowly at the edge of the animal pole with 0.5, 5, or 10 ng of mRNA for 
each transcription factor.  
5.4.3 RNA isolation and Reverse Transcription 
 RNA isolation was performed using RNeasy kit (Qiagen). Deviations from 
standard protocol are detailed below. Four oocytes were lysed in buffer RLT and 
vortexed to homogenize until no macroscopic oocyte structure remains intact. Ethanol 
precipitation proceeds directly on this sample without centrifugation. 3 -5 µL DNAse I in 
a 70 µL buffered solution was applied to the column and incubated at room temperature 
for 30 min. RNA was eluted in 20 µL of RNAse-free water. This eluent was then passed 
through the column a second time for complete recovery. Samples were stored at -80 ºC 
until ready for reverse transcription.  
 Reverse transcription was performed using the Transcriptor First-Strand cDNA 
Synthesis kit (Roche). Deviations from standard protocol are detailed below. 1 µL (~300 
ng) of total RNA extract was added to a 20 µL reaction containing polythymine [dT]18 
primer. RNA, primer, and water were denatured at 65 ºC for 10 minutes and cooled on 
ice before the addition of buffer, dNTP, RNase Inhibitor, and reverse transcriptase. This 
reaction was incubated for 30 min at 50 ºC before transcriptase denaturation by 
incubation at 85 ºC for 5 min.   
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5.4.4 quantitative Real-Time PCR 
 20  µL qPCR reactions employed the 2X SYBR Green Master Mix (Roche). 
1.25 µL each from 10 µM forward and reverse primer stocks was added along with 2 µL 
from the reverse transcription reaction. cDNA for reactions with luciferase for each of the 
reference gene primers was split from the same reverse transcription product. Each 
condition was run in triplicate.  
 19.5 µL of each sample was transferred to a 96-well plate, taking care to avoid 
bubbles, covered, and run on a Bio-Rad CFX96 Real-Time system qPCR with a 2-step 
cycle. An initial denaturation of 95 ºC for 10 min preceded 40 cycles of 10 s at 95 ºC and 
30 s at the annealing temperature (48 ºC for all conditions except those specified 
otherwise in the main text). Following the final cycle, a temperature gradient ramping 
from 58 – 88 ºC, raising two degrees per minute, was run.  
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Appendix 1 
 
Investigation of Potential 5-HT3 Receptor Molecular Chaperoning 
 
A1.1 ABSTRACT 
 Cys-loop receptors undergo a slow and highly inefficient maturation process 
before arriving at the plasma membrane. Several proteins, termed molecular chaperones, 
facilitate this process. Two such chaperones of Cys-loop receptors are RIC-3 and Lynx1. 
Here we test the abilities of these proteins to facilitate 5-HT3 receptor expression on the 
plasma membrane of Xenopus laevis oocytes. We find that, across a wide range of 
relative abundances, RIC-3 decreases 5-HT3A expression on the plasma membrane. 
Maximal serotonin currents suggest that Lynx1 has a bimodal interaction with 5-HT3 
subunits. At high relative abundances, Lynx1 inhibits 5-HT3 assembly, while at lower 
abundances Lynx1 appears to selectively chaperone 5-HT3A and not 5-HT3AB receptors. 
Lynx1 is unable to bias assembly toward 5-HT3A receptors in oocytes expressing a 
mixed population of receptors however, suggesting either that the maximal serotonin 
current data were misleading or that the B subunit has a higher affinity for the A subunit 
than does Lynx1.  
 
A1.2 INTRODUCTION 
 Cys-loop receptors, as multimeric integral membrane proteins, undergo a complex 
process of maturation. Individual receptor subunits complex to form pentamers in the 
endoplasmic reticulum (ER) before passage through the Golgi and insertion in the plasma 
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membrane (1). The assembly process is slow and highly inefficient however (2). 
Receptor subunits must overcome a varied mixture of ER retention and exit motifs, be 
decorated at various glycosylation sites, oxidize proper disulfide bonds, cleave N-
terminal signaling sequences, and find complementary subunits with which to assemble 
in acceptable functional stoichiometries (1, 3, 4). Perhaps unsurprisingly then, a large 
majority of translated subunits remain unassembled in the ER, where they lead to the 
activation of ER stress signaling responses (5-7).  
 Given this landscape, one could imagine that increased subunit translation levels 
might lead to increased ER stress rather than to increased mature functional receptor. 
Thus, in some cases, in order to efficiently modulate the amount of mature receptor on 
the plasma membrane, accessory proteins facilitate the assembly process (8, 9). These 
facilitators, known as molecular chaperones, bind to and stabilize subunits in partially 
assembled receptors within the ER (8, 9). There are two major molecular chaperones for 
nicotinic acetylcholine receptors (nAChR):  RIC-3 and Lynx (10, 11).  
 RIC-3 was identified by a mutagenic screen in C. elegans, where it is required for 
expression of nAChRs (12). The human homologue of RIC-3 was found to greatly 
increase the expression of α7 nAChRs in heterologous systems (13-15). Further, the 
endogenous expression level of RIC-3, which is primarily located in the ER, correlates 
with the functional expression of α7 nAChRs on the plasma membrane. While it is 
known that RIC-3 directly binds to nAChRs, and its function is contingent on nAChR 
transmembrane region or intracellular loop identity, the exact mechanism of its 
interaction is unclear (13, 16-18). Converse to its actions on α7, RIC-3 inhibits functional 
expression of many other nAChR subtypes (11).  
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 For non-nicotinic Cys-loop receptors the data are less clear. In Xenopus laevis 
oocytes, it appears that RIC-3 blocks the expression of 5-HT3A receptors (13). However, 
other studies in human cell lines show up-regulation of plasma membrane 5-HT3A 
receptor (19). This up-regulation also appears to be subunit-specific, as RIC-3 does not 
bind the 5-HT3B subunit (20, 21). Thus, it appears either that there may be additional cell 
type specific factors that enable RIC-3 function or that one set of studies is mistaken.  
 Lynx1 was identified through sequence homology with a family of toxins, 
including α-bungarotoxin, known to target and bind nAChRs (22). Lynx1 is widely 
expressed in the brain and experiments in heterologous expression systems demonstrate 
that co-expression of Lynx1 and α4β2 nAChRs results in many changes to the 
acetylcholine response, including current intensity, receptor desensitization rate, and 
ligand potency (23). In vivo, these changes have been found to underlie the closure of the 
early developmental period of synaptic plasticity in the visual cortex (24).  
Lynx1’s functional effects result from its direct binding to the receptor (23). Co-
immunoprecipitation experiments show that Lynx is capable of binding many different 
nAChR subunits. NMR studies have confirmed that Lynx1 forms a three finger toxin-like 
β-fold (25). Like those toxins, Lynx1 is believed to bind to the receptor at the interface of 
adjacent subunits just below the orthosteric binding site (25, 26). Lynx1 is decorated with 
a GPI-linker in the ER and recent evidence suggests that Lynx1 binding to nAChRs in the 
ER may facilitate receptor assembly (10).  
In attempting to determine the relationships between structure and function in the 
5-HT3 receptor, many mutations that decrease receptor assembly and efficacy are 
encountered. This effect is compounded by the inefficiency of the nonsense suppression 
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methodology. Therefore we attempted to characterize the effects of RIC-3 and of Lynx1 
on 5-HT3 receptors.  
 
A1.3 RESULTS AND DISCUSSION 
A1.3.1 RIC-3 Inhibits 5-HT3A Functional Expression at the Plasma Membrane  
 In order to determine if RIC-3 is capable of chaperoning 5-HT3A receptors in 
Xenopus laevis oocytes, the mRNA of both proteins were co-injected at varying relative 
abundances. The total maximal serotonin current elicited from these oocytes was then 
compared to paired ooctyes bearing the same amount of receptor subunit mRNA but 
lacking RIC-3 mRNA. The paired oocytes were taken from the same batch, had been 
injected and assayed at the same time as the RIC-3 bearing oocytes, and handled 
identically in between. Despite the normal variability of maximal currents across oocytes, 
given a large sample size culled from multiple oocyte preparations, it was hoped that 
meaningful interpretations could be made.  
 RIC-3 : 5-HT3A mass ratios of 1:1, 
1:10, and 1:100 were compared to oocytes 
injected with 5-HT3A alone (Figure A1.1). In 
all cases of RIC-3 coinjection, maximal 
serotonin response was significantly 
decreased (p < 0.05, student’s T-test). The 
strongest inhibition occurs at the highest 
relative abundance of RIC-3, with the effect 
trailing off as RIC-3 scarcity increases. This is 
moles mRNA injected 
 (A : RIC-3) 
Figure A1.1 Effects of RIC-3 on 
5-HT3A receptor maximal current. 
Normalized to the 5-HT Imax for 5-HT3A 
receptor in the absence of RIC-3. 
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in agreement with the effects reported previously in Xenopus laevis oocytes and contrary 
to findings in human cell lines, confirming the validity of the early oocyte work and 
suggesting that addition factors present in human cells influence RIC-3 function.  
A1.3.2 Lynx1 Appears to Selectively Regulate 5-HT3A but not 5-HT3AB Receptors 
 When Lynx1 and 5-HT3A subunits were co-injected at various relative 
abundances according to the protocol delineated above for RIC-3, two different effects 
became apparent (Figure A1.2, A; Table A1.1). Similarly to RIC-3, at high Lynx1 relative 
abundances the serotonin maximal current was inhibited. Unlike RIC-3 however, there 
exists a ratio at which the serotonin maximal current meaningfully increases (p < 0.01, 
student’s T-test) before trailing off again toward levels seen in the absense of Lynx1. 
This suggests that Lynx1 is capable of chaperoning 5-HT3A receptors to the plasma 
membrane. Assuming equally efficient translation of the constructs, the ratio at which 
increases in maximal current are observed equates to one Lynx1 molecule per ten 
assembled receptors. This sub-stoichiometric effect is somewhat puzzling until one 
remembers the strong inhibitory effect at ten lynx molecules per one assembled receptor. 
It is possible that current increases are not seen at one Lynx1 molecule per receptor, 
because this overall ratio likely is a combination of mono-liganded receptors that 
potentiate and multi-liganded receptors that inhibit observed currents.  
 When the same experiment is repeated with oocytes injected with both 5-HT3A 
and 5-HT3B subunits, the reduction of maximal serotonin current is again observed at 
high ratios of Lynx1 to receptor subunit (Figure A1.2, B; Table A1.1). There is no further 
effect, however, as currents resemble those for oocytes lacking Lynx1 at all other 
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injection ratios. This suggests that the potentiating effect seen above for the 5-HT3A 
receptor is subunit specific.  
Figure A1.2 Effect of Lynx1 co-expression on 5-HT maximal currents. (A) 5-HT3A 
receptor responses normalized to maximal current in the absence of Lynx1. (B) 5-HT3AB 
receptor responses normalized to maximal current in the absence of Lynx1. Asterisks 
mark conditions that are significantly (p < 0.01) deviated from the reference condition.  
 
 
Receptor 5-HT3A : Lynx1 Normalized Imax p < 0.01 # Cells 
A - 1.00 ± 0.15   30 
A 1:2 0.31 ± 0.04 * 30 
A 5:1 0.96 ± 0.09   43 
A 50:1 2.12 ± 0.34 * 36 
A 500:1 1.19 ± 0.22   21 
AB - 1.00 ± 0.11   29 
AB 1:2 0.43 ± 0.06 * 27 
AB 5:1 1.12 ± 0.15   31 
AB 50:1 0.96 ± 0.15   30 
AB 500:1 0.88 ± 0.08   33 
 
Table A1.1 Effect of Lynx1 co-expression on 5-HT maximal currents. In all cases, the 
injection ratio of A to B subunits in 5-HT3AB receptors is 1:3. P-values are determined 
by student’s t-test. Values are reported as mean ± standard error.  
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A1.3.3 Lynx1 Appears Unable to Bias Assembly in Mixed Populations of 5-HT3A and 
5-HT3AB Receptors  
 The subunit selectivity of 5-HT3 receptor upregulation by Lynx1 observed above 
raises the possibility that Lynx1 acts to shape the serotonin receptor expression profile in 
vivo, biasing toward assembly of the homomeric receptor. To test this hypothesis, oocytes 
were injected with a ratio of 5-HT3A and 5-HT3B subunits shown to generate a mixed 
population of homomeric and heteromeric receptors (Figure A1.3). The dose-response 
curve resulting from this mixed population shows a biphasic response with components 
relating to each of receptor subtypes. The fit of this biphasic response provides the 
proportion of total serotonin response arising from each receptor subtype.  
Figure A1.3 Biphasic dose-response relationship resulting from co-expression of 5-HT3A 
and 5-HT3AB receptors. Injected subunit mRNA ratio is 100:1 5-HT3A:5-HT3B. The fit 
of the biphasic curve shows 40 % of total response to arise from homomeric channels at 
this subunit injection ratio.  
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Varying amounts of Lynx1 were then co-injected along with this mix of receptor 
subunits. If Lynx1 increases the likelihood of 5-HT3A receptor assembly at the expense 
of 5-HT3AB receptor assembly, it would be expected that the components of the biphasic 
dose response curve arising from the homomeric channel would increase as a proportion 
of the normalized total response. Unfortunately, this is not what is observed (Table A1.2). 
The proportion of homomeric and heteromeric receptors is unaffected by any relative 
abundance of Lynx1. This can mean either of two things: one, that the Lynx effect on 
5-HT3A maximal currents was a statistical aberration arising from an inherently noisy 
metric, or two, that the effect on maximal currents was real but that it is mitigated by the 
presence of competing 5-HT3B subunits. The latter scenario could be possible if 
B subunit association with A subunits is stronger than that of Lynx1.  
  
5-HT3A : 
Lynx1 
% Response 
Homomer # Cells 
- 28 ± 3 10 
1:2 24 ± 2 5 
5:1 30 ± 3 8 
50:1 29 ± 2 10 
500:1 26 ± 2 10 
 
Table A1.2 Effect of Lynx1 on a mixed population of 5-HT3A and 5-HT3AB receptors. 
In all conditions the ratio of A and B subunits is 100:1. The percent of normalized 5-HT 
response corresponding to each receptor type was calculated from the fit of the biphasic 
dose-response curve and the percentage corresponding to homomeric 5-HT3A receptors is 
reported here.  
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A1.4 METHODS  
A1.4.1 Mutagenesis and Preparation of cRNA and Oocytes  
Wild type 5-HT3A and 5-HT3B receptor subunits, within the complete coding 
sequence for the human 5-HT3A and 5-HT3B receptor subunit (accession numbers 
P46098-1; NP_006019), were cloned into pGEMhe. Mouse Lynx1 was cloned into 
pDH105 vector. Harvested stage V-VI Xenopus oocytes were washed in four changes of 
Ca2+-free OR2 buffer (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.5), 
de-folliculated in 1 mg/ml collagenase for approximately 1 h, washed again in four 
changes of Ca2+-free OR2, and transferred to ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM 
CaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.5) supplemented with 0.28 mg/ml pyruvate, 
0.05 mg/ml Gentamicin, and 0.12 mg/ml theophylline.  Oocytes were injected with 5-25 
ng mRNA produced by in vitro transcription using the mMESSAGE MACHINE kit 
(Ambion, Austin, Texas, USA) from cDNA subcloned into pGEMhe as previously 
described (27). All 5-HT3AB receptor experiment injections contained a 1:3 A:B subunit 
mole ratio. Electrophysiological measurements were performed after incubation for 24 - 
72 h post-injection at 18o C. 
A1.4.2 Characterization of receptors 
Agonist-induced currents were recorded at 22-25o C from individual oocytes 
using the OpusXpress system (Molecular Devices Axon Instruments, Union City, CA). 
5-HT, and m-chlorophenylbiguanide (mCPBG) (Sigma) were stored as 25 mM aliquots at 
-20o C, diluted in Ca2+-free ND96 buffer (96 mM NaCl, 2 mM KCl, 1 mM MgCl2,, 5 mM 
HEPES, pH 7.5), and delivered to cells via the automated perfusion system of the 
OpusXpress. Glass microelectrodes were backfilled with 3 M KCl and had a resistance of 
143 
~1 MΩ. The holding potential was -60 mV. Agonist doses in Ca2+-free ND96 were 
applied for 15 s followed by a 116 s wash with the running buffer. Dose-response data 
were obtained for ≥ 8 agonist concentrations on ≥ 8 cells. To determine EC50 values, 
concentration-response data were fitted to the four-parameter logistic equation 
I = Imax/[1 + (EC50/[A])nH], where Imax is the maximal response plateau, [A] is the log 
concentration of agonist, and nH is the Hill coefficient, using KaleidaGraph v3.6 
software (Synergy Software, Reading, PA). A detailed error analysis of nonsense 
suppression experiments shows that data are reproducible to ±50% in EC50 (28). Efficacy 
was calculated for individual cells and then averaged and reported as mean ± S.E.M.  
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